Thioredoxin family proteins in physiology and disease by Hanschmann, Eva-Maria & Lillig, Christopher Horst (Dr.)

Vom Fachbereich Medizin der Philipps-Universität Marburg als Dissertation
angenommen am: 02.09.2011
Gedruckt mit Genehmigung des Fachbereichs:
Dekan: Prof. Dr. med. Matthias Rothmund
Referent: PD Dr. rer. nat. Christopher Horst Lillig
Korreferent: Prof. Dr. med. Joachim Hoyer
Department of Clinical Cytobiology and Cytopathology, Prof. Dr. Roland Lill, 
Medical Faculty of the Philipps-Universität Marburg
______________________________________________________________________
Thioredoxin family proteins in 
physiology and disease
Eva-Maria Hanschmann
Marburg, 2011
Numerous cellular  processes are controlled by redox regulation via posttranslational 
modifications at thiol (SH) groups, i.e. for instance the formation of disulfide bonds 
(S-S), glutathionylation (S-SG) and nitrosylation (S-NO). Redox signaling is mediated 
by reactive oxygen species (ROS) and reactive nitrogen species (RNS) and members of 
the thioredoxin family of proteins.  Exemplary human Trx1 is  depicted in the cover 
picture.  Redox  signaling  is  essential  for  regulating  the  fate  of  a  cell.  Hence, 
disregulation of redox control has  been implicated in various diseases leading e.g. to 
enhanced proliferation in cancer or to apoptosis in degenerative disorders. 
The cover picture depicts a healthy cell to the left and a cell undergoing apoptosis to the 
right, characterised by condensation of DNA, membrane blebbing and phagocytosis of 
damaged organelles. 
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special issue on redox control of cell function, Biochimica et Biophysica Acta, (2008), 
1780(11).
To my family, 
especially to my grandfather Prof. Dr. Rolf Hanschmann
Summary
Proteins  of the thioredoxin (Trx)  family are ubiquitously expressed oxidoreductases. 
They  use  cysteinyl  residues  within  their  active  site  to  modify  substrate  proteins 
posttranslationally by reduction/oxidation reactions or de-/glutathionylation. They play 
a crucial role in regulating cellular functions such as proliferation, differentiation and 
apoptosis. This thesis entitled “Thioredoxin family proteins in physiology and disease” 
focusses on these proteins, i.e. the Trx systems, the glutaredoxin (Grx) systems and the 
peroxiredoxins (Prxs). Because descriptions of cellular functions of redoxins are rare, 
we aimed at identifying new interaction partners and functions under physiological and 
hypoxic conditions in various cell culture and animal models.  
We described the mitochondrial Grx2 as novel electron donor for Prx3, using a 2-Cys 
Prx-specific redox blot.  Silencing the expression of Trx2, before this thesis the only 
known electron donor, or Grx2 in HeLa cells did not increase the level of oxidised Prx3, 
but simultaneous silencing did. Prx3 distribution in mouse tissues, was linked to the 
expression of either Trx2 or Grx2, depending on the cell type. 
Knock-down of Trx1 and Grx2 affected iron regulation in HeLa cells. Especially Grx3 
depletion  resulted  in  strong  defects  in  iron  homeostasis,  impairing  cytosolic  and 
mitochondrial  heme-  and  iron-sulfur  cluster  containing  proteins  in  HeLa  cells and 
hemoglobin maturation in zebrafish. 
Trx family proteins showed a tissue- and cell type-specific expression and distribution 
in the rat CNS and responded tissue- and cell type-specific to oxygen deprivation in 
numerous cell lines and models for perinatal asphyxia, renal ischemia/reperfusion (I/R) 
injury and transplantation of pancreatic β-cells.  
Perinatal asphyxia in rat pups led to an immediate increase in the expression of Grx2, 
Trx1 and Trx2 four hours after induction of hypoxia. No significant longterm changes 
after 7 days were determined.
Renal I/R injury led to segment-specific alterations in the distribution and expression of 
Trx  family  proteins  in  the  ischemic  kidney,  but  also  to  systemic  effects  in  the 
contralateral kidney. In proximal tubule cells, which can regenerate after an I/R insult, 
levels of Grx2, Prx3 and Prx6 were upregulated. Overexpression of these proteins in 
HEK293 cells had a positive impact on cell proliferation and survival under hypoxic 
conditions.       
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The protein levels of many cytosolic members of the Trx family were decreased, while 
the  levels  of  mitochondrial  proteins  were  increased  in  mouse  models  of  pancreatic 
β-cell  transplantation.  Trx1  was  secreted  during  hypoxia  and  reduced  macrophage 
migration, potentially preventing the initiation of the immune response. Overexpression 
of  Trx1  and  Trx2  enhanced  cell  proliferation  and  survival  following 
hypoxia/reoxygenation,  by affecting the phosphorylation pattern of the MAP kinases 
ERK, JNK and p38. 
This  thesis  emphasizes  the  concept  of  compartmentalised  redox  signaling  and 
demonstrates not only the complexity of the Trx family proteins, but the species-, tissue- 
and cell type-specific responses to oxygen deprivation and the distinct contribution of 
the redoxins to controling the fate of a cell.
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Zusammenfassung
Proteine der Thioredoxin (Trx) Familie sind ubiquitär exprimierte Oxidoreduktasen, die 
Cysteine innerhalb ihres aktiven Zentrums dazu nutzen, Proteine posttranslational durch 
Reduktions-Oxidations  Reaktionen  oder  De-/Glutathionylierung  zu  modifizieren.  Sie 
regulieren  Prozesse  wie  Proliferation,  Differenzierung  und  Apoptose.  Diese 
Doktorarbeit  mit  dem Titel  “Thioredoxin family proteins in physiology and disease” 
konzentriert  sich auf  die  Trx Systeme,  die  Glutaredoxin (Grx)  Systeme und auf  die 
Peroxiredoxine (Prx). Da nur wenige zelluläre Funktionen dieser Proteine bekannt sind, 
galt  es  neue  Interaktionspartner  sowie  Funktionen  unter  physiologischen  und 
hypoxischen Bedingungen in verschiedenen Zell- und Tiermodellen aufzudecken. 
Mittels eines 2-Cys Prx-spezifischen Redoxblots wurde das mitochondrielle Grx2 als 
Elektronendonor für Prx3 identifiziert. Die Verringerung der Proteinlevel von Trx2, dem 
vor dieser Studie einzigen bekannten Elektronendonor, oder Grx2 erhöhte die Menge an 
oxidiertem  Prx3  nicht;  jedoch  die  simultane  Verringerung  beider  Redoxine.  Die 
Verteilung  von  Prx3  in  Geweben  der  Maus  korrelierte,  je  nach  Zelltyp,  mit  der 
Expression von Trx2 oder Grx2.               
Die Reduktion der  Trx1 und Grx2 Proteinmenge störte  die  Eisenregulation in HeLa 
Zellen.  Die  Verminderung  des  Grx3  Levels  beeinträchtigte  die  Eisenhomöostase 
besonders,  d.h.  führte  zu  einer  Reduktion  der  Aktivitäten  von  zytosolischen  und 
mitochondriellen Häm- und Eisen-Schwefel Proteinen in HeLa Zellen, sowie zu einer 
verminderten Hämoglobin Produktion im Zebrafisch.
Proteine  der  Trx  Familie  zeigten  eine  gewebs-  und  zell-spezifische  Expression  und 
Verteilung  im Zentralen  Nervensystem  der  Ratte,  sowie  eine  gewebs-  und  zell-
spezifische Antwort auf Sauerstoffmangel in verschiedenen Zelllinien und Tiermodellen 
für  perinatale  Asphyxie,  renale  Ischämie/Reperfusion  (I/R)  und  Betazell-
Transplantation.                    
Perinatale Asphyxie in Rattenjungen führte zu einer direkten Erhöhung der Proteinlevel 
von Grx2, Trx1 und Trx2, vier Stunden nach Induktion der Hypoxie. Es konnten keine 
signifikanten Langzeitveränderungen nach sieben Tagen nachgewiesen werden.  
Renale  I/R  führte  zu  segment-spezifischen  Veränderungen  in  der  Verteilung  und 
Expression der Redoxine in der ischämischen und aufgrund systemischer Effekte in der 
kontralateralen  Niere.  In  proximalen Tubuluszellen,  die  sich nach einem I/R Vorfall 
regenerieren können, wurden Grx2, Prx3 und Prx6 hochreguliert. Überexpression dieser 
III
Redoxine in HEK293 Zellen führte zu einer erhöhten Proliferations- und Überlebensrate 
unter hypoxischen Bedingungen.  
In Modellen für die Transplantation von  β-Zellen des Pankreas wurden zytosolische 
Redoxine  herunterreguliert  und  mitochondrielle  Proteine  hochreguliert.  Trx1  wurde 
nach  Hypoxie  extrazellulär  detektiert,  wo  es  die  Migration  von  Makrophagen 
verlangsamte und somit die Einleitung der Immunantwort zu unterdrücken scheint. Die 
Überexpression von Trx1 und Trx2 erhöhte die Zellproliferations- und Überlebensrate 
nach Hypoxie/Reoxygenierung, durch Veränderungen der Phosphorylierungen der MAP 
Kinasen ERK, JNK und p38. 
Diese Arbeit  unterstreicht  das  Konzept  des  kompartimentalisierten Redox-Signalings 
und zeigt nicht nur die Komplexität  der Trx Familie,  sondern spezies-, gewebs- und 
zell-spezifische  Antworten  auf  Hypoxie  und  den  unterschiedlichen  Beitrag  der 
Redoxine an der Kontrolle über das Zellschicksal.
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1. Introduction
In all kingdoms of life cellular processes are redox controlled. Lipids, nucleic acids and 
proteins  can  be  redox  modified,  but  only  the  latter  are  regulated  by  reversible 
modifications  at  thiol  groups  (Schafer  and  Buettner,  2001). The  thioredoxin  (Trx) 
family proteins constitute key players in maintaining cellular redox homeostasis and 
redox signaling  (Nordberg and Arnér, 2001),  (Lillig et al.  2008). Cell organelles are 
equipped  with  distinct  sets  of  these  proteins,  or  reductants  in  general,  and  exhibit 
several  sources  of  oxidants,  leading  to  compartmentalised  redox  signaling 
(Jones,  2010) and a broad,  but  specific  range of  substrates  and functions for  redox 
regulation.  Disregulation  of  redox  signaling  and an  increased  formation  of  reactive 
oxygen  species  (ROS)  and  reactive  nitrogen  species  (RNS)  are  correlated  with 
numerous  pathologies,  including  cancer,  cardiovascular-  and  degenerative  disorders 
(Lillig and Holmgren, 2007). 
1.1 Redox regulation of proteins
Protein activity, structure, subcellular distribution and interactions with substrates are 
controlled  by  posttranslational  modifications.  These  modifications  include 
phosphorylation, acetylation, glycosylation, methylation and ubiquitylation (reviewed 
in  Walsh et al. 2005). In addition, oxidative modifications display alterations at redox 
reactive  amino  acids.  Here,  cysteine  (Cys)  constitutes  the  main  target,  but  also 
methionine and selenocysteine can undergo redox reactions. Cys is a polar amino acid, 
commonly found on the surface of proteins, containing a reactive thiol group. Adjacent 
to basic amino acids, thiol groups are extremely reactive at physiological pH, due to a 
lowering of the pKa from typically eight to between five and seven (Foster et al. 2009). 
The  human  genome  encodes  for  approximately  24000  proteins,  comprising  about 
214000 cysteine residues (Jones, 2010). Miseta and Csutora stated that the Cys content 
and the general number of proteins containing at least one Cys increased along with 
animal evolution, indicating a development of signaling and regulatory functions of this 
amino acid  (Miseta  and Csutora,  2000),  (Fomenko et  al.  2008).  Cys  is  particularly 
important for stabilizing the structure of proteins or crosslinking different proteins via 
the oxidation of two Cys residues to a cystine or a so called disulfide bridge. Single Cys 
residues can be modified by glutathionylation, the formation of a disulfide bond with a
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glutathione  (GSH) 
molecule. They can also be 
nitrosylated by nitric oxide 
(NO), sulfhydrated by H2S, 
can  form  thiolhemiacetals 
in the presence of aldehydes 
or  can  be  alcylated  by 
acetyl-CoA. Another feature 
of  the  amino  acid  is  the 
ability  to  coordinate  metal 
clusters, such as iron-sulfur 
(FeS)  clusters  (Jones, 
2008).  Sustained  oxidative 
conditions  can  lead  to 
irreversible  modifications 
i.e.  the  overoxidation  to 
sulfinic  or  sulfonic  acid, 
changing the activity and/or 
function  of  a  protein 
unalterably. Both, reversible 
and irreversible modifications of Cys residues are summarized in Figure 1.
1.1.1 Redox regulated cellular pathways
Basic requirements for signaling cascades are substrate specificity and rapid, reversible 
changes in protein activity following specific stimuli, leading to a distinct outcome in 
cellular function (Janssen-Heininger et al. 2008). Redox signaling fulfils these criteria. 
Disulfide  oxidoreductases  of  the  Trx  family  and  ROS,  such  as  hydrogen  peroxide 
(H2O2),  mediate  redox  regulation  of  proteins.  Cells  are  surrounded  by  a  plasma 
membrane,  which  separates  the  intracellular  reducing  space  from  the  extracellular 
oxidising  environment.  In  this  lipid  bilayer  different  kinds  of  polypeptides  are 
embedded  including  adhesion  proteins,  ion  channels  and  membrane  receptors, 
triggering  intracellular  signaling  cascades  in  response  to  environmental  factors. 
Membrane proteins are generally known to contain disulfides, which are stable in the 
extracellular  room.  However,  several  reports  show that  redox  regulation  of  protein 
Figure  1: Cysteine  can  be  posttranslationally  modified. The 
reactive  thiol  group  is  posttranslationally  modified  reversibly 
(green) and irreversibly (red): (1) formation of disulfide bridges, 
(2)  glutathionylation,  (3)  nitrosylation,  (4)  formation of  sulfenic 
acid and latter (5) sulfinic and sulfonic acid, (6) coordination of 
metals/  metal  clusters.  These  modifications  regulate  proteins  in 
terms of structure, intracellular distribution, protein interaction and 
activity and thereby affect a proteins function(s).
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function is not restricted to the intracellular space  (Moriarty-Craige and Jones, 2004). 
Glycerophosphodiester  phosphodiesterases  (GDE)  constitute  a  family  of 
transmembrane signaling proteins, which regulate differentiation processes in diverse 
cellular  contexts.  Yan  and  collegues  have  shown that  the  peroxidase  peroxiredoxin 
(Prx)  1  reduces  an  intermolecular  disulfide  of  GDE2,  thereby  controling  the 
differentiation of spinal motor neurons (Yan et al. 2009).             
A similar  regulatory  mechanism  was  found  in  the  family  of  multimeric  transient 
receptor  potential  (TRP) channels,  which transports  cations  including  Ca2+,  Na+ and 
Mg2+ ions across the membrane  (Venkatachalam and Montell, 2007). Several of these 
channels were shown to possess two conserved Cys residues. Xu et al. treated HEK293 
cells, expressing TRPC5-TRPC1 channels with the reductants dithiothreitol (DTT) and 
Tris(2-carboxyethyl)phosphine  (TCEP),  as  well  as  extracellular  with  reduced  Trx1, 
demonstrating  a  reduction  of  an  intramolecular  disulfide  between  the  conserved 
thiol groups and a subsequent activation of the ion channel (Xu et al. 2008). Hara et al. 
showed that the addition of oxidants such as H2O2 activated the LTRPC2 channel in 
HEK293 cells,  introducing the channel as a mediator of cell  death due to a cellular 
cation-overload  in  response  to  a  disregulated  redox  state  (Hara  et  al.  2002). 
Other  targets  of  hydrogen  peroxide  include  molecular  chaperones,  peptidases  and 
tyrosine phosphatases. Heat shock proteins (Hsp) are cellular  chaperones facilitating 
protein folding. Bacterial Hsp33 is a redox sensitive chaperone, which refolds proteins 
coping  with  severe  oxidising  conditions,  when  reduced  to  its  monomeric  form. 
Monomeric Hsp33 contains four Cys residues coordinating a zinc atom. Upon oxidising 
conditions,  the  zinc  is  lost  and  intramolecular  disulfides  are  formed,  initiating 
chaperone  activity  (Jakob  et  al.  1999).  The  induction  of  an  immediate  heat  shock 
response is essential for cell survival. Besides disulfide formation, several chaperones 
have been shown to be regulated by reversible glutathionylation, reviewed in Berndt et 
al. 2008 or nitrosylation (Martínez-Ruiz et al. 2005). The oxidoreductase glutaredoxin 
(Grx)  1  was  shown  to  reduce  glutathionylated  human  Hsp70,  attenuating  protein 
activity (Hoppe et al. 2004).                                                                   
Cys-dependent  aspartate-directed  proteases  (Caspases)  catalyse  the  degradation  of 
proteins by hydrolysis of peptide bonds at specific amino acids. They possess a Cys 
residue  within  their  conserved  Gln-Ala-Cys-X-Gly  active  site  motif.  Reduction  or 
rather  de-nitrosylation leads  to  activation  of  the protease,  following a  pro-apoptotic 
stimulus. It was shown that H2O2 exhibits caspase activation at low concentrations, but 
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induces  necrosis  at  higher  levels  (Saito  et  al.  2006).  Furthermore,  there  are  studies 
showing regulatory mechanisms of Trx family proteins. Mitchell et al. revealed an anti-
apoptotic effect of Trx1 in Jurkat cells, due to S-nitrosylation of pro-caspase-3 (Mitchell 
et  al.  2007).  Pan  and  Berk  demonstrated  that  S-glutathionylation  renders  caspases 
inactive.  Grx1  catalyses  the  de-glutathionylation  of  caspase-3  functioning  in  tumor 
necrosis factor α (TNFα)-induced apoptosis (Pan and Berk, 2007).  
Tyrosine phosphatases, enzymes which catalyse the de-phosphorylation of proteins on 
tyrosine residues, are regulated in a similar way. Oxidation of a redox active Cys in 
their active site renders them inactive, leading to an increase in phosphorylated target 
proteins. It is well documented that growth factors such as the epidermal growth factor 
lead  to  intracellular  production  of  H2O2 followed by the  oxidation  of  the  cysteinyl 
residue (Lee et al. 1998), (Xu et al. 2002). The antagonists of phosphatases are kinases, 
which catalyse the phosphorylation of target proteins. Mitogen-activated protein (MAP) 
kinases, including apoptosis signal regulating kinase 1 (Ask1), extracellularly regulated 
kinase (ERK), c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase 
(reviewed  in  Matsuzawa  and  Ichijo,  2008) are  key  players  in  signaling  cascades 
regulating cell proliferation, differentiation and apoptosis. These proteins are not only 
regulated  by de-phosphorylation,  but  also  by redox modifications  at  conserved Cys 
residues. Ask1 is a known substrate of Trx1. Strictly speaking it is not redox regulated, 
but it  is kept in an inactive state by reduced Trx1. Upon oxidising conditions, Trx1 
becomes oxidised, releasing Ask1, which in turn induces apoptosis (Saitoh et al. 1998). 
Ivarsson et al. studied redox regulation of exocytosis in rat pancreatic β-cells. Treatment 
with glucose leads to secretion of insulin and at the same time increases the NADPH/ 
NADP+ ratio. Direct addition of NADPH leads to exocytosis of insulin granules itself. 
Mediators of this effect seem to be the NADPH-dependent oxidoreductases Grx and Trx 
(Ivarsson et  al.  2005).  Many transcription  factors  have  been  described  to  be  redox 
regulated via Cys residues at their DNA-binding domain, for instance nuclear factor-κB 
(NFκB) and activator protein-1 (AP-1), which are involved in the response to various 
stimuli including alterations of the redox state (Sen and Packer, 1996). NFκB, which is 
important  for  cell  adhesion,  growth  control,  immune  modulation  and  inflammatory 
response (reviewed in  Luqman and Pezzuto,  2010) has a critical  Cys which can be 
reduced by nuclear Trx1, inducing transcription  (Hayashi et al. 1993). Cytosolic Trx1 
seems to have the opposite effect, by promoting the binding of the inhibitor protein IκB 
to NFκB (Hirota et al. 1999). 
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The gene encoding heme oxygenase-1 (HO-1) e.g. contains NFκB regulatory elements 
in the promotor region (Naidu et al. 2008). HO-1 is a protein catalysing the degradation 
of heme. Iron is essential for the cell  and is needed for the synthesis of heme, FeS 
proteins and as cofactor. However, iron homeostasis has to be tightly controlled to avoid 
iron deficiency or iron overload.  Cellular iron levels  are controlled by the two iron 
regulatory  proteins  IRP1  and  IRP2,  which  bind  to  cis-regulatory  iron  responsive 
elements  (IRE)  on  the 
mRNAs of the iron import 
transferrin  receptor  (TfR), 
the  iron  storage  protein 
ferritin and the iron export 
protein  ferroportin 
(Muckenthaler et al. 2008), 
(Wallander  et  al.  2006). 
IRP1  is  an  iron-sulfur 
protein.  Upon  iron 
deficiency  it  loses  the 
cluster,  binds  to  IREs 
where  it  for  instance 
stabilizes the mRNA of the 
TfR  and  represses  the 
translation  of  ferritin. 
Similarly,  the  cytosolic 
monothiol  Grx3  and  Grx4 
in yeast form a FeS-bridged 
complex,  which  was  also 
shown to act as iron sensor. 
Depletion  of  Grx3  and 
Grx4 in yeast cells, leads to 
impaired  intra-
compartimental  trafficking 
of  iron  and  the  disturbed 
synthesis of heme- and FeS 
cluster-containing  proteins 
Figure  2:  Reversible  posttranslational  modifications  regulate  
protein  function. Caspases,  channel  proteins,  chaperones  and 
phosphatases  can  be  regulated  via  intra-  and  intermolecular 
disulfides,  de-/glutathionylation  and  de-/nitrosylation.  Hsp33 
coordinates a zinc atom in its inactive form, which is lost for protein 
activation.  The  kinase Ask1 is  kept  in  an  inactive complex  with 
Trx1. Upon oxidation it gets released and becomes activated (red = 
inactive, green = active).
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(Mühlenhoff et al. 2010). Yeast mutants lacking the mitochondrial monothiol Grx5 are 
characterized  by  the  accumulation  of  iron  and  inactivated  FeS  cluster  containing 
proteins (Kim et al. 2010). 
1.2 Thioredoxin family proteins in 
mammals
The  Trx  family  comprises  Trx  -  the  founding  member  of  this  protein  family  - 
glutaredoxins,  peroxiredoxins,  protein  disulfide  isomerases  (PDI),  glutathione-
peroxidases (GPx), glutathione-S-transferases (GST) and chloride channels. All these 
proteins share a common structural motif, the Trx fold, consisting of a central core of 
four-stranded  β-sheets  surrounded  by three  α-helices, and  the  conserved  active  site 
Cys-X-X-Cys (Martin, 1995). In the following, the mammalian proteins analysed in this 
study, i.e. Trxs, Grxs and Prxs and related proteins, will be introduced and discussed in 
terms of structure, intracellular localisation (summarized in  Figure 7), substrates and 
functions. 
1.2.1 Thioredoxin system
The mammalian Trx system consists  of Trx,  the selenoprotein thioredoxin reductase 
(TrxR) and NADPH (Figure 3). It exerts a variety of functions due to a broad substrate 
specificity  of  Trx  and  TrxR  itself.  The  Trx  system is  essential  for  DNA synthesis 
(Laurent et al. 1964), proliferation, protection against apoptosis (Powis et al. 1998) and 
regulation of transcription (Abate et al. 1990), (Matthews et al. 1992). It is an essential 
antioxidative  system, 
regulating  the  redox 
state  of  proteins  and 
modulating  signaling 
cascades  and  the 
immune  response,  by 
reducing substrates via 
the  dithiol  mechanism 
(Holmgren, 1985). The 
N-terminal active site Cys of Trx is characterized by a low pKa value, which allows it 
to initiate a nucleophilic attack at a target dithiol. A covalently bound mixed dithiol is 
Figure 3: Electron flow of the thioredoxin system. NADPH reduces the 
selenoprotein TrxR, which in turn reduces Trx.
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generated, which is reduced by the C-terminal Cys yielding a reduced substrate and an 
oxidised  Trx.  The  protein  disulfide  in  the  active  site  of  Trx  is  reduced  by  TrxR, 
receiving  electrons  from NADPH  (Holmgren,  1995).  In  mammals  two Trx  systems 
exist, a cytosolic (Trx1, TrxR1) and a mitochondrial system (Trx2, TrxR2). Reduced 
Trx is inhibited by Txnip (thioredoxin interacting protein), which structurally is not part 
of the Trx family (Nishiyama et al. 1999). 
1.2.1.1 Thioredoxin reductase
Thioredoxin  reductase  is  a  NADPH-dependent  flavoenzyme  and  is  one  of 
25 selenoproteins in humans (Kryukov et al. 2003). The 55-60 kDa protein is a homo-
dimer in a head-to-tail conformation, with every subunit consisting of a flavin adenine 
dinucleotide (FAD) domain, a NADPH binding domain and an interface domain. TrxR 
contains two active sites.  The active site motif  Gly-Cys-Sec-Gly is found at  the N-
terminus; the active site motif  Cys-Val-Asn-Val-Gly-Cys at  the C-terminus, in close 
proximity to the FAD domain. TrxR is closely related to glutathione reductase (GR); 
both belong to a family of homo-dimeric pyridine nucleotide-disulfide oxidoreductases 
(Arnér, 2009). Even though these enzymes possess similar structures, TrxR contains the 
selenocysteine in a 16 amino acid extension, which is not present in GR  (Urig et al. 
2006),  (Zhong et al. 1998). Due to high accessibility and reactivity of selenocysteine, 
TrxR has a broad substrate specificity, with Trx being the main target. Other substrates 
include PDI (Lundström and Holmgren, 1990), glutaredoxin 2 (Johansson et al. 2004) 
and  dehydroascorbate  (May  et  al.  1997).  In  mammals,  there  are  three  thioredoxin 
reductases, the cytosolic TrxR1, the mitochondrial TrxR2 and the testis-specific TrxR3, 
which is mainly expressed in germ cells and will not be further discussed within this 
thesis. Different splice variants of TrxR have been described, giving rise to different 
proteins with distinct functions (Rundlöf et al. 2004), (Turanov et al. 2006). Knock-out 
of  either  TrxR1  or  TrxR2  in  mice  causes  embryonic  lethality.  TrxR1  expression  is 
evidently  essential  during  embryogenesis  in  most  tissues  except  for  the  heart 
(Jakupoglu et al. 2005), while TrxR2 is crucial in both hematopoiesis and heart function 
(Conrad et al. 2004).
1.2.1.2 Thioredoxin 
The 12 kDa Trx was discovered 1964 in  E. coli as electron donor for ribonucleotide 
reductase (RNR), the enzyme essential for DNA synthesis in all organisms (Laurent et 
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al.  1964),  (Moore  et  al.  1964),  and  was  recognized  as  general  cellular  disulfide 
reductase in 1979 (Holmgren, 1979). The oxidoreductase contains the active site motif 
Cys-Gly-Pro-Cys  (Holmgren,  1968),  which is  highly conserved throughout  different 
species from bacteria to human (Eklund et al. 1991). It is a primarily cytosolic protein, 
which can translocate into the nucleus upon various stimuli (Hirota et al. 1999) or can 
be secreted (Rubartelli et al. 1992). Mitochondrial Trx2 possesses the active site motif 
of Trx1, but lacks additional structural cysteines. Both proteins share 35 % sequence 
homology and similar catalytic properties  in vitro (Spyrou et al. 1997). Knock-out of 
either Trx1 or Trx2 in mice is lethal. Trx1 expression seems to be important for early 
differentiation  and  morphogenesis  of  the  embryo  (Matsui  et  al.  1996),  while  Trx2 
knock-out mice show an increased apoptosis  rate  coinciding with the maturation of 
mitochondria around day 12.5 (Nonn et al. 2003). As described above, Trx1, as well as 
Trx2, regulate  Ask1 and thereby the p38 and the JNK pathway  (Saitoh et al.  1998), 
(Saxena et al. 2010). Trx1 regulates the activity of various transcription factors which 
have Cys residues in their DNA binding domains, including for instance NFκB. Another 
group of substrates are the related Prxs, that constitute the major cellular peroxidases 
(Rhee et al. 1999), (Berggren et al. 2001). 
1.2.1.3 Txnip
Txnip, also known as TBP2 (thioredoxin binding protein 2) (Nishiyama et al. 1999) or 
VDUP1 (Vitamin D upregulating protein 1) (Schulze et al. 2002), was discovered in a 
yeast two-hybrid system as binding partner of Trx (Nishiyama et al. 1999), (Yamanaka 
et al.  2000). Structurally, Txnip is assigned to the arrestin superfamily of regulatory 
proteins, which is characterized by two wing-like arrestin domains forming a central 
core  that  binds  to  phosphates  on  activated  receptors.  The  interaction  between  the 
50  kDa Txnip  and Trx depends  on  a  disulfide  linkage  between reduced active  site 
cysteines of Trx (Nishiyama et al. 1999) and two Cys residues of the inhibitor protein 
(Patwari et al. 2006). These residues are not conserved in the arrestin family, giving 
Txnip a prominent and unique role. Txnip regulates the Trx1/Ask1-dependent apoptosis 
pathway (Chen et al. 2008). This interaction was recently also shown for mitochondrial 
Trx2  in  pancreatic  β-cells,  which  is  regulated  by  Txnip  shuttling  between  cytosol, 
nucleus and mitochondria (Saxena et al. 2010). The pro-apoptotic role was analysed by 
Minn  et al.,  showing that the overexpression of Txnip induces apoptosis through an 
increase in the Bax/Bcl-2 ratio, and caspase-3 expression (Minn et al. 2005). By binding 
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Trx and inhibiting its disulfide reductase activity, Txnip is involved in various cellular 
processes including cell proliferation and apoptosis. However, Patwari  and coworkers 
demonstrated that the function of Txnip is not necessarily connected to the binding of 
Trx. The overexpression of wildtype Txnip and a cysteine-serine mutant protein, which 
is not able to bind Trx, inhibited glucose uptake in mature adipocytes in equal measure 
(Patwari et al. 2009). Txnip has been shown to be dramatically induced by glucose, 
suppressed by insulin and strongly upregulated in diabetes  (Parikh et al. 2007). This 
function as regulator of glucose metabolism is underlined by the fatal  phenotype of 
Txnip  knock-out  mice,  which  have  fasting  hypoglycaemia  with  increased  glucose 
uptake in peripheral tissues (Chutkow et al. 2008), (Hui et al. 2004). In addition, these 
mice have an impaired lipid metabolism (Oka et al. 2006).
1.2.1.4 Nucleoredoxin
Nucleoredoxin (Nrx)  contains  two N-terminal  Trx-like  domains  with  the  active  site 
motif Trp-Cys-Pro-Pro-Cys and a C-terminal PDI-like Trx domain without any redox 
active Cys residues  (Funato and Miki,  2007). It is located in the cytosol and in the 
nucleus, even though no nuclear localisation sequence was found. Nrx was shown to 
bind to the dishevelled (Dvl) protein, suppressing the Wnt/β-catenin pathway, which is 
essential for embryonic development.  The active site motif of Nrx was shown to be 
essential for Nrx-Dvl interaction (Funato et al. 2006). A similar regulatory function was 
described for Toll-like receptor 4 signaling (Hayashi et al. 2010). Nrx knock-out mice 
are  characterised  by  skeletal  and  cardiovascular  defects.  Funato  et  al. showed  that 
Wnt signaling is increased in mouse Nrx-/- osteoblasts, confirming previous findings in 
cell culture and Xenopus laevis. However, they demonstrated decreased activity in Nrx-/- 
cardiocytes.  In this  study Nrx was introduced as a  novel stabilizing protein of Dvl, 
protecting  it  from  ubiquitination  and  thereby  retaining  a  pool  of  Dvl,  which  is 
responsive to Wnt signaling (Funato et al. 2010).
1.2.2 Peroxiredoxins
Cells  contain  three  types  of  peroxidases,  i.e.  Prxs,  catalases  and  glutathione 
peroxidases. Prxs are unique among these enzymes because they catalyse the reduction 
of  peroxides  using their  cysteine(s)-containing active site.  Prxs are  highly abundant 
proteins, which can account for up to 1 % of soluble cellular proteins (Chae et al. 1999), 
(Wood et al.  2003). Mammalian cells contain six Prxs, which are divided into three 
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groups, based on their structure and catalytic mechanism: 2-Cys Prxs (Prx1-4), atypical 
2-Cys Prxs (Prx5), 1-Cys Prx (Prx6) (Seo et al. 2000), (Rhee et al. 2001). 2-Cys Prxs 
contain conserved C- and N-terminal Cys residues and exist as homo-dimers and high 
oligomers, whereas atypical 2-Cys and 1-Cys Prxs only contain the N-terminal Cys and 
do not form dimers. During the reduction of peroxides, the N-terminal Cys of 2-Cys 
Prxs is oxidised to sulfenic acid which forms an intermolecular disulfide with the C-
terminal “resolving” Cys of another Prx subunit and an intra-molecular disulfide with a 
non conserved Cys at the C-terminus in the case of atypical 2-Cys Prxs. 2-Cys and 
atypical 2-Cys Prxs are substrates for the Trx system (Figure 4).
1-Cys  Prxs  lack  additional  cysteines  and  are  reduced  by GSH  (Rhee  et  al.  2001). 
Over-oxidised Prxs are reduced by sulfiredoxins (Woo et al. 2005). Prxs are 20-30 kDa 
proteins, varying in the subcellular localization  (Hofmann et al.  2002),  (Wood et al. 
2003).  In  addition  to  the  function  as  peroxidase,  alternative  functions  have  been 
proposed, including the role as molecular chaperones (Kumsta and Jakob, 2009), (Jang 
et al. 2004) and controling the levels of the cellular signaling molecule H2O2. Prx1 is 
mainly localized in the cytosol and in the nucleus. It was also found to be secreted 
(Chang et al.  2005). Prx1 knock-out mice are viable, but develop hemolytic anemia 
with  oxidative  damaged erythrocytes  and bone marrow cells  after  nine  months  and 
develop significantly more malignant tumors with age (Neumann et al. 2003). Prx2 is 
present in the cytosol and the nucleus. Prx2-deficient macrophages show an enhanced 
inflammatory response when stimulated with lipopolysaccharides (LPS)  (Yang et  al. 
Figure 4: Electron donors for peroxiredoxins. 2-Cys Prxs are reduced by the Trx system (upper panel), 
whereas 1-Cys Prxs are reduced by GSH (lower panel).
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2007). Knock-out mice are viable but develop a splenomegaly caused by congestion of 
the  red  pulp  with  hemosiderin  accumulation  and  show  morphologically  different 
erythrocytes (Lee et al. 2003). Functions of Prx2 in inflammation and the life cycle of 
erythrocytes have been proposed. Knock-out mice of the mitochondrial Prx3 develop 
normally but show a reduction in body weight. These mice are believed to have higher 
levels of intracellular ROS and were shown to be more susceptible to LPS-induced lung 
damage (Li et al. 2007). Prx4 is found in the cytosol and in the endoplasmic reticulum. 
It  contains  a  leader-peptide,  which  is  believed  to  be  essential  for  protein  secretion 
(Okado-Matsumoto et al. 2000). Mice lacking Prx4 were viable and fertile, but showed 
a size-reduction of male testicles due to an elevated apoptosis rate of spermatogenic 
cells  (Iuchi et al.  2009). Prx5 was found in cytosol,  mitochondria and peroxisomes. 
Overexpression of Prx5 prevents peroxide-induced mitochondrial DNA damage (Zhou 
et al. 2000). Cytosolic Prx6 is not essential in mice, but macrophages without detectable 
levels  of Prx6 were characterised by higher cellular  levels  of H2O2 and an elevated 
apoptosis rate (Wang et al. 2006).  
1.2.3 Glutaredoxin system
Grxs and Trxs share a lot of structural and functional features. However, Grxs are more 
versatile. They do not only catalyse the reduction of disulfides, but also the protein de-/ 
glutathionylation. Grxs display unique features in their Trx-folded structures: a GSH 
binding  site  (Bushweller  et  al.  1994) and  a  hydrophobic  surface  area  for  substrate 
interaction (Xia et al. 1992). As depicted in Figure 5, GSH constitutes the main electron 
Figure 5: Electron flow of the glutaredoxin system. Grx is reduced by GSH, which is reduced by GR 
receiving electrons from NADPH. In the case of Grx2, TrxR can act as alternative electron donor.
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donor for the oxidoreductase Grx, which in turn is reduced by glutathione reductase 
and NADPH  (Meister and Tate, 1976). In addition, Grx2 can receive electrons from 
TrxR (Johansson et al. 2004). 
Grxs contain the active site 
motif  Cys-X-X-Cys,  using 
both  thiol  groups  for  the 
catalysis  of  disulfides  via 
the dithiol  mechanism and 
only the  N-terminal  active 
site  thiol  for the reduction 
of  glutathione-mixed 
disulfides and the catalysis 
of  de-/glutathionylation  of 
proteins  via  the  monothiol 
mechanism  (Lillig  et  al. 
2008), (Yoshitake  et  al. 
1994), (Yang  and  Wells, 
1991). Besides  the  so 
called  dithiol  Grxs,  Grxs 
with  the  active  site  motif 
Cys-X-X-X were classified 
as monothiol Grxs, which so far have not been shown to be catalytically active, but 
function in iron homeostasis and in the biosynthesis of FeS proteins (Herrero and de la 
Torre-Ruiz, 2007). So far, four Grxs have been discovered in mammals: Grx1, Grx2, 
Grx3 (also known as protein interacting cousin of Trx – PICOT)  and Grx5.
1.2.3.1 Glutathione
GSH is a tripeptide which is synthesized in the cytosol in two ATP-dependent reactions. 
Glutamate and cysteine are linked in the rate-limiting step by the enzyme glutamate 
cysteine synthetase (γGCS), which consists of a catalytic and a modulatory subunit. 
Mice lacking the catalytic subunit are embryonically lethal (Dalton et al. 2000). Glycine 
is  attached to  γ-glutamyl  cysteine  by the  γ-glutamyltranspeptidase.  85-90 % of  the 
synthesized GSH build the cytosolic GSH pool, the other 10-15 % are transported into 
distinct organelles, including mitochondria, where they build different, separated redox 
Figure  6: Reaction mechanisms.  The dithiol mechanism, depends 
on both active site cysteines. The N-terminal Cys forms a protein-
mixed disulfide (1),  which is reduced by the C-terminal Cys (2). 
Grx is reduced by GSH (3,4). The monothiol mechanism depends 
on  the  N-terminal  Cys,  forming  a  Grx-GSH-mixed  disulfide  (5), 
which is reduced by GSH (4) (Berndt et al. 2007).
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environments  (Griffith and Meister, 1985). GSH exists in a reduced and an oxidised 
state (GSSG), with GSSG being reduced by GR. It constitutes the major cellular thiol 
compound with intracellular concentrations in the millimolar range. GSH and GSSG act 
as buffer for the intracellular redox state of proteins. GSH scavenges free radicals either 
directly or as cofactor for GSTs, GPxs or as electron donor for the reduction of Grx, 
ascorbic acid and vitamin E (reviewed in  Forman et al. 2009). It is used to detoxify 
xenobiotics  and  protects  important  thiols  in  proteins  from  oxidation  by 
glutathionylation  (Fratelli et al. 2004), which above that regulates protein function in 
processes including proliferation, differentiation and metabolism (Lind et al. 2002). 
1.2.3.2 Glutathione reductase
Glutathione  reductase  is  a  102  kDa  enzyme,  belonging  to  the  pyridine  nucleotide 
disulfide  oxidoreductase  family.  Like  TrxR,  GR  is  a  homo-dimer  in  a  head-to-tail 
conformation,  with  every subunit  consisting  of  a  FAD domain,  a  NADPH binding 
domain  and  an  interface  domain  (Karplus  and  Schulz,  1987).  The  flavoenzyme 
catalyses  the  reduction  of  GSSG  to  GSH  using  the  N-terminal  active  site  motif 
Cys-Val-Asn-Val-Gly-Cys and is highly conserved in all kingdoms of life. However, 
there are species that do not depend on the enzyme for maintaining the GSH redox 
state. For instance, in Drosophila melanogaster Trx reduces GSH (Kanzok et al. 2001). 
NADPH donates two electrons to the FAD domain, which are transferred to the active 
site at the FAD binding domain. These electrons are transferred to GSSG reducing it to 
two molecules of GSH. GR is located in the cytosol and mitochondria (Taniguchi et al. 
1986), reducing different pools of GSH.
1.2.3.3 Glutaredoxin
The dithiol 12 kDa Grx1 is mainly localized in the cytosol, but can be translocated into 
the nucleus or exported from the cell (Björnstedt et al. 1994). Grx1 has the active site 
motif Cys-Pro-Tyr-Cys. The oxidoreductase regulates the activity of various proteins, 
including RNR (Holmgren, 1976), Ask1  (Murata et al. 2003) and NFκB (Daily et al. 
2001). Mice  lacking  Grx1 are  vital,  although no  compensatory de-glutathionylation 
activity could be detected (Ho et al. 2007). The dithiol Grx2 is located in mitochondria, 
but  different  cancer/testis-specific  isoforms,  restricted  to  the  cytosol  have  been 
described in mouse and human (Hudemann et al. 2009), (Lönn et al. 2008). Grx2 has a 
molecular mass of 14 kDa and shares 34 % sequence homology with Grx1. The single 
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amino acid change within the active site motif Cys-Ser-Tyr-Cys enables the protein to 
receive electrons from TrxR (Johansson et al. 2004) and is essential for coordination of 
a  [2Fe2S]  cluster  (Berndt  et  al.  2007),  (Lillig  et  al.  2005).  Grx2  is  involved  in 
mitochondrial redox regulation and antioxidant defence, reducing disulfides and GSH-
mixed  disulfides.  It  was  furthermore  shown  to  catalyse  reversible  oxidation  and 
glutathionylation of membrane proteins (Beer et al. 2004). Grx2 stimulates proliferation 
and protects cells against apoptosis  (Enoksson et  al.  2005),  (Lillig et  al.  2004).  The 
monothiol Grx3 is a multi-domain protein, containing one C-terminal Trx domain with 
the active site Ala-Pro-Gln-Cys and two N-terminal monothiol domains with the active 
site Cys-Gly-Phe-Ser. Grx3 is found in the cytosol, nucleus and extracellular. It was 
identified in a yeast-two hybrid screen as a potential binding partner of protein kinase 
C-θ.  The  overexpression  of  Grx3  leads  to  attenuated  activation  of  JNK  and  the 
transcription  factor  NFκB  (Witte  et  al.  2000). In  addition,  Grx3  affects  immune 
signaling  (Kato  et  al.  2008),  (Babichev  and  Isakov,  2001),  protects  against  cardiac 
hypertrophy  (Jeong et  al.  2006),  (Jeong et  al.  2008),  (Cha et  al.  2008) and was the 
second  mammalian  glutaredoxin  identified  as  FeS  protein  (Haunhorst  et  al.  2010). 
Knock-out of Grx3 in mice is embryonically lethal between days 12.5 and 14, with 
embryos not showing any defects in organogenesis  (Cha et al. 2008).  The monothiol 
Grx5 shares the active site motif of Grx3 and has a mitochondrial translocation signal. 
Grx5 is located in mitochondria and so far, no disulfide reductase activity was observed. 
Up to now, there are no reports on knock-out mice, but loss of Grx5 in zebrafish leads 
to the so called “shiraz” phenotype which is characterised by hypochromic anemia due 
to  a  disruption in  iron homeostasis  (Wingert  et  al.  2005). A similar  phenotype was 
observed in a patient with reduced Grx5 levels (Camaschella et al. 2007).      
Figure  7 illustrates  the  compartmentalisation  of  a  cell  into  nucleus,  cytosol, 
mitochondrium and peroxisome, as well as the thioredoxin family proteins and related 
proteins described above. Each protein is depicted, showing the individual Grx- and/or 
Trx-domain(s) as well as the cysteine-containing active site motif(s). The localisation, 
as well as the electron flow, of the Trx system (NADPH, TrxR, Trx, Txnip and Nrx), the 
Grx system (NADPH, GR, GSH, Grx and  γGCS) and the peroxiredoxins is  shown. 
The discovered translocation and secretion of particular proteins is also included.
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1.3 Hypoxia-related disorders
The term hypoxia describes  a  condition of  insufficient  oxygen supply,  either  to  the 
whole  body  or  to  single  organs  or  tissues.  This  condition  has  been  implicated  in 
different disorders. However, O2 concentrations are essential in regulating embryonic 
development as well, i.e. some cell types proliferate at low O2 concentrations, whereas 
higher oxygen levels promote cell differentiation  (Covello et al. 2006),  (Studer et al. 
2000). The same is valid for placental development (Adelman et al. 2000). Pathologies 
triggered by a hypoxic insult usually result from a blockage or reduction in blood flow 
leading  not  only  to  the  absence  of  oxygen,  but  also  ATP and  other  substrates  and 
nutrients. Reasons can be a cerebral stroke or a heart attack, but it can also occur during 
organ transplantation. Most of the tissue and cellular damage occurs when the oxygen 
returns to the affected tissue. This reoxygenation phase leads to molecular and cellular 
alterations  such  as  morphological  changes,  loss  of  cell  polarity,  elevated  release  of 
neurotransmitters  in  the  brain,  defective  osmoregulation  and  inhibition  of  protein 
synthesis (Johnston et al. 2001). Many cancer cell lines have been shown to grow under 
Figure 7: Trx family proteins in different cellular compartments. Trxs are depicted in green, Prxs in 
blue, Grxs in red. Protein domains and active site motifs of every protein are indicated. C=cytosol, 
M=mitochondrium, N=nucleus, P=peroxisome, S=subcellular space (adapted from Godoy et al. 2011a).
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low oxygen levels,  with  tumor hypoxia  being  a  criterium for  aggressiveness  of  the 
disease  and  resistance  to  radiation  therapy  (Harris,  2002).  Physiological  and 
pathological processes are generally dependent on the hypoxia-inducible factors (HIF) 
1 and 2, transcription factors regulating the expression of at least 180 genes. Targets 
include erythropoietin, increasing the production of erythrocytes, vascular endothelial 
growth  factor,  elevating  vascularization  of  affected  tissues,  as  well  as  metabolic 
proteins (Adelman et al. 1999), (Semenza, 2000).
1.3.1 Perinatal asphyxia
Perinatal  asphyxia is  a condition where a newborn suffers from oxygen deprivation 
caused for instance by a drop in maternal blood pressure, placental abruption, umbilical 
cord compression during child birth or the inability to breath after birth. Worldwide, 
perinatal asphyxia constitutes with 920,000 neonatal deaths annually a major cause of 
death. It is furthermore associated with 1.1 million intrapartum stillbirths (Lawn et al. 
2005). 25 % of the surviving infants suffer from permanent neurological deficits such as 
spasticity, epilepsy, mental retardation and vision and hearing impairments, as well as 
learning  deficits  (Vannucci  and  Perlman,  1997),  (Gunn,  2000),  (Shankaran,  2009). 
So far, no effective therapeutic approaches to prevent or treat the damage caused by the 
hypoxia/ischemia insult are available. However, since the first report in 1964 by Miller 
and coworkers, many publications have described hypothermia as an effective treatment 
for hypoxia-induced damages to the brain  (Miller et al.  1964),  (Capani et al.  2003), 
(Webster  et  al.  2009).  Golgi  type  I  neurons  in  cerebral  cortex,  hippocampus, 
neostriatum and cerebellum (Capani et al. 2009), (Kirino et al. 1992) are most affected. 
The mechanisms leading to neuronal cell death have up to now, not been understood. 
However, many immediate as well as long term alterations have been described such as 
overrelease of excitatory amino acids, overactivation of glutamate receptors placed on 
the post-synaptic density (Choi et al. 1989), (Choi et al. 1995) NO and ROS (Capani et 
al. 1997), (Capani et al. 2001) and reactive astrogliosis, high immunoreactivity of high 
weight neurofilaments  (Saraceno et al. 2010) and increased levels of ubi-proteins and 
free ubiquitin at the postsynaptic density in the neostriatum (Capani et al. 2009).
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1.3.2 Renal ischemia/reperfusion injury
Renal ischemia/reperfusion (I/R) injury constitutes a major clinical problem, for which 
no treatment is available yet. It is the leading cause of acute renal failure and may lead 
to the development of chronic kidney diseases (Weight et al. 1996), (Sutton et al. 2002). 
It is caused by a temporary blockage or decrease in the blood supply of the kidney, 
caused by a functional constriction of blood vessels or after an organ transplantation. 
The ischemic period is followed by the restoration of the blood flow, the reperfusion, 
which itself leads to additional cellular damage (Mejía-Vilet et al. 2007). Tubular cells 
are most susceptible to an ischemic insult and undergo necrosis and apoptosis due to 
complex molecular and structural alterations. During the reperfusion period a strong 
immune  response  is  initiated.  Various  cytokines,  as  well  as  endothelial  adhesion 
molecules are upregulated. ROS, produced by activated leukocytes and NO, produced 
by inducible nitric oxide synthetase, harm different cellular structures and molecules, 
leading to a dismorphic cell shape and loss of cell polarity. In addition, activation of 
mitogen-activated protein kinases, leads to increased cell death (Hutchens et al. 2008). 
Trx1 was analysed in a mouse model for renal I/R injury. Kasuno et al. demonstrated 
that  the  expression  of  Trx1  was  increased  in  the  medullary  thick  ascending  limbs 
(mTALs) after an ischemic insult, while the protein was secreted from cortical proximal 
tubuli into the urine. Moreover, Trx1 overexpressing mice were less susceptible to the 
I/R injury of the kidney, especially to the mTALs (Kasuno et al. 2003).
1.3.3 Transplantation of pancreatic β-cells – 
therapeutic approach for diabetes mellitus 
Diabetes mellitus is a chronic disease, which constitutes an emerging health problem 
with 220 million cases worldwide according to the WHO in 2010. Type I diabetes is an 
autoimmune  disease.  The  immune  system  attacks  the  β-cells  of  the  pancreas  that 
synthesize and release insulin into the portal vein. Consequently, not enough insulin is 
produced, a hormone needed for the regulation and cellular uptake of glucose, as well 
as glucose storage as glycogen. Type II diabetes results from insulin resistance, i.e. the 
insulin is not efficiently used and due to constant glucose overflow pancreatic  β-cells 
will gradually die from metabolic stress (Liu et al. 2000). Symptoms of the disease are 
glycaemia,  polyuria,  polydipsia,  constant  hunger,  weight  loss,  vision  changes  and 
fatigue. Long-term effects include damage of heart, kidneys, eyes, blood vessels and 
neurons, e.g. 50 % of patients die of a cardiovascular disease. Treatments include a 
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change in diet and the administration of insulin. Since the 1960s, surgical treatment for 
diabetes  mellitus  has  improved  and  constitutes  an  alternative  to  permanent  insulin 
injections (Jahansouz et al. 2011). The transplantation of pancreatic islets is a promising 
strategy in  order  to  restore  insulin  secretion.  However,  ROS generated  during  islet 
isolation and transplantation,  as well as general inflammation reactions may prevent 
long-term survival and regeneration of β-cells  (Chou and Sytwu, 2009). It was shown 
that  Txnip is  induced by glucose and is  upregulated in  diabetic  animal  models and 
patients, inhibiting Trx activity (Schulze et al. 2004). Overexpression of Trx1 in models 
for type I and type II diabetes minimized cellular damage and improved the survival of 
β-cells (Hotta et al. 1998), (Yamamoto et al. 2008). Moreover, it reduced and prevented 
associated  conditions  such  as  diabetic  embryopathy  (Kamimoto  et  al.  2010) and 
diabetic  osteopenia  (Hamada  et  al.  2009).  Wolf  and  collegues stated  that 
downregulation  of  Prx3 in  rat  insulinoma cells  led  to  insufficient  insulin  secretion, 
while overexpression protected the cells against various agents, including H2O2, NO, 
proinflammatory cytokines  and  streptozotocin,  a  β-cell  toxin (Wolf  et  al.  2010).  In 
addition,  Chou and Sytwu  transfected  healthy mouse  islets  with  a  lentivirus  vector 
coding for Trx1, before transplantation into diabetic NOD mice. Trx1 overexpressing 
islets were resistant against inflammatory processes and significantly prolonged islet 
survival after transplantation, without showing any differences in the glucose-dependent 
insulin secretion in vitro (Chou and Sytwu, 2009). 
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1.4 Aims of the study
The proteins of the thioredoxin family are major players in redox regulation as they 
control the redox state of protein thiols and the levels of the signal molecule hydrogen 
peroxide. Some of the thioredoxin family members have significant effects on the cell 
cycle. Our overall aim was to understand the role of these redoxins under physiological 
as well as pathological conditions, i.e.  under oxygen deprivation using different cell 
culture and animal models. We were especially interested in determining and defining 
the  role  of  the  Trx  family  proteins  in  terms  of  controling  the  fate  of  cells.  We 
furthermore  wanted  to  gain  more  information  on  single  proteins  of  the  Trx  family, 
looking at protein interactions, target proteins and specific functions. The specific aims 
of this thesis were:
• to create new tools for the analysis of intracellular levels of distinct redoxins, 
namely  the  generation  of  specific  polyclonal  antibodies  and  a  Grx2-specific 
sandwich ELISA.
• to establish the use of siRNAs and create overexpressing plasmids for selected 
redoxins in order to manipulate protein levels in different cell lines.
• to answer the question if Grx2 can donate electrons to the mitochondrial Prx3 in  
vivo.
• to  determine  if  other  members  of  the  thioredoxin  family of  proteins,  except 
Grx5, are involved in iron homeostasis and FeS cluster biosynthesis.  
• to analyse the distribution of Trx family proteins in the central nervous system 
(CNS) of the rat.
• to examine the expression level and distribution/ translocation of the Trx family 
proteins upon oxygen deprivation in distinct cell lines and animal models for 
perinatal asphyxia, renal ischemia-reperfusion injury and the transplantation of 
pancreatic β-cells, as a therapeutic approach for diabetes.
• to explore if the overexpression of redoxins in distinct cell types can alter the 
fate of a cell i.e. protecting cells against cell death, induced by a hypoxic insult.
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2. Materials and Methods
2.1 Materials
2.1.1 Instruments
Äkta Prime FPLC system GE Healthcare (Uppsala, Sweden) 
Agarose gel electrophoresis system Varia 1 Roth (Karlsruhe, Germany) 
Autoclave Systec (Wettenberg, Germany) 
Camera Chemocam HR16 Intas (Göttingen, Germany) 
Centrifuges  
Avanti J-20 XP Beckmann (Munich, Germany) 
Table centrifuge Biofuge fresco/pico Heraeus (Hanau, Germany)  
Easyject Plus Equibio Electroporator Equibio (Willstätt, Germany) 
Electrophoresis power supply ECPS3000/150 GE Healthcare (Uppsala, Sweden) 
Fermenter R´ALF PLUS SOLO, 6,7 l Bioengineering (Wald, Switzerland) 
Gel Imager Kodak (Stuttgart, Germany)  
Heating Block Epptherm Liebisch (Bielefeld, Germany) 
Incubator Heraeus (Hanau, Germany) 
Liquid homogenizer Microlor (Villers-Les-Nancy, 
France)  
Magnetic Stirrer MR3000 Heidolph (Kehlheim, Germany) 
Microscopes  
Confocal microscope LCS SP2 Leica (Wetzlar, Germany) 
Light microscope Leica Diaplan Leica (Wetzlar, Germany) 
Microscope Camera Micro Publisher Qimaging (Surrey BC, Canada) 
PH meter G-Tech Instruments (Hsinchu, 
Taiwan)  
Photometer Specord S300 UV Vis Analytic Jena (Jena, Germany) 
Scintillation counter Beckman Coulter (USA)  
Shaking incubator Innova 4300 New Brunswick Scientific (New 
Jersey, USA)  
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Sterile Benches Integra Biosc. (Fernwald, Germany) 
Thermocycler T3000 Biometra (Göttingen, Germany) 
Vortex genie II Scientific Industries Inc. (USA) 
Water bath Lauda M3 Lauda Dr. R. Wobster GmbH 
Xcell IITM Blot Module Invitrogen (Karlsruhe, Germany) 
Xcell SureLock® Mini Cell, PAGE Chamber Invitrogen (Karlsruhe, Germany) 
96-well plate reader Infinite M200 Tecan (Crailsheim, Germany)
2.1.2 Chemicals
Chemicals used in this study were purchased in analytic grade or better at the following 
companies:  Carl-Roth  (Karlsruhe,  Germany),  Fermentas  (St.  Leon-Rot,  Germany), 
Gibco Life  Technology (Karlsruhe,  Germany),  Merck (Darmstadt,  Germany),  Roche 
Diagnostics  GmbH  (Mannheim,  Germany),  Sigma-Aldrich  (Steinheim,  Germany). 
Consumable supplies like pipette tips, Falcon tubes and cell culture bottles were from 
Carl-Roth (Karlsruhe, Germany), Greiner (Frickenhausen, Germany), Kobe (Marburg, 
Germany) and Sarstedt (Nuembrecht, Germany). Various Kits used in this study were 
bought from BioRad (Hercules, USA), Fermentas (St. Leon-Rot, Germany), Promega 
(Mannheim, Germany), Quiagen (Hilden,  Germany), and Roche Diagnostics GmbH 
(Mannheim, Germany). Columns for protein purification and nitrocellulose membranes 
were  purchased  from  GE  Healthcare  (Uppsala,  Sweden);  SDS  gradient  gels  from 
Thermoscientific Fisher (Schwerte, Germany). Compounds such as antibiotics, buffer, 
cell  media  and  supplements,  enzymes,  marker  for  DNA and  proteins  were  from 
Fermentas  (St.  Leon-Rot,  Germany),  Finnzymes  (Espoo,  Finnland),  Invitrogen 
(Groningen, Germany), New England Biolabs (Frankfurt, Germany) and PAA (Cölbe, 
Germany).
2.1.3 Antibodies
In order to detect specific proteins in cells, cell lysates or mouse/rat tissues, we have 
used specific polyclonal antibodies.  
Most of these antibodies were generated by the AG Lillig as described in 2.2.3.2, part of 
them within this study (compare to 3.1.1), or were purchased from companies stated in 
Table 1. 
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Name Source  Western Blot IHC Origin/ Company
Actin Mouse 1 to 5000 - Santa Cruz Biotechnology (USA)
DNP Rabbit 1 to 1000 - Acria Antibodies (Hiddenhausen, Germany)
ERK Rabbit 1 to 1000 - Cell signaling Technology (USA)
ERK (ph) Rabbit 1 to 1000 - Cell signaling Technology (USA)
Ferritin Rabbit 1 to 1000 - MP Biomedicals (USA)
GAPDH Rabbit 1 to 5000 - Sigma Aldrich (Steinheim, Germany)
GPAT Rabbit 1 to 7500 - Kind gift of AG Lill (Marburg, Germany)
Grx1 Rabbit 1 to 200 1 to 200 Santa Cruz Biotechnology (USA)
Grx2 Rabbit ELISA 1 to 500 Serum and affinity purified, AG Lillig
Grx3 Rabbit 1 to 1000 1 to 25 Serum and affinity purified, AG Lillig
Grx5 Rabbit 1 to 1000 1 to 1000 Serum, AG Lillig (Marburg, Germany)
GSH Mouse 1 to 1000 - Virogen (Boston, USA)
IRP1 Rabbit 1 to 1000 - Serum, AG Lillig
JNK Rabbit 1 to 1000 - Cell signaling Technology (USA)
JNK  (ph) Rabbit 1 to 1000 - Cell signaling Technology (USA)
Mouse HRP Goat 1 to 5000 - BioRad (Hercules, USA)
mtAco3 Rabbit 1 to 3000 - Kind gift of AG Lill (Marburg, Germany)
mTrx1 Rabbit 1 to 1000 1 to 1000 Serum, AG Lillig
Nrx Rabbit 1 to 1000 - Kind gift of AG Zimmermann (Homburg, Germany)
p38 Rabbit 1 to 1000 - Cell signaling Technology (USA)
p38 (ph) Rabbit 1 to 1000 - Cell signaling Technology (USA)
Prx1* Rabbit 1 to 1000 1 to 500 Serum, AG Lillig
Prx2* Rabbit 1 to 1000 1 to 200 Santa Cruz Biotechnology and serum, AG Lillig
Prx3 Rabbit 1 to 1000 1 to 500 Serum, AG Lillig
Prx4* Rabbit 1 to 2000 1 to 500 Santa Cruz Biotechnology (USA)
Prx5 Rabbit 1 to 1000 1 to 500 Serum, AG Lillig
Prx6* Rabbit 1 to 1000 1 to 500 Serum, AG Lillig
Rabbit HRP Goat 1 to 5000 - BioRad (Hercules, USA)
rTrxR1 Rabbit 1 to 1000 1 to 100 Serum and affinity purified, AG Lillig
TfR Mouse 1 to 3000 - Zymed (San Franscisco, USA)
Trx1 Rabbit 1 to 1000 - Serum, AG Lillig
Trx2 Rabbit 1 to 1000 1 to 1000 Serum, AG Lillig
TrxR1 Rabbit 1 to 1000 - Serum, AG Lillig
TrxR2 Rabbit 1 to 200 1 to 200 Santa Cruz Biotechnology (USA)
Tubulin Mouse 1 to 5000 - Sigma-Aldrich (Steinheim, Germany)
Txnip Rabbit 1 to 200 1 to 200 Sigma-Aldrich (Steinheim, Germany)
γGCS Rabbit 1 to 200 1 to 100 Santa Cruz Biotechnology (USA)
Table 1: Sera and purchased antibodies used within this study. Sera were generated within this study 
(*); (ph=phosphorylated). Dilutions for Western Blot and Immunohistochemistry (IHC) are enlisted.
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2.1.4 Oligonucleotides
Oligonucleotides used in this study were designed according to the following rules: The 
length was around 16-30 bp and the guanine/cytosine content was around 50 %. Primer 
pairs  were  designed  with  melting  temperatures  (Tm)  as  similar  as  possible. 
Tm was  calculated  using  Promegas biomath calculators 
(www.promega.com/biomath/Default.htm). Oligonucleotides were ordered from DNA 
Technology GmbH (Aarhus, Denmark), used in stock concentrations of 100 pmol/µl 
and stored at -20 °C. All primer pairs are summarized in  Table 2 and Table 3, stating 
their sequence, amplificates, endonucleases as well as the target plasmid.  
Name: amplificate Endo-
nucleases
Sequence Target plasmid
PREMH1: hPrx1, Fw
PREMH2: hPrx1, Rv 
NdeI
BamHI
CATATGtcttcaggaaatgctaaaattgg
GGATCCtcacttctgcttggagaaatattc
pet15b
PREMH3: hPrx2, Fw
PREMH4: hPrx2, Rv 
NdeI
BamHI
CATATGgcctccggtaacgcg
GGATCCctaattgtgtttggagaaatattccttg
pet15b
PREMH7: Prx6, Fw
PREMH8: Prx6, Rv 
NdeI
BglII
CATATGcccggaggtctgc
AGATCTttaaggctggggtgtgtag
pet15b
PREMH9: hPrx3, Fw
PREMH10: hPrx3, Rv 
NheI
BglII
GCTAGCatggcggctgctgtaggac
AGATCTctactgatttaccttctgaaagtactc
pExpress
PREMH11: hPrx5, Fw
PREMH12: hPrx5, Rv
NheI
BglII
GCTAGCatggccccaatcaaggtggg
AGATCTtcagagctgtgagatgatattggg
pExpress
PREMH13: hPrx4, Fw
PREMH14: hPrx4, Rv
NdeI
BamHI
CATATGgaggcgctgc 
GGATCCggatcctcaattcagtttatcgaaatacttc
pet15b
PREMH15: hPrx1, Fw
PREMH16: hPrx1, Rv
NheI
BglII
GCTAGCatgtcttcaggaaatgctaaaattgg 
AGATCTtcacttctgcttggagaaatattc
pExpress
PREMH17: hPrx2, Fw
PREMH18: hPrx2, Rv
NheI
BglII
GCTAGCatggcctccggtaacgcg 
AGATCTctaattgtgtttggagaaatattccttg
pExpress
PREMH19: hPrx4, Fw
PREMH20: hPrx4, Rv
NheI
BglII
GCTAGCatggaggcgctgc
AGATCTggatcctcaattcagtttatcgaaatacttc
pExpress
PREMH21: hPrx6, Fw
PREMH12: hPrx6, Rv
NheI 
BglII
GCTAGCatgcccggaggtctgc
AGATCTtcagagctgtgagatgatattggg
pExpress
Table  2: Oligonucleotides for cloning peroxiredoxins. Prxs 1, 2, 4 and 6 were cloned in pet15b for 
protein production and generation of antibodies. Prxs 1, 2, 3, 4, 5 and 6 were cloned in pExpress for 
overexpression in human cells. Primer sequences include restriction sides for the indicated restriction 
enzymes, which are written in cover letters.
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Name Target Mutation Purpose
PRVCM001
PRVCM001R
Grx2 in pEGFP-N1 S74P Active site  mutation;  protein cannot  hold an 
FeS cluster.
PRVCM002
PRVCM002R
Grx2 in pEGFP-N1 T95R Mutation leading to an attenuated binding of 
GSH and thus of the FeS cluster.
Table 3: Oligonucleotides for mutagenesis of human glutaredoxin 2 in pEGFP-N1.
2.1.5 siRNAs
Specific  siRNAs were  used  to  silence  the  expression  of  different  redoxins  in  cells. 
Unspecific  scrambled  siRNA  was  used  as  control.  Double-stranded  RNAs  were 
designed with sequences complementary to the gene of interest and were purchased 
from Ambion  (Austin,  USA)  or  Eurogentec  (Seraing,  Belgium).  They were  thawn, 
aliquoted and stored at – 80 °C. All established and used siRNAs are listed in Table 4.
Name Target protein Sequences (sense, antisense)
Scram* none; control CAUUCACUCAGGUCAUCA, CUGAUGACCUGAGUGAAU
Grx1si* hGrx1 GGGCUUCUGGAAUUUGUCG, CGACAAAUUCCAGAAGCCC
Grx2si* hGrx2 GGUGCAACUGACACUCAU; UAUGAGUGUCAGUUGCAC
Grx3si hGrx3 GCCUAUUCCAGUUGGCCUA; UAGGCCAACUGGAAUAGGC
Trx1si* hTrx1 GUAGAUGUGGAUGACUGUC, GACAGUCAUCCACAUCUAC
Trx2si* hTrx2 GGAUCUCCUUGACAACCU; AAGGUUGUCAAGGAGAUC
Table 4: SiRNAs used to silence the expression of redoxins in human cell lines. SiRNAs labeled with 
an asterisk were established within this study.
2.1.6 Computer based data mining
2.1.6.1 Analysis of Western Blots
Image J was used to analyse and quantify the protein bands on Western Blots. 
2.1.6.2 Figures
Figures  and  diagrams  were  created  using  the  GNU  Image  Manipulation  Program, 
InkScape or Xmgrace. 
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2.1.7 Strains and plasmids
2.1.7.1 Bacteria
E. coli XL-1 blue mrf`: Δ(mcrA)183 Δ(mcrCB-hsdSMR-mrr)173 endA1 
supE44 thi-1 recA1 gyrA1 gyrA96 relA1 lac 
F`[proABlacIqZΔM15 Tn10(Tetr)]c Stratagene
(tetracycline resistance)
E. coli BL21(DE3)pRIL: hasdS gal (λIts857 ind 1 Sam7 nin5 lac UV5-T7 gene 1) 
Stratagene, (chloramphenicol resistance)
2.1.7.2 Cell lines
HeLa cells are derived from a cervical carcinoma of the patient Henrietta Lacks in the 
1950th. They constitute an established cell line of human epithelial cells and the most 
commonly used human cell line. HeLa cells were cultivated in low glucose DMEM 
supplemented  with  10  %  heat  inactivated  fetal  calf  serum  (FCS)  and  100  U/ml 
penicillin and streptomycin.
HEK293 cells are derived from human kidney cells, obtained from a healthy aborted 
fetus. The cells were immortalised using adenovirus 5 DNA. Cells were cultivated in 
low glucose  DMEM supplemented  with  10  % heat  inactivated  FCS and 100 U/ml 
penicillin and streptomycin.
INS1 cells  are  derived  from rat  pancreatic  β-cells.  Cells  were  cultivated  in  RPMI 
medium  supplemented  with  10  %  heat  inactivated  FCS,  100  U/ml  penicillin  and 
streptomycin, 10 mM HEPES, 1 mM sodium pyruvate and 50 µM mercaptoethanol.
MIN6 cells  are  derived  from  mouse  pancreatic  β-cells.  They  constitute  a  highly 
differentiated  and  glucose  responsive  cell  line.  MIN6 cells  were  cultivated  in  high 
glucose DMEM, supplemented with 20 % heat inactivated FCS, 100 U/ml penicillin 
and streptomycin, 1 mM sodium pyruvate and 71 µM mercaptoethanol.
Primary islet cells are healthy, non immortalised cells, derived from pigs. These cells do 
not divide. They were kept in CMRL 1066 medium, supplemented with 20 % heat-
inactivated  FCS,  100  U/ml  penicillin  and  streptomycin,  2.5  mM  glutamine,  1  mM 
sodium pyruvate, 7 % glucose, 0.2 % sodium bicarbonate, ciprobay 200.
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2.1.7.3 Plasmids
pGEM-T Vector (Promega):
The  pGEM-T vector  was  used  for  direct 
cloning of PCR products. It contains single 
3`thymine  overhangs  at  the  insertion  site, 
carries  a  T7  promoter  and  ampicillin 
resistance (Figure 8).
(vector cards were derived from the manufacturors) 
pet15b  (Novagen):  
The  pet15b  vector  was  used  for  protein 
expression. It carries a T7 promoter, a His 
Tag sequence and an ampicillin resistance 
(Figure 9).
pExpress (Arakawa et al. 2001):
The  plasmid  was  used  for  the  general 
overexpression of proteins in cells. It uses 
two promoters, allowing transcription in E. 
coli  and  in  eukaryotic  cells.  pExpress 
carries an ampicillin resistance (Figure 10). 
pEGFP-N1 (Clontech, Germany):
The  plasmid  was  used  for  protein  over-
expression in cells with attention to protein 
localization.  pEGFP-N1  contains  a 
fluorescent  protein  (Excitation:  488nm; 
Emission:  507  nm)  at  the  N-terminus, 
which is fused to the protein of interest. It 
carries  two  promoters  for  transcription  in 
E.  coli and  eukaryotic  cells  and  a 
kanamycin resistance (Figure 11). 
Figure 11: pEGFP-N1 vector information.
Figure 10: pExpress vector information.
Figure 9: pet15b vector information. 
Figure 8: pGEM-T vector information. 
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2.1.8 Animal models
All experiments were performed in agreement with the legislation for the ethical use of 
laboratory animals in each country.
2.1.8.1 Rat model for perinatal asphyxia
Pregnant female rats were kept in individual cages with controlled 12:12 h light/dark 
cycle (temperature: circa 21 °C; humidity: circa 65 %). Animals were divided into three 
groups:  1.  control  group,  which  gave  birth  to  control  pups;  2.  surrogate  mothers; 
3. animals assigned to the perinatal asphyxia procedure. Fullterm pregnant rats were 
rendered  unconscious  by  CO2  inhalation  (Dorfman  et  al.  2006) and  were  rapidly 
decapitated. An abdominal incision was made and the uterus horns were isolated. The 
pups were put into a 37 °C warm waterbath for maximum 19 min. Times exceeding 
19 minutes lead to a very low survival rate of the animals. Subsequently the uterus 
horns were opened and the pups were cleaned from amniotic fluid. The pups breathing 
was stimulated for a few minutes by performing tactile intermittent until the pups were 
breathing regularly. The umbilical cord was cut and the pups were observed for approx. 
1 hour, while keeping them warm using a heating lamp. The pups were marked and 
mixed with the litters of the surrogate mothers as soon as their physiological conditions 
improved (Figure 12). Only male animals were used for later analysis.
Figure  12: Rat model for induction of perinatal asphyxia.  Fullterm pregnant rats were killed by CO2 
inhalation, the uterus horns were isolated and incubated in a 37 °C waterbath for 19 min. Pubs were 
extracted, cleaned from uterus tissue and breathing was stimulated. Control pubs were isolated in the 
same way, without exposing them to the asphyxic condition. All pubs were labeled and were mixed with 
the litters, vaginal delivered by the surrogate mothers (provided by Prof. Dr. Francisco Capani). 
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2.1.8.2 Mouse model for ischemia/reperfusion injury
Male  (10-12  weeks  old)  C57BL/6J 
mice (Charles River, Germany) were 
narcotised with 100 mg/kg ketamine 
(Pfizer,  Karlsruhe,  Germany)  and  5 
mg/kg  xylazine  (Rompun,  Bayer 
Leverkusen,  Germany).  To  ensure  a 
constant  body temperature of  37 °C 
the  mice  were  operated  on  a  heat 
plate.  An incision  was  made on the 
right side, exposing the right kidney. 
The kidney pedicle was clamped. The 
kidney  was  kept  warm  and  moist 
during the whole procedure. After 30 
min  the  clamp  was  removed,  the 
restoration  of  the  blood  flow  was 
observed  and  the  incision  was 
sutured.  In  control  animals  or  so 
called  sham  operated  mice  the 
incision  was  made  and  the  kidney 
was exposed for 30 min,  but it  was 
not clamped. The animals were kept in cages and blood and urine samples were taken 
after 24 h reperfusion time. The mice were sacrificed by carbon dioxide intoxication 
followed by cervical dislocation and the ischemic, as well as the contralateral kidney 
were removed. 
2.1.8.3 Mouse model for diabetes mellitus
In the AG Linn (Justus-Liebig Universität, Faculty of Medicine, Gießen) mice models 
have been established, which mimic different aspects of diabetes. One model for type-I 
diabetes  is  the  streptozotocin-induced  diabetes.  Streptozotocin  is  a  β-cell  toxin. 
C57BL/6 mice were injected intra-peritoneal with 200 mg/kg streptozotocin. Control 
animals received citrate buffer instead. Within the following three days the blood sugar 
levels were determined; if the blood sugar level was higher than 200 mg/dl for more 
Figure  13:  Mouse  model  for  renal  ischemia/  
reperfusion  injury.  Male  C57BL/6J  mice  were 
anaesthetised, an incision was made and the pedicle of 
the right kidney was clamped, restricting the blood flow. 
After  30  min  the  clamp was  removed  and  the  blood 
flow was restored (provided by Dr. José Godoy). 
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than  2  days  the  animal  was  considered  diabetic.  To mimic  the  conditions  during  a 
transplantation of pancreatic islet cells, islets from healthy donor mice were isolated 
and injected into the portal vein of a diabetic mouse. 
2.1.8.3.1 Isolation of pancreatic islets
Hank solution:  9.5  g/l  Hank´s  balanced salts,  0.35 g/l  NaHCO3,  penicillin  0.6  g/l;  
Collagenase solution: 30 mg collagenase in 12 ml Hank solution
Mice were narcotised using 0.3 ml/20 g avertin and sacrificed by cervical dislocation. 
The pancreas was removed and 3 ml collagenase solution were injected into the ductus 
choledochus/pancreaticus. The pancreas was incubated with the rest of the collagenase 
solution for 10 min at 37 °C. The digestion was improved mechanically by vortexing 
every 2-3 min. The tissue was put on ice and cold Hank solution was added. After 
centrifuging  for  3  min  at  1500  rpm  the  supernatant  was  mixed  with  medium 
supplemented with 10 % FCS. The cells were transferred into a petri dish. Single islets 
were hand-picked, transferred into another petri dish and were cultivated over night at 
37 °C in a humidified atmosphere containing 5 % CO2 and 20 % O2.
2.2 Methods
2.2.1 Molecular biological methods
2.2.1.1 Standard techniques
Agarose-gelelectrophoresis, ligation, DNA digestion with endonucleases and extraction 
of DNA were performed  according to  standard protocols.  Ligation in pGEM-T was 
performed according  to  the  manufacturer´s  protocol  (Promega).  For  gel  elution and 
DNA extraction the Nucleo-Spin-Extract Kit II was used.
2.2.1.2 Polymerase chain reaction
The polymerase chain reaction (PCR) is a method to amplify DNA. The reaction takes 
place in a thermocycler in the presence of: 2-20 ng template DNA, 20 pmol/µl of a 
specific  primer  pair,  0.2  mM dNTPs,  1x reaction buffer  containing 1.5 mM MgCl2 
(Finnzymes, Espoo, Finland) and 0.5-2.5 U DyNAzyme EXT. DNA was denatured for 
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1 min at 94 °C. 34 cycles of denaturing at 92 °C for 30 sec; annealing at a primer 
specific temperature for 45 sec; elongation at 72 °C for 45 sec, followed. After a final 
elongation step at 72 °C for 10 min the PCR product was loaded on a 1 % agarose gel 
and was extracted using the Nucleo-Spin-Extract Kit II.
2.2.1.2.1 Rolling circle PCR
The  rolling  circle  polymerase  chain  reaction  or  mutagenesis  PCR is  similar  to  the 
conventional  PCR  reaction.  Special  primers,  containing  a  mismatch  in  the  middle, 
leading to a point mutation, are used and an extended elongation time is needed for 
amplifying the whole vector.  DNA was denatured for 1 min at  90 °C. 15 cycles of 
denaturing at 90 °C for 30 sec; annealing at a primer specific temperature for 1 min; 
elongation at 68 °C for a plasmid size specific duration (1000 bp correlate to 1 min), 
followed. The amplified DNA was digested with the restriction enzyme  DpnI, which 
cuts only methylated template DNA.
2.2.1.3 Generation and transformation of competent cells
RF1 buffer: 100 mM RbCl, 50 mM MgCl2, 30 mM potassium acetate, 10 mM CaCl2,  
15 % glycerol, pH 5.8; RF2 buffer: 10 mM MOPS, 10 mM RbCl, 75 mM CaCl2, 15 % 
glycerol, pH 6.8
Competent bacteria were generated based on the rubidiumchloride method. E. coli cells 
were grown until they had reached the exponential phase (OD600  of 0.6). Cells were 
incubated on ice for 15 min and were spun down in DNA free tubes in a centrifuge at 
1000xg for another 15 min. The pellet was resuspended in 1/3 volume of RF1 buffer 
without vortexing and was incubated on ice for 15 min. The bacteria were centrifuged 
at 1000xg for 15 min and were resuspended in 1/12.5 volumes of RF2  buffer. After 
another incubation on ice for 15 minutes,  the cells were aliquoted,  frozen in liquid 
nitrogen and stored at -80 °C. 25 ng of DNA and 200 µl competent cells were incubated 
on ice for 20 min. A heat shock was performed at 42 °C for 90 seconds in a heating 
block. After an incubation on ice for 5 min, the sample was incubated with 800 µl LB 
medium at 37 °C for 45 min. Cells were spun down in a centrifuge for 2 min at 8000 
rpm, the pellet was resuspended in 50 µl LB medium and bacteria were transferred to a 
LB plate, containing special antibiotics, which was incubated over night at 37 °C.
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2.2.1.4 Sequencing
All plasmids generated in this  study were send to Seqlab (Göttingen,  Germany) for 
sequencing. Ferograms were analysed using Finch TV, sequences using NCBI BLAST 
and ExPASy.
2.2.2. Cell biological methods 
2.2.2.1 Cell cultivation and cell splitting
All cell lines used in this study were cultured at 37 °C in a humidified atmosphere 
containing 5 % CO2 and 20 % O2, if not stated otherwise. Cell lines and the appropriate 
medium are mentioned in 2.1.7.2. In general, the medium was changed every 3 days. 
When cells were confluent, they were splitted. Old medium was removed, cells were 
washed once with PBS and were incubated a few minutes with trypsin at 37 °C. By 
adding fresh medium the reaction was stopped. Cells were splitted in a ratio between 
1:3 – 1:10. MIN6 cells were centrifuged for 5 min at 700 rpm to get rid of the trypsin, 
before seeding them out in fresh medium in a ratio of 1:2 or 1:3.
2.2.2.2 Freezing and thawing of cells
Cells were harvested and resuspended in medium supplemented with FCS and 10 % 
DMSO. Cells were frozen in an isopropanol chamber at -80 °C. After 48 h, cells were 
transferred  in  liquid  nitrogen.  Cells  were thawn in  5 ml  fresh medium. To remove 
DMSO, cells were centrifuged for 5 min at 700 rpm. Cells were seeded out in fresh 
medium. 
2.2.2.3 Cell counting
Cells  were  counted  using  a  Neubauer  counting  chamber  according  to  the  provider. 
20 µl of the cell suspension were added to the chamber. Cells were counted using a 
light microscope.
2.2.2.4 Cell lysis and preparation of crude cell extract 
NP40-lysis buffer: 10 mM Tris/HCl, 0.1 % NP40, 10 mM NaCl, 3 mM MgCl2, protease 
and phosphatase inhibitors, pH 7.4; NEM-lysis buffer: 40 mM HEPES, 50 mM NaCl,  
1 mM EDTA, 1 mM EGTA, 100 mM NEM, protease and phosphatase inhibitors, pH 7.4 
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Cells were harvested, washed with PBS and resuspended in lysis buffer and incubated 
at RT for 15 min, before freezing the cells in liquid nitrogen. In the case of NEM-lysis, 
2  %  CHAPS  were  added  right  before  freezing.  Samples  were  stored  at  -20  °C. 
Samples were thawn, centrifuged at 4 °C for 5 min at 13000 rpm and the supernatant 
and the crude cell extract were transferred into new tubes.
2.2.2.5 Cell fractionation
Mitobuffer:  5  mM Tris/HCl,  250 mM sucrose,  1 mM EDTA, 1 mM EGTA, 1.5 mM 
MgCl2, protease inhibitors, pH 7.4; Digitonin buffer: Mitobuffer containing 0.008 % 
digitonin
Cells were harvested, washed once in PBS and were lysed in ice cold digitonin buffer (2 
ml for 3.5 Mio cells). After an incubation on ice for 10 min one third was transferred to 
a  new tube and was frozen in  liquid nitrogen as the total  cell  lysate.  The rest  was 
centrifuged at 4 °C for 10 min at 13000 rpm. The supernatant was transferred to a new 
tube and was frozen as the cytosolic fraction. The pellet was washed once with 1 ml 
Mitobuffer and was resuspended in 200 µl of Mitobuffer. This part was shock frozen as 
mitochondria-rich fraction. Samples were stored at -80 °C.
2.2.2.6 Cell transfection
2.2.2.6.1 Electroporation
Electroporation buffer: 21 mM HEPES, 137 mM NaCl, 5 mM KCl, 0.7 mM Na2HPO4,  
6 mM D-glucose, pH 7.15
3.5 Mio HeLa cells  were harvested,  washed once in  PBS and were resuspended in 
600 µl electroporation buffer. 15 µg plasmid DNA or siRNA were mixed thoroughly 
with the cells and were transfected in an electroporation cuvette using 250 mV and 
1500 µF for 25-30 ms. 600 µl FCS were added immediately to the cells before seeding 
them out in 1:5 conditioned medium. 
2.2.2.6.2 Chemical transfection using lipofectamin
Different amounts of MIN6 cells were seeded out in different well plates (see Table 5). 
DNA and lipofectamin were incubated in 200 µl antibiotic free medium separately for 
5 min, before mixing them. After a 30 min incubation at RT the DNA-Lipofectamin 
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complexes  were  transferred  to  the  cells  which  were  cultivated  in  antibiotic  free 
medium.  
Plate Cells/ well DNA in medium Lipofectamin in medium Plating medium Purpose
12 wells 50000 1 µg in 200 µl 2 µl in 200 µl 500 µl Microscopy
6 wells 1 Mio l 4 µg in 200 µl 8 µl in 200 µl 2 ml Cell lysis
Table 5: Pipetting scheme for chemical transfection with lipofectamin.
2.2.2.7 Cell viability assay
2.2.2.7.1 XTT assay
XTT labeling mixture:  XTT labeling reagent and electron coupling reagent (50:1)
The proliferation/viability of cells was measured by a colorimetric assay based on the 
cleavage of the yellow tetrazolium salt XTT to an orange formazan dye. 10000 cells 
were seeded out in a 96-well plate and were treated as indicated. Cells were washed 
with PBS and 100 µl fresh medium as well as 50 µl of the XTT labeling mixture were 
added to each well in a final XTT concentration of 0.3 mg/ml. The cells were incubated 
at 37 °C for 4-24 h. The absorbance was measured using the Tecan microplate reader. 
The  formazan dye  was measured  at  a  wavelength  of  490 nm,  the  background at  a 
wavelength of 650 nm. 
2.2.3 Biochemical methods 
2.2.3.1 Protein expression and purification 
LB medium: 1 % (w/v) NaCl, 1 % (w/v) peptone, 0.5 % (w/v) yeast extract, pH 7.4; 
Washing  buffer:  300  mM  NaCl,  25  mM  NaH2PO4,  25  mM  Na2HPO4,  pH  8;  
Equilibration buffer: 30 mM imidazole in washing buffer, pH 8; Elution buffer: 250 mM 
imidazole in washing buffer, pH 8
Proteins were expressed using a 5 l Fermenter allowing the expression of high amounts 
of recombinant proteins.  5 l of LB medium, supplemented with selective antibiotics 
were inoculated at 37 °C with 1 % of an overnight culture of E. coli BL21(DE3)pRIL, 
transformed with the pet15b plasmid. Cells were grown at 37 °C until they had reached 
the exponential growth phase (OD600 of 0.6). The temperature was reduced to 22 °C and 
0.5 mM IPTG were added to induce the expression of the protein of interest. Cells were 
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harvested after 20 h at 4 °C at 5000x g for 10 min. The pellet was washed in 20 ml 
washing  buffer,  centrifuged  and  stored  for  protein  purification  at  -20  °C.  Proteins 
cloned  as  His-tagged  fusion  proteins  were  purified  according  to  the  IMAC 
(immobilized metal  affinity chromatography)  technique using the Äkta Prime FPLC 
system. The pellet was resuspended in 20 ml of equilibration buffer and cells were lysed 
on  ice  using  a  liquid  homogenizer  applying  10000  psi.  The  cell  suspension  was 
centrifuged at 4 °C at 20000x g for 30 min. The supernatant was loaded on a, with 
equilibration  buffer  equilibrated,  His-Trap  column.  The  column  was  washed  with 
washing buffer to avoid unspecific binding. The protein was eluted in 1 ml fractions by 
adding elution buffer to the column. 
2.2.3.2 Generation and purification of antibodies
Antibodies used in this study are listed in  Table 1. 40 µg of recombinant protein in 
500  µl  Complete  Freund´s  adjuvant  (Sigma-Aldrich,  Steinheim,  Germany) were 
injected  into  rabbits,  to  produce  polyclonal  antibodies.  Every  3-4  weeks  injections 
followed  using  40  µg  of  protein  in  500  µl  Incomplete  Freund´s  adjuvant  (Sigma-
Aldrich). After the third-sixth injection blood was collected. Serum was obtained by 
incubating the blood for 30-120 min at RT, before centrifuging for 5 min at 5000 rpm. 
Supernatant was collected and centrifuged for 15 min at 15000 rpm. Serum incubated at 
56  °C  for  20  min  to  inactivate  the  complement  immune  system.  Purification  of 
antibodies was performed using 5 mg of antigen coupled to cyanogenbromid (CnBr) 
activated sepharose according to the manufacturer. The sepharose was washed with 150 
ml PBS, equilibrated with 2 ml coupling buffer and incubated with antigen for 90 min 
at  RT  on  a rotating  table.  Free  reactive  groups  were  blocked  by  adding  30  % 
ethanolamine.  After  2  h  the  column  was  equilibrated  with  6  ml  1  M  acidic  acid 
containing 0.5 M NaCl. In a second step 6 ml 0.1 M Tris containing 0.5 M NaCl were 
applied to the column. In two final equilibration steps 10 ml 10 mM Tris pH 8.8 and 10 
ml 10 mM Tris pH 7.5 were administered. 1 ml of the serum was added to the column 
before washing with 10 ml 10 mM Tris pH 7.5, 10 ml 10 mM Tris pH 7.5 containing 
0.5 M NaCl and with 3 ml 10 mM Tris pH 7.5. Antibody was eluted in 500 µl fractions 
using  5  ml  100  mM  glycine  pH 2.5.  Antibody containing  fractions  determined  by 
Bradford were rebuffered in PBS using a NAP5 column. After determining the protein 
concentration the antibody was aliquoted, shock frozen and stored at -20 °C.
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2.2.3.3 Biotinylation of purified antibodies
2 mg affinity purified antibody were incubated with 200 µg immunopure NHS-LC-
biotin (Pierce) for at least 2 h on ice. The antibody was loaded on a NAP5 column and 
was eluted with PBS. After  determining the protein concentration the antibody was 
aliquoted, shock frozen and stored at -20 °C.
2.2.3.3.1 Validation of antibodies
All sera and purified antibodies used and produced in this study were validated for 
specificity by Western Blotting. Antibody stained samples were compared to samples 
which were stained with antibodies that were prior incubated or rather blocked with 
10-200 µg/ ml of the specific antigen. Only antibodies that showed specific staining 
were used in this study.
2.2.3.4 Protein determination
The total amount of proteins in cell lysates was colorimetrically determined according 
to Bradford. This assay was performed in a 96-well plate with BSA standards ranging 
from 0-0.8 mg/ml using the protein-dyeing kit (BioRad,  Hercules, USA) according to 
the manufacturer´s protocol.  
The  protein  concentration  of  recombinantly  expressed  and  purified  proteins  was 
determined spectrophotometrically using the extinction coefficient at 280 nm calculated 
from the protein sequences using ProtParam (www.expasy.ch).
Protein Molecular weight (g/mol) ε coefficient (ε280 1/M*cm)
hPrx1 22110 18700
hPrx2 21892 21555
hPrx4 30539 36900
hPrx6 25035 22585
Table 6: Molecular weight and extinction coefficients of distinct peroxiredoxins.
2.2.3.5 ELISA
Coatingbuffer:  1.59  g/l  Na2CO3,  2.93  g/l  NaHCO3,  200  mg/l  NaN3,  pH  9.6;  
Blockingbuffer:  1  %  BSA  in  PBS;  Washingbuffer:  0.05  %  Tween20  in  PBS; 
Incubationbuffer:  0.5  %  (w/v)  BSA,  0.05  %  (v/v)  Tween20,  0.02  NaN3 in  PBS;  
Substratebuffer: 1 M diethanolamin, 0.5 mM MgCl2, 0.02 % NaN3, pH 9.8
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The  Enzyme-linked  immunosorbent  assay (ELISA)  is  a  method to  quantify  protein 
expression by the use of specific affinity purified antibodies. A special ELISA microtiter 
plate was incubated with primary antibody in coatingbuffer over night at 4 °C. The plate 
was washed 4 times with washingbuffer and was incubated with 200 µl blockingbuffer 
for  2  h  at  RT.  Standards  in  the  range  from  0-32  µg/ml  and  samples  diluted  in 
incubationbuffer were incubated over night at 4 °C. The plate was washed 4 times and 
after a 2 h incubation with the secondary biotinylated antibody, streptavidin-ALP was 
added  for  1  h  at  RT.  The  plate  was  washed  6  times  before  adding  the  substrate 
p-nitrophenylphosphate in substratebuffer. The colorimetric reaction was measured in a 
96-well plate reader (Tecan) at 405 nm.
2.2.3.6 SDS polyacrylamide gel electrophoresis
Loading Dye: 0.3 M Tris/HCl, pH 7, 50 % glycerol, 5 % SDS, 0.1 % bromphenol blue; 
Runningbuffer: 1 M Tris Base, 1 M HEPES, 0.1 % SDS
Proteins  can  be  separated  by size  using denaturing  SDS polyacrylamid  gel  electro-
phoresis (PAGE). 5-30 µg of total protein were diluted and combined with loading dye. 
Proteins were reduced by a 30 min incubation at RT with 100 mM DTT and 50 mM 
TCEP if indicated, which was followed by an additional incubation for 10 min at 94 °C. 
Proteins  were  separated  on  a  non-reducing  SDS-PAGE for  50  min  at  120 V using 
4-12 % gradient gels (Thermoscientific Fisher, Schwerte, Germany). Gels were washed 
3 times with aqua bidest,  incubated over night in PageBlue-solution (Fermentas,  St. 
Leon-Rot, Germany) and washed with aqua bidest to remove excessive staining.
2.2.3.7 Western Blot
Transferbuffer: 0.02 % (w/v) SDS, 20 mM Tris, 150 mM glycin, 20 % (v/v) methanol;  
TBS: 25 mM Tris, 150 mM NaCl, 2.7 mM KCl; TBST: TBS, 0.05 % (v/v) Tween20,  
pH  7.4;  Blockingbuffer:  1  %  (w/v)  BSA,  5  %  (w/v)  milk  powder  in  TBST;  ECL1  
solution:  100 mM Tris, 2.5 mM luminol in DMSO, 0.4 mM p-Coumaracid in DMSO,  
pH  8.5;  ECL2  solution:  100  mM Tris,  0.018  % (v/v)  hydrogen  peroxide,  pH  8.5;  
Strippingbuffer: 1 g/l SDS, 15 g/l glycerin, 10 ml/l Tween20, pH 2.2; PBS: 8 g/l NaCl,  
0.2 g/l KCl, 1.44 g Na2HPO4, 0.24 g KH2PO4
The Western Blot is used to detect specific proteins on a polyacrylamid gel, which have 
been separated by SDS-PAGE. Proteins were transferred from the gel to a nitrocellulose 
2. Materials and Methods                                                                                                  37  
membrane  (equilibration  in  aqua  bidest)  or  PVDF  membrane  (equilibration  in 
methanol) respectively using the wet-blot technique. The transfer was performed on ice 
for 2 h at 40 V. Membranes were washed 3 times with TBS before blocking for 1 h at 
RT. Primary antibodies were diluted in blocking buffer as stated in Table 1. Membranes 
were incubated with the primary antibodies at 4 °C over night on a shaking incubator. 
Membranes  were  washed  5  times  in  TBST  before  the  secondary  horseradish-
peroxidase(HRP)-coupled antibody was added in blocking buffer without BSA. After a 
1 h incubation at RT the membrane was washed 5 times and proteins were detected 
adding  equal  amounts  of  ECL1  and  ECL2  to  the  membranes.  The  detection  was 
performed using the Chemostar system. Membranes could be stripped from antibodies 
and analysed for a different protein, by washing twice with strippingbuffer for 10 min, 
twice with PBS for 10 minutes and twice with TBST for 5 min.
2.2.3.7.1 2-Cys Prx specific redox blot
NEM-lysis buffer: 40 mM HEPES, pH 7.4, 50 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1x 
protease  inhibitors,  100 mM N-ethylmaleimide;  CHAPS:  2  %;  loading  dye:  0.3  M 
Tris-HCl, pH 7, 50 % glycerol, 5 % SDS, 0.1 % bromphenol blue
In order to detect the redox state of 2-Cys Prxs, cells were lysed in NEM-lysis buffer to 
block free thiols.  Samples  were diluted and combined with loading dye;  no further 
incubation with any reducing agent was necessary. Proteins were separated by SDS-
PAGE (described in 2.2.3.6), immunological labeled with antibodies and analysed using 
the enhanced chemiluminescence (described in 2.2.3.7). 
2.2.3.7.2 Carbonylation Blot
2,4-dinitrophenylhydrazine (DNPH) solution: 10 mM DNPH in 10 % trifluoroacetic  
acid, stop solution: 2 M Tris, 30 % glycerol and 15 % β-mercaptoethanol
30 µg of total cell extract were incubated with 6 % SDS for 2-3 minutes at 100 °C. 
DNPH solution was added in a ratio 1:1 for 20 min at 25 °C. One third stop solution 
was added and mixed gently. Loading dye was added to the samples before following 
the standard protocol for SDS PAGE (described in 2.2.3.6) and Western blot (described 
in 2.2.3.7) using a DNP antibody. Samples could be stored at – 20 °C for later analysis.
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2.2.3.8 Immunohistochemistry of rat tissues
Anesthetic solution: 28 % (w/v) chloral hydrate, 0.1 ml/100 g of body weight; Perfusion 
solution/ Fixation solution: 4 % paraformaldehyde in phosphate buffer 0.1 M, pH 7.4;  
Immersion solution: 5 % sucrose in  phosphate buffer 0.1 M, pH 7.4
Male rats  were anesthetized and perfused through the abdominal aorta.  Brains were 
dissected and fixated for 2 h, before immersing over night. Tissue sections were cut on 
an Oxford vibratome. Part of the sections were stained with cresyl violet according to 
Capani et al.  2009. The other part  was incubated with primary antibodies overnight 
using the dilutions stated in Table 1. After several washing steps with PBS, slides were 
incubated with a secondary antibody for 2 h at RT, followed by several washingsteps 
and  an  additional  incubation  with  a  biotin-streptavidin  complex  (HRP Histo  Mark, 
Caramillo, California, USA) for 1 h at RT. Slides were developed after several washing 
steps using the AEC substrate kit (Invitrogen Gaithersburg, MD, USA). Images were 
obtained using a CCD video camera CU-50 (Sony Inc.). Images were analysed using 
the program Adope Photoshop 8.0 CS3.
2.2.3.9 Immunocytochemistry
Blocking- and Permeabilisation buffer: 10 mM HEPES, 3 % (w/v), 0.3 % (v/v) Triton-
X-100 in PBS
Cells were seeded out on glas slides and were incubated at distinct O2 concentrations. 
Cells were washed with PBS and mitochondria were stained using 200 nM Mitotracker 
Deep Red 633. Cells were incubated for 20 min at 37 °C, before washing 3 times with 
PBS. Cells were fixed with 4 % paraform aldehyde (PFA) for 20 min at RT. Cells were 
washed 3 times with PBS before incubating with blocking- and permeabilisation buffer 
for 1 h at RT, before adding antibodies, diluted in blocking- and permeabilisation buffer. 
After an incubation at 4 °C over night cells were washed three times with PBS and a 
secondary-Alexa Fluor 488 labeled antibody was added and incubated for 1 h at RT. 
Cells were washed 3 times with PBS. The actin-cytosceleton was stained using 6.6 nM 
Phalloidin Alexa Fluor 546 in PBS containing 1 % BSA. After one hour at RT and three 
washing steps nuclei were stained with 1 ng/ml Dapi. After a 5 min incubation at RT 
and three washing steps, the cells were mounted using Mowiol. Samples were stored in 
the dark at 4 °C. Images were obtained using the confocal microscope LCS SP2 (Leica). 
Deconvolution of images was performed using the program Huygens.
2. Materials and Methods                                                                                                  39  
2.2.3.10 Total glutathione assay
TE buffer: 10 mM Tris, 1 mM EDTA, pH 8
The  protein  content  of  cell  lysates  was  determined  before  protein  precipitation  by 
incubation with 4 % 5-sulfosalicylic acid over night at 4 °C. Samples were centrifuged 
for 30 min at 13000 rpm at 4 °C. The supernatant was transferred to a new tube and was 
neutralised to a pH of 7 by adding 1 M NaOH. Various dilutions in the linear range 
were analysed for total GSH level by a colorimetric assay based on the reduction of 
5,5'-Dithio-bis-(2-Nitrobenzoic  acid)  (DTNB)  to  the  yellow  product  TNB,  using 
standards  with known GSH concentrations  in  a range between 0 and 0.4 mM. The 
reaction  mixture  contained  1.5  mM  NADPH,  yeast  GR  and  1.5  mM  DTNB.  The 
reaction was measured as end-point in the Tecan reader at 412 nm.                  
2.2.3.11 Iron related enzymatic assays
Aconitase buffer: 100 mM Triethanolamin pH 8, 1.5 mM MgCl2, 0.1 % Triton-X-100;  
Citrate Synthase buffer: 50 mM Tris/HCl pH 8, 100 mM NaCl, 0.5 mM 5,5'-Dithio-bis-
(2-Nitrobenzoic acid), 0.1 % Triton-X-100
Cells  were fractionated as described before.  To determine protein activity,  the three 
fractions were analysed in different colorimetric assays, which were analysed using the 
Tecan microplate reader. Aconitase-Isocitrate Dehydrogenase activity was measured for 
2 h at 340 nm in a 96 well plate. The reaction mix contained aconitase buffer, 1.25 mM 
NADP, 1 mM cis aconitate and 40 mU/µl isocitrate dehydrogenase. Citrate Synthase 
activity was measured for 1 h at 412 nm in a 96 well plate. The reaction mix contained 
citrate synthase buffer, 25 µg acetyl CoA and 25 µg oxalacetate (Stehling et al. 2007). 
2.2.3.11.1 Measuring ferrochelatase activity 
Cells were harvested, washed twice in PBS and were frozen as cell pellets in liquid 
nitrogen. Cells were thawn and resuspended in 20 mM HEPES, pH 7.4, 50 mM KCl, 
1 mM MgSO4, 0.6 M sorbitol. 200 µg of protein, 1 mM ascorbate, 2 mM succinate, 
2.5 µM deuteroporphyrine and 1 µCi/10 µl 55Fe-Chloride were incubated for 15 min at 
30 °C, gently shaking. Samples were put on ice and stop-solution (100 mM FeCl2 in 
5 M HCl) and butylacetate were added. Samples were vortexed twice for 30 sec and 
were centrifuged for 5 min at 14000 rpm, before analysing using a scintillation counter.
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3. Results
3.1 Generation of new tools
In order to detect and quantify protein levels in samples of distinct origins, specific 
polyclonal antibodies were generated (3.1.1) and validated for Western blot analysis 
(described in 2.2.3.7). The specificity of the antibodies against antigens derived from 
human, mouse and rat was determined.  In general,  the Western blot is considered a 
strong tool to detect the protein of interest in samples containing a mixture of antigens, 
such as cell or tissue extracts. However, this method has limitations when it comes to 
proteins with low concentrations, such as Grx2. Therefore, a Grx2-specific sandwich 
ELISA (described in 2.2.3.5) was established (3.1.2), which constitutes a more sensitive 
method, also based on antigen detection by a specific antibody.  
Plasmids for protein overexpression in mammalian cell lines were generated (3.1.3), 
using the pExpress plasmid (Figure 10). In addition, the RNA interference technique 
was established in the work group, to specifically knock-down the protein expression of 
various oxidoreductases (3.1.3). Table 7 summarizes the new established tools. 
3.1.1 Generation and evaluation of new antibodies
Human  Prxs  1,  2,  4  and  6  were  cloned  from  human  cDNA (Biocat,  Heidelberg, 
Germany) using the primer pairs listed in  Table 2. The PCR products were integrated 
into the pGEM-T plasmid (Figure 8), before subcloning them into the pet15b plasmid 
(Figure  9)  for  protein  expression.  After  verification  by  sequencing,  plasmids  were 
transformed into the BL21(DE3)pRIL strain of  E. coli  (described in 2.1.7.1).  Bacteria 
were  cultivated  and proteins  were  expressed  as  His-tag  proteins  using  a  Fermenter 
(described 2.2.3.1) and purified using the Äkta Prime FPLC system (2.2.3.1). Rabbits 
were immunized by several injections of 40 µg protein (described in 2.2.3.2). Blood 
samples were taken and the serum was isolated. After heat inactivation, the serum was 
evaluated  by Western  blot  using  20  µg of  human,  mouse  and rat  cell  extracts  and 
tissues, which were prior to analysis reduced by 100 mM DTT. All generated antibodies 
led  to  clear  and  specific  bands  at  the  estimated  protein  sizes.  Using  antibodies 
preincubated with 100 µg of the respective antigen, resulted in a complete loss of signal 
(data not shown). Figure 14 exemplary shows the results for the 22 kDa hPrx1. 
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3.1.2 Grx2-specific sandwich ELISA
A Grx2-specific sandwich ELISA was established, to quantify protein levels in samples 
of distinct origins such as cell lysates, tissues or human patient samples. Mouse Grx2c 
antiserum  was  affinity-purified  and  biotinylated  (described  in  2.2.3.3).  Various 
concentrations  of  primary  and  secondary  antibodies  ranging  from  0.5  µg/ml  to 
10 µg/ml, as well as antigen standards of recombinantly expressed human, mouse or rat 
protein in the range of 0-100 µg/ml were tested (data not shown). Subsequently,  all 
experiments were performed using 0.5 µg/ml primary, 0.5 µg/ml secondary antibody 
and protein standards in the range of 0-32 µg/ml of human, mouse or rat Grx2. Even 
though  the  antibody  used  in  this  study  was  directed  against  the  mouse  protein,  it 
crossreacted with human and rat antigens with essentially the same specificity and a 
sensitivity of below 5 ng/mg total protein. Since the antibody was directed against the 
core part of the protein it was not possible to distinguish between the different isoforms 
of Grx2, but rather measure total levels of the oxidoreductase.  
Figure 14: Expression and purification of the 22 kDa hPrx1, showing coomassie-stained SDS gels,  
as well as antibody validation by Western blot. Protein expression (1-3) and purification (4-8) of 
BL21(DE3)pRIL  E.  coli cells,  transfected  with  hPrx1-pet15b.  Purified  protein  was  injected  into 
rabbits producing polyclonal anti-hPrx1 serum, tested for specificity by Western blot using distinct 
antigens (9-12). 1: Crude cell extract prior IPTG induced protein expression; 2: Crude cell extract 
after IPTG induced protein expression; 3+4: protein marker; 5: crude cell extract; 6: flow through; 
7: elution of the main fraction using 200 mM imidazole; 8: elution of the side fraction; 9: human 
HeLa cell extract; 10: murine MIN6 cell extract; 11: rat INS1 cell extract; 12: murine brain extract.
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Figure 15 shows a standard curve for human Grx2 and illustrates Grx2 levels in HeLa 
cells  (2.1.7.2)  transfected  with  siRNA against  all  isoforms  of  Grx2  and  a  Grx2c-
pExpress plasmid, compared to wildtype cells.
3.1.3 Overexpressing and silencing intracellular 
protein levels
Human  peroxiredoxins  1-6  were  cloned  from  human  cDNA (Biocat,  Heidelberg, 
Germany) using the primer pairs listed in  Table 2. The PCR products were amplified 
using the pGEM-T plasmid and subsequently transferred into the pExpress plasmid. 
After verifying the plasmids by sequencing (Seqlab, Göttingen, Germany), 3.5 million 
HeLa cells were transfected with 15 µg of DNA using the electroporation technique 
(described 2.2.2.6.1). HeLa cells transfected with an empty pExpress plasmid were used 
as  control.  Overexpression  was  analysed  after  24  h  by the  Western  blot  technique. 
20 µg of total cell extracts were reduced by a 20 min incubation with 100 mM DTT at 
RT, which was followed by a 10 min incubation at 94 °C. Proteins were separated by 
denaturing SDS-PAGE (described in 2.2.3.6), blotted on nitrocellulose membranes and 
analysed for protein levels using specific primary antibodies (stated in Table 1), HRP-
labeled secondary antibodies (stated in  Table 1) and the chemiluminescence method. 
Overexpression in HeLa cells was detected for all Prxs, which was at least two-fold the 
level of protein, compared to the control (data not shown).                
Figure 15: Grx2-specific sandwich ELISA. Left: standard curve using human protein standards in the 
range of 0-32 µg/ml. Right: Grx2 levels in HeLa WT cells (1), HeLa cells transfected with Grx2-
specific siRNA (2) and a Grx2c-pExpress plasmid (3).
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In addition,  we have performed site-directed mutagenesis (described in 2.2.1.2.1) to 
integrate  mutations  into  the  hGrx2c gene  incorporated  into  the  plasmid  pEGFP-N1 
(Figure 11). Human Grx2 was identified as an iron-sulfur protein. The [2Fe2S] cluster 
was shown to be coordinated by the N-terminal active site cysteinyl residues from two 
Grx2 monomers and two molecules of reduced GSH, which were non-covalently bound 
to hGrx2. Mutating the N-terminal Cys74 to a serine rendered the protein unable to bind 
the metal cofactor. Introducing the Thr95Arg mutation into the Grx2 gene attenuated 
the binding of GSH towards Grx2, affecting the stability of the cluster  (Lillig et al. 
2005), (Berndt et al. 2007). 
Within this study, the use of 
siRNAs  against  hGrx1, 
hGrx2, hTrx1 and hTrx2, as 
well as a scrambled control 
siRNA  was  established. 
HeLa cells were transfected 
with  15  µg  of  three 
different  test  siRNAs  per 
gene/protein  using  the 
electroporation  method. 
Protein  knock-down  was 
analysed  in  total  cell  extracts  after  three  days,  as  well  as  after  another  three  days 
following  a  second transfection.  The  protein  content  was  measured  photometrically 
according to Bradford (described in 2.2.3.4). 20 µg of total cell extracts were analysed 
for protein amounts by Western blot,  as  described above.  In the case of hGrx2, the 
protein  level  was  quantified  by  the  Grx2-specific  sandwich  ELISA  which  was 
established and optimized as described before (3.1.2).  Figure 16 exemplary shows the 
protein expression of HeLa cells transfected with test siRNAs against hTrx2 (Trx2si 
A,B,C). Trx2si B and C led to a significant reduction of Trx2 protein levels, whereas 
Trx2si A rather led to a slight increase. The first  transfection already resulted in an 
efficient reduction, which was even further decreased by the second transfection. HeLa 
cells  treated  with  scrambled  siRNA,  as  well  as  wildtype  HeLa  cells  were  used  as 
control.  Table 4 shows the sequences of the siRNAs which led to the lowest protein 
amount, including Trx2si C, and were used throughout this study. 
Figure  16: HeLa cells  were transfected with three test  siRNAs 
against hTrx2 (Trx2si A, Trx2si B, Trx2si C). After 3 days cells 
were transfected a second time. Scrambled siRNA treated cells as 
well  as  wildtype  HeLa  cells  were  used  as  transfection  control. 
Tubulin was used as loading control. 
3. Results                                                                                                                           44  
Tool Purpose Chapter
Antibody mGrx2c, affinity purified Protein detection by ELISA 3.1.2
Antibody mGrx2c, biotinylated Protein detection by ELISA 3.1.2
Antiserum hPrx1 Protein detection by Western blot and IHC 3.1.1
Antiserum hPrx2 Protein detection by Western blot and IHC 3.1.1
Antiserum hPrx4 Protein detection by Western blot and IHC 3.1.1
Antiserum hPrx6 Protein detection by Western blot and IHC 3.1.1
Grx2-specific ELISA Protein detection by ELISA 3.1.2
pet15b hPrx1 plasmid Protein expression in E. coli 3.1.1
pet15b hPrx2 plasmid Protein expression in E. coli 3.1.1
pet15b hPrx4 plasmid Protein expression in E. coli 3.1.1
pet15b hPrx6 plasmid Protein expression in E. coli 3.1.1
pExpress hPrx1 plasmid Protein overexpression in cells 3.1.3
pExpress hPrx2 plasmid Protein overexpression in cells 3.1.3
pExpress hPrx3 plasmid Protein overexpression in cells 3.1.3
pExpress hPrx4 plasmid Protein overexpression in cells 3.1.3
pExpress hPrx5 plasmid Protein overexpression in cells 3.1.3
pExpress hPrx6 plasmid Protein overexpression in cells 3.1.3
pGFP-N1 hGrx2 S74P Protein overexpression in cells 3.1.3
pGFP-N1 hGrx2 T95R Protein overexpression in cells 3.1.3
Protein hGrx2c Protein standards for ELISA 3.1.2
Protein hPrx1 Antiserum production in rabbits 3.1.1
Protein hPrx2 Antiserum production in rabbits 3.1.1
Protein hPrx4 Antiserum production in rabbits 3.1.1
Protein hPrx6 Antiserum production in rabbits 3.1.1
Protein mGrx2c Protein standards for ELISA 3.1.2
Protein rGrx2c Protein standards for ELISA 3.1.2
siRNA hGrx1 Silencing protein expression 3.1.3
siRNA hGrx2 Silencing protein expression 3.1.3
siRNA hTrx1 Silencing protein expression 3.1.3
siRNA hTrx2 Silencing protein expression 3.1.3
siRNA scrambled control Silencing protein expression 3.1.3
Table 7: Tools generated within this study, listed in alphabetic order.
3. Results                                                                                                                           45  
3.2 Does mitochondrial hGrx2 reduce 
Prx3 in vivo?
Prior to this study, in vitro kinetics of recombinantly expressed human proteins revealed 
that the mitochondrial Grx2 could donate electrons to the 2-Cys Prx3, but not to the 
atypical  2-Cys  Prx5.  So  far,  the  reduction  of  mammalian  peroxiredoxins  was  only 
ascribed to the Trx system. To analyse if Prx3 is a substrate for Grx2 in vivo, HeLa cells 
were transfected twice with specific siRNAs against  hGrx2 and hTrx2, reducing the 
protein  levels  to  5-20  % compared  to  control  cells  treated  with  scrambled  siRNA, 
analysed by ELISA or Western blot (Figure 17C), respectively.  
Prior  to  cell  lysis,  cells  were  treated  with  100  mM  N-ethylmalemeide  (NEM),  an 
alkylating  agent  which  exclusively  and  irreversibly  binds  to  reduced  thiol  groups, 
preventing them from further oxidation. Cell extracts were analysed via a specific redox 
blot for 2-Cys Prxs (described in 2.2.3.7.1). Due to an intermolecular disulfide, oxidised 
Prx3 could be identified as a dimeric band at 46 kDa and reduced, monomeric Prx3 at 
23 kDa. 10 µg of total cell extracts were separated via denaturing SDS-PAGE, blotted 
on  PVDF  membranes  and  analysed  using  a  specific,  polyclonal  primary  antibody 
against  Prx3,  HRP-labeled  secondary antibody and the  chemiluminescence  method. 
Silencing the expression of only Grx2 or Trx2 did not significantly increase the levels 
of oxidised Prx3, compared to scrambled siRNA control cells. However, transfecting 
HeLa cells with both siRNAs simultaneously led to the accumulation of oxidised Prx3 
(Figure 17A,B). To exclude that the oxidation of Prx3 was a secondary effect due to 
generally  increasing  oxidative  conditions  resulting  from  the  absence  of  the  two 
mitochondrial  redoxins  and  major  antioxidants,  cell  extracts  were  analysed  for 
oxidative modifications of proteins, i.e. glutathionylation and carbonylation.  
Glutathionylation  constitutes  the  reversible,  covalent  binding  of  GSH  to  cysteinyl 
residues of target proteins. It is regarded as cellular response to changes in the redox 
state, transducing oxidative stimuli into adjusted protein function. In addition, it was 
proposed  that  glutathionylation  could  be  a  mechanism  to  protect  proteins  from 
irreversible  oxidation  (Fratelli  et  al.  2004).  Glutathionylation  was  analysed  by  the 
Western blot technique using a specific antibody against GSH.  
Carbonylation on the other hand is an irreversible modification, which generally is used 
as marker for protein modifications induced by increased oxidative conditions. 
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In order to measure carbonylation (described in 2.2.3.7.2), 30 µg of cell extracts were 
incubated  with  2,4-dinitrophenylhydrazine,  forming  protein-bound  2,4-
dinitrophenylhydrazones (DNP). These hydranozones were analysed by Western blot 
using a specific DNP antibody. Neither the detection of glutathionylated proteins, nor 
the analysis of protein carbonylation showed any differences in the amount of oxidative 
modified proteins in the differently treated cell extracts (data not shown). 
Figure 17: Prx3 is a substrate for the mitochondrial Trx and Grx systems. A) The redox state of hPrx3 
was analysed in HeLa cells with decreased expression levels of Grx2, Trx2 or both oxidoreductases, due 
to transfection with specific siRNAs. HeLa cells transfected with unspecific scrambled (scr) siRNA were 
used as control. Cell extracts were, prior to cell lysis, treated with NEM to block free thiol groups and 
analysed by Western blot.  Due to an intermolecular  disulfide,  oxidised Prx3 could be detected as a 
dimeric band at 46 kDa and reduced Prx3 as monomeric band at 23 kDa. B) The results from three 
independent Western blots were quantified using ImageJ. Oxidised Prx3 is constituted in %. C) Grx2 
levels were analysed by a specific sandwich ELISA, and Trx2 levels by Western blot. The diagrams 
represent data from three independent experiments (Hanschmann et al. 2010).
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Redox  reactions  are  rapid  and  specific  signaling  events.  Reducing  or  oxidising 
compounds respectively,  can  lead  to  posttranslational  modifications  of  cysteinyl 
residues.  The  general  kinetics  behind  these  events  are  missing,  i.e.  how  fast  the 
oxidation of a certain protein upon an oxidizing stimuli is, as well as the subsequent 
reduction or regeneration.                        
To answer these questions for the oxidation and subsequent reduction of hPrx3 in vivo, 
HeLa cells were treated with 50 µM H2O2 – a concentration which led to a rapid, but 
fully reversible oxidation of the peroxidase. HeLa cells were harvested, washed once 
with  PBS  and  were  incubated  with  H2O2,  diluted  in  PBS  buffer.  After  different 
incubation times the cells were centrifuged at 2000 rpm for one minute, incubated in 
NEM-lysis buffer for 15 minutes and shock frozen in liquid nitrogen. Cell extracts were 
analysed for total protein amount according to Bradford and for the redox state of hPrx3 
via the above described 2-Cys Prx-specific redox blot.  
Figure 18 illustrates the quantification of the Western blot bands using the programs 
ImageJ and Grace. Without the oxidizing stimuli, HeLa cells contained 87 % reduced 
hPrx3.  Upon  H2O2 
treatment the peroxidase 
was  rapidly  oxidised. 
After an incubation time 
of two minutes, less than 
30  % of  the  peroxidase 
were in  the catalytically 
active  state.  After  five 
minutes  the  oxidised 
protein   recovered  to 
35 %, after another five 
minutes  to  50  %. 
30  minutes  after  the 
H2O2 treatment  the 
peroxidase  recovered, 
with more than 80 % of 
the  protein  being  in  the 
monomeric,  catalytically 
active form.
Figure  18: Oxidation of intracellular hPrx3 by H2O2 in HeLa cells. 
HeLa cells were treated with 50 µM H2O2. The oxidation was stopped at 
different time points by adding the alkylating agent N-ethylmalemeide, 
which prevented oxidation of free thiol groups irreversibly. Cell extracts 
were analysed by Western blot. Densitometric analysis was performed 
using ImageJ and Grace.
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3.3 Trx proteins in iron homeostasis
Iron  is  an  essential  trace  element  functioning  for  instance  in  the  mitochondrial 
respiratory chain, the tricarboxylic acid cycle and DNA synthesis as cofactor of proteins 
such as hemoglobin, cytochromes and iron-sulfur proteins. Iron regulation needs to be 
tightly  controlled  because  iron  starvation  and  also  iron  overload  constitute  toxic 
conditions for cells.  
Glutaredoxins were shown to be involved in iron regulation and FeS cluster assembly in 
various  organisms.  However,  the  only report  in  mammals  described  a  homozygous 
silent mutation in the Grx5 gene of a human patient, suffering from sideroblastic-like 
microcytic anemia and iron overload (Camaschella et al. 2007). 
Here,  the  impact  of  silencing  the  expression  of  distinct  Trx  family proteins  on  the 
cellular iron regulation and the biosynthesis of FeS clusters was examined. HeLa cells 
were  transfected  twice  with  specific  siRNAs,  reducing the  protein  levels  of 
cytosolic/nuclear  dithiol  Trx1,  mitochondrial  dithiol  Grx2  and  cytosolic/nuclear 
monothiol Grx3 to less than 5-10 % compared to control cells treated with scrambled 
siRNA.  Crude  cell  extracts  were  analysed  for  protein  levels  of  the  iron  regulatory 
protein  IRP1  and  the 
target  proteins  ferritin 
and  the  transferrin 
receptor  using  the 
Western  blot 
technique.  IRP1 
contains  a  [4Fe4S] 
cluster  and  catalyses 
the  conversion  from 
citrate  to  isocitrate  in 
the  tricarboxylic  acid 
cycle.  Upon  iron 
deficiency the cofactor 
is  lost  and the protein 
binds  to  IREs  on  the 
mRNA  of  distinct 
targets,  upregulating 
Figure 19: Iron regulation and FeS cluster synthesis in HeLa cells with  
reduced Trx1 and Grx2 protein levels. Cells transfected with scrambled 
siRNA were used  as  control.  Protein expression levels  of  tubulin,  the 
cytosolic iron-regulatory protein 1 (IRP1), transferrin receptor (TfR) and 
ferritin  (Fer),  as  well  as  the  cytosolic  FeS  protein  glutamine 
phosphoribosylpyrophosphate amidotransferase (GPAT) were detected by 
Western Blot  and were quantified.  Data are presented in %,  regarding 
scrambled control cells as 100 %.
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for  instance  the  expression  of  the  TfR  and  repressing  the  translation  of  ferritin. 
Moreover,  the  cytosolic  glutamine  phosphoribosylpyrophosphate  amidotransferase 
(GPAT), coordinating a [4Fe4S] cluster was analysed. The enzyme catalyses the first 
reaction of the de novo purine pathway. GPAT is regarded as a marker protein for the 
intact biosynthesis of iron-sulfur cluster coordinating proteins, because it is less stable 
and quickly degraded without  the  iron  cofactor (Zhou et  al.  1992),  (Stehling  et  al. 
2008). 
20  µg  of  total  cell  extracts  were  separated  by  SDS-PAGE  without  prior  protein 
reduction.  Proteins  were  transferred  on  nitrocellulose  membranes  and  detected  by 
specific  primary  antibodies,  HRP-coupled  secondary  antibodies  and  the 
chemiluminescence method. Antibodies and dilutions are listed in Table 1.  
Western blot analysis of Trx1 depleted cells revealed an affected iron regulation, but no 
effect on FeS cluster biosynthesis (Figure 19). Compared to control cells, IRP1 levels 
were reduced to 50 % and ferritin decreased to approximately 25 %. The amount of the 
TfR was increased to 124 %. Knock-down of Trx1 showed no changes in GPAT levels 
(Figure 19).                                                   
Iron regulation in Grx2 depleted cells was not comprehensibly affected. IRP1 levels 
were slightly decreased,  the TfR was slightly increased and ferritin  was reduced to 
32 %, compared to  scrambled  control  cells.  However,  GPAT was downregulated to 
60  %,  indicating  that  Grx2  knock-down  affected  the  biosynthesis  of  FeS  cluster- 
coordinating proteins (Figure 19).                    
Knock-down  of  Grx3  in  HeLa  cells  had  the  strongest  effect  on  cellular  iron 
homeostasis,  impairing  not  only  general  iron  regulation,  but  also  FeS  cluster 
biosynthesis. IRP1 was downregulated to less than 50 %, ferritin to 12 % and the TfR 
was upregulated to more than 200 %. The expression level of GPAT was reduced to 
50 % (Figure 20A,B).  
Because Grx3 depletion resulted in the strongest phenotype, we focussed on analysing 
the  effects  of  reduced  protein  levels  of  the  monothiol,  multidomain  glutaredoxin. 
Since the protein amount of IRP1 was decreased to 50 %, the activity of the regulatory 
protein was analysed in Grx3 depleted cells, which were fractionated using digitonin 
(described  in  2.2.2.5).  Protein  activity  was  measured  in  total  cell  lysates,  cytosolic 
fractions and pellet fractions, containing membrane enclosed compartments including 
nuclei and mitochondria. Enzyme activity of the cytosolic aconitase was measured in an 
enzymatic assay following NADP consumption at  412 nm in a 96-well  plate reader 
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(Tecan)  (described  in  2.2.3.11).  Activity  of  citrate  synthase,  another  enzyme of  the 
tricarboxylic acid cycle which does not coordinate an iron-sulfur cluster and was not 
affected by Grx3 depletion was used as a control (data not shown).
Down-regulation of Grx3 resulted in diminished protein activity of cytosolic aconitase 
of 40 % compared to control cells (Figure 20C). In order to determine if Grx3 depletion 
also  affected  mitochondrial  proteins,  the  activity  of  mitochondrial  FeS  and  heme 
proteins was  investigated.  Activity of the mitochondrial  heme protein cytochrome  c 
oxidase, i.e. complex V of the respiratory chain, was measured photometrically in the 
pellet  fraction.  Knock-down  of  Grx3  led  to  a  decrease  in  enzyme  activity  of 
approximately  20  %  (Figure  21A).  A  similar  reduction  in  enzyme  activity  was 
determined for the mitochondrial ferrochelatase, which coordinates a FeS cluster that is 
essential  for  protein  activity.  It  catalyses  the  last  step  in  the  biosynthesis  of  heme. 
Protein  activity  was  determined  in  whole  cells,  following  the  insertion  of  55Fe  in 
deuteroporphyrine using a scintillation counter.  Grx3 depleted HeLa cells  showed a 
reduced  enzyme  activity  of  80  %,  compared  to  control  cells  (Figure  21B). 
Mitochondrial  aconitase activity was essentially the same, compared to control cells 
Figure 20: Knock-down of hGrx3 affects cytosolic iron homeostasis and biosynthesis of FeS clusters. 
HeLa cells were transfected with siRNA against hGrx3 and scrambled siRNA as control. Protein levels 
of Grx3, tubulin, iron-regulatory protein 1 (IRP1), transferrin receptor (TfR) and ferritin (Fer), as well as 
the FeS protein GPAT were detected by Western blot (A) and were quantified using ImageJ (B). Cells 
were  fractionated  and  cytosolic  aconitase  activity  (C)  was  measured.  Enzyme  activity  is  stated 
in %, regarding scrambled control cells as 100 % (modified from Haunhorst et al. 2011, unpublished 
manuscript, compare to 4.3). 
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(Figure 21C). However, when these data were correlated to the actual protein levels of 
mitochondrial aconitase (Figure 21D), determined by Western blot and quantified by 
ImageJ, a decrease in specific activity to approximately 80 % was determined (data not 
shown).
Figure 21: Knock-down of Grx3 affects mitochondrial iron homeostasis and biosynthesis of FeS and 
heme proteins. HeLa cells were transfected with siRNA against Grx3 and scrambled siRNA as control 
and fractionated using digitonin. Activity of the heme protein cytochrome c oxidase (A), ferrochelatase, 
which depends on the insertion of a FeS cluster (B) and mitochondrial aconitase (C) were measured. 
Western blot  of  control  and Grx3-depleted cells  shows the protein levels of  mitochondrial  aconitase 
(mtAco) (D) (Haunhorst et al. 2011, manuscript, compare to 4.3). 
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3.4 Localization of Trx family proteins in 
the normal and the asphyxic brain 
In a cooperative project with the group of Prof. MD, PhD Francisco Capani from the 
University of Buenos Aires, the distribution of thioredoxin family proteins (Trx1, Trx2, 
TrxR1, TrxR2, Grx1, Grx2, Grx3, Grx5, Prx1, Prx2, Prx3, Prx4, Prx5, Prx6) and related 
proteins  (Txnip,  γGCS)  was  studied  in  the  rat  central  nervous  system  by 
immunohistochemistry (described in 2.2.3.8; performed by Laura Aon-Bertolino). The 
cerebellum, striatum, hippocampus, spinal cord, substantia nigra, cortex and retina – 
regions of the brain which are most sensitive to an ischemic insult – were analysed. The 
aim of this project was to examine the localisation of the above mentioned proteins in 
order  to  understand why various  cell  types  differ  in  their  susceptibility  towards  an 
ischemia/reperfusion insult. All antibodies used within this study are stated in  Table 1 
and were validated for rat tissue. 30 µg of cell extracts of the rat insulinoma cell line 
INS1  were  reduced  with  100  mM  DTT for  20  min  at  RT and  another  10  min  at 
94  °C.  In  addition,  50  mM TCEP were  added to  ensure  better  disulfide  reduction. 
Samples were analysed for protein expression by Western blot. The antibody against 
γGCS recognized the catalytic subunit of the protein.  
Figure 22: Antibody specificity in rat cell extracts. 30 µg of cell extracts of rat insulinoma cells (INS1) 
were reduced with 100 mM DTT and 50 mM TCEP, separated by denaturing SDS-PAGE, blotted on 
nitrocellulose membranes, stained using primary antibodies, HRP-coupled secondary antibodies and the 
enhanced  chemiluminescence  method.  The  scale  to  the  left  indicates  the  protein  size  in  kDa 
(Aon-Bertolino et al. 2011).
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All antibodies detected the rat antigen and showed specific bands at the expected sizes 
(Figure 22). Weak bands e.g. in the case of Prx1 indicated insufficient protein reduction. 
All  proteins  were detected throughout  the brain and showed a tissue and cell  type- 
specific  staining.  Figure  32 exemplary  shows  the  distribution  of  redoxins  in  the 
hippocampus.  
We have furthermore collected samples from a rat model mimicking perinatal asphyxia 
(described in 2.1.8.1), a condition where a newborn suffers from oxygen deprivation. 
Trx  family  proteins  have  been  implicated  in  various  diseases,  including  conditions 
related to oxygen deprivation. To understand the role of the protein family in hypoxia, 
we have analysed the expression and distribution of these proteins.  
Fullterm  pregnant  rats  were  rendered  unconscious  by  CO2  inhalation  and  were 
decapitated. The uterus horns were isolated and incubated in a waterbath at 37 °C. After 
19 minutes the uterus horns were opened, the pubs were cleaned and monitored for 
one hour while stimulating breathing by performing tactile intermittent. One hour to 
seven days after the procedure, male animals were killed by CO2  inhalation, the brain 
was extracted and the hippocampus was isolated. Part of the tissue was homogenized 
and prepared for  analysis  by Western blot  and ELISA. The other  part  was cut  into 
sections  for  IHC  analysis,  performed  by  Laura  Aon-Bertolino.  Expression  and 
distribution of Grx1, Grx2, Trx1 and Trx2 were determined. Tissues of untreated pubs 
were used as control.  
Grx2, Trx1 and Trx2 showed the strongest staining four hours after the induction of 
hypoxia, compared to control samples. In the samples, collected after seven days, no 
significant changes in protein expression were detected (data not shown). 
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3.5 Trx family proteins in ischemia/  
reperfusion injury
HEK293  cells  (2.1.7.2)  -  human  embryonic 
kidney cells – were used as a cell model to 
analyse  if  cellular  protein  levels  and 
localisation  of  members  of  the  Trx  protein 
family depend on the environmental  oxygen 
concentration.  Cells  were  cultivated  in  an 
atmosphere containing distinct concentrations 
of oxygen for 24 h: 20 % O2, a concentration 
commonly  used  for  cell  culture,  1  %  and 
0.1 %. Cells  were washed with PBS buffer, 
harvested  and  lysed  in  NP40-lysis  buffer. 
Protein  levels  of  Trx  family  proteins  were 
analysed by the Western blot technique using 
10-20  µg  of  cell  extracts,  reduced  with 
100 mM DTT and 50 mM TCEP as described 
above.  Various  proteins,  commonly  used  as 
loading  controls,  i.e  the  cytosceletal 
components  tubulin  and  actin,  as  well  as 
glyceraldehyde  3-phosphate  dehydrogenase 
(GAPDH),  the  enzyme  catalysing  the  sixth 
step  of  glycolysis,  were  also  analysed.  All 
proteins  responded  to  the  hypoxic  insult. 
GAPDH for  instance,  was  upregulated  with 
decreasing  O2 concentrations  (Figure  23). 
However, the overall protein concentration of 
all  samples  was  thoroughly  analysed  by 
Bradford. Figure 23 summarizes the results of 
the  Western  blot  analysis.  Generally,  Trx 
family proteins showed a complex response to 
the  hypoxic  insults.  Protein  levels  of  Grx1, 
Grx5,  Prx2,  TrxR1  and  Nrx  increased, 
Figure 23: Protein expression of Trx family 
proteins  is  sensitive  to  oxygen 
concentrations. HEK293 cells were grown in 
an atmosphere containing distinct O2 (0.1 %, 
1  %,  20  %)  concentrations.  Protein  levels 
were analysed by Western blot, using 20 µg 
of  total  cell  extracts,  preincubated  with 
100 mM DTT and 50 mM TCEP.
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whereas the levels of Prx1, Prx5 and TrxR2 decreased. Grx3, Trx1 and Trx2 showed 
similar levels at 0.1 % and 20 %, but were downregulated at 1 %, whereas Prx4 was 
upregulated  at  1  %.  Prx3  and  Prx6  did  not  display  any  significant  changes.  We 
subsequently  analysed  Trx  family  proteins  in  a  mouse  model,  where  renal 
ischemia/reperfusion injury (2.1.8.2) was induced by clamping the pedicle of the right 
kidney for 30 min and releasing it afterwards for another 24 h. This animal model was 
established in the AG Lillig by Dr. José Godoy, who performed all animal experiments. 
Blood and urine specimens, as well as the ischemic and the contralateral kidney were 
used for  analysis.  Sham operated mice,  animals  where the kidney was exposed for 
30 min, but was not clamped,  were used as control. Numerous parameters including 
consistent body weight, decreased urea elimination, proteinuria, increased segmented 
nuclei cells, indicating the start of an inflammation as well as histological changes of 
the kidney, such as loss of brush borders, tubular cell flattening and luminal obstruction 
indicated the success of the procedure (Godoy et al. 2011b, Table 9, Figure 33). 
Figure 24: Expression levels of Trx family proteins in a model for renal ischemia/reperfusion injury. 
The I/R (right kidney), contralateral (left kidney) and sham kidneys were analysed for protein levels by 
Western blot and in the case of Grx2 by sandwich ELISA. Data were quantified using ImageJ and state 
the fold-increase in percent as means +/- SEM, comparing I/R and contralateral kidneys to the control 
sham kidneys (Godoy et al. 2011b, compare to 4.3).
3. Results                                                                                                                           56  
Protein levels of members of the Trx family were analysed in the ischemic and the 
contralateral  kidney by Western blot and ELISA.  Figure 24 summarizes the results, 
representing the means +/- SEM, stating the fold-increase in percent of each protein of 
the I/R or the contralateral kidney with respect to the control sham operated kidneys. 
Most of the proteins did not show any significant changes, neither in the ischemic, nor 
in  the  contralateral  kidney.  However,  the  levels  of  Grx5,  Trx1  and  Trx2  were 
significantly increased to approximately 140-150 %, following the I/R insult. Grx1 was 
decreased to 82 %. In contralateral kidneys Grx5 was upregulated to more than 150 % 
and Prx6 to 138 %. TrxR2, Prx4 and Prx5 were downregulated compared to the control 
kidneys.  Immunohistochemical  analysis  of  the  distribution  of  redoxins  in  distinct 
regions of the kidney revealed that Grx2, Prx3 and Prx6 were the only redoxins which 
were  exclusively  overexpressed  in  proximal  tubule  cells,  a  cell  type  which  can 
regenerate  after  an  I/R insult  (Sutton  et  al.  2002),  (Nony and Schnellmann,  2003). 
Members  of  the  Trx  family  have 
been  shown  to  affect  the  cell 
cycle,  regulating  proliferation, 
differentiation  and  apoptosis 
(Powis  et  al.  1998),  (Lillig  et  al. 
2004) (Enoksson et  al.  2005). To 
analyse  if  this  is  generally  also 
valid for hypoxic conditions, Grx2, 
Prx3 and Prx6 were overexpressed 
in  HEK293  cells  using  pExpress 
plasmids  (compare  to  Figure  10 
and  3.1.3).  HEK293  cells  were 
chemically  transfected  using 
lipofectamin  (described  in 
2.2.2.6.2).  Six  hours  after 
transfection, cells were transferred 
into the hypoxic incubator at 0.1 % 
O2 for  24  h,  followed  by  a 
reoxygenation  period  at  20 % O2 
for another 24 h. The efficiency of 
chemical  transfection  was 
Figure  25: Overexpression of Grx2,  Prx3 and Prx6 in  
HEK293 cells exposed to hypoxia. Cells were transiently 
transfected with redoxins and an empty plasmid as control 
(ctrl) using lipofectamin. Cells were incubated at 0.1 % O2 
for 24 h and reoxygenated at 20 % O2 for another 24 h. The 
cell  number  was  determined  using  an  automatic  cell 
counter.  The  average  of  ≥ 5 independent  experiments  is 
illustrated ± the standard error of the mean (adapted from 
Godoy et al. 2011b). 
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generally similar to the physical approach of electroporation, analysed by Western blot 
and ELISA, leading to a two to three fold overexpression, compared to control cells 
transfected with an empty pExpress plasmid (data not shown). Overexpression of all 
three redoxins in HEK293 cells led to an increase in cell number compared to control 
cells, analysed using an automatic cell counter (Cellometer, PeqLab). Figure 25 depicts 
the  increase  in  cell  number  normalised  to  the  control.  Overexpression  of  the 
mitochondrial hGrx2 increased the cell number about 1.5 times, hPrx3 overexpression 
about 1.8 times and  Prx6 more than two times. 
3.6 Trx family proteins in a cellular model  
for pancreatic β-cell transplantation
We have used the murine cell  line MIN6 (compare to 2.1.7.2) as cellular  model to 
analyse  the responses  of pancreatic  β-cells  to  changes  in  the environmental  oxygen 
concentrations. MIN6 cells constitute a highly differentiated and glucose responsive cell 
line,  which  is  widely  used  in  the  field  of  diabetes  research.  Transplantation  of 
pancreatic β-cells is regarded as a promising therapeutic approach for diabetes mellitus. 
However,  during  the  isolation  and  subsequent  implantation,  β-cells  are  exposed  to 
different oxygen concentrations.  The generation of ROS and inflammatory reactions 
may prevent longterm cell survival, regeneration of β-cells and restoration of insulin 
production (Chou and Sytwu, 2009). MIN6 cells were very sensitive towards hypoxic 
insults, compared to the analysed HEK293 cells. MIN6 cells were cultured for 12 h at 
1 % and 2 % O2 – an incubation time which led to 40 % cell death compared to cells 
incubated at 20 % O2, measured with the proliferation and viability XTT kit (Roche, 
Mannheim, Germany) (data not shown). Part of the cultures were reoxygenated for 12 h 
at 20 % O2. Medium was collected to analyse protein secretion, as well as cells, lysed in 
NP40-containing buffer, to determine GSH and protein levels. Total GSH levels were 
analysed in a colorimetric enzymatic assay measuring the formation of the yellow TNB 
from DTNB, using a 96-well plate reader (described in 2.2.3.10). Figure 26 illustrates 
that  the  intracellular  GSH levels  decreased  upon  the  hypoxic  insult  in  an  oxygen-
dependent way. Cells grown under 20 % O2 contained 20 nmol/mg protein total GSH, 
whereas cells grown in an atmosphere containing 1 % or 2 % O2 only had GSH levels 
of  4 nmol/mg protein and less than 5 nmol/mg protein, respectively. This effect was 
reversible, the levels increased again to 7 nmol/mg protein and 9 nmol/mg protein for 
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cells cultured at 1 % and 2 % oxygen, respectively. Grx2 levels were analysed using the 
established  sandwich  ELISA.  Figure  26 shows  that  the  intracellular  Grx2  levels 
responded similar to the total GSH levels. Grx2 levels decreased upon low levels of 
oxygen. Cells cultured in an atmosphere containing 2 % oxygen contained 55 % Grx2, 
cells grown at 1 % oxygen 40 %, compared to cells grown under normoxic, i.e. 20 % 
O2,  conditions.  Reoxygenation  led  to  an  increase  in  both  cases  with  Grx2  levels 
recovering to approximately 80 %. The other redoxins were analysed by Western blot 
using  20 µg of  total  cell  extracts,  reduced with  100 mM DTT and 50 mM TCEP. 
Figure 26 summarizes the Western blots. The hypoxic insults led to distinct responses in 
the protein amount of the redoxins. Grx1, Grx3 and Grx5 diminished with lower O2 
concentrations.  For  Grx1 a  higher  expression was detected  after  the  reoxygenation, 
compared to the hypoxic condition, whereas no change was seen for the monothiol Grxs 
Grx3 and Grx5. Prxs responded differently to the hypoxic insults. The protein amounts 
of  Prx2  and  Prx6 
strongly  decreased  with 
less oxygen, while Prx4 
levels  increased.  Prx3 
was  also  downregulated 
upon  hypoxia  and  even 
less protein was detected 
after  the  reoxygenation 
period.  Cytosolic  Prx1 
and  mitochondrial  Prx5 
showed similar changes, 
with  strongly  increased 
protein  levels  after 
hypoxia  and  decreased 
levels  following  the 
reoxygenation.  The  Trx 
system showed opposite 
responses  to  the  growth 
conditions,  when 
comparing  the  cytosolic 
and  the  mitochondrial 
Figure  26: Total GSH levels and protein expression of Trx family  
proteins in MIN6 cells grown for 12 h at 1 %, 2 % or 20 % O2, plus  
12  h  reoxygenation  at  20  %,  if  indicated. Total  GSH levels  were 
measured  in  a  colorimetric  assay using DTNB as  substrate.  Protein 
levels were analysed by ELISA and Western blot.
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systems. The levels of cytosolic Trx1 and TrxR1 were significantly decreased, whereas 
the levels of mitochondrial Trx2 and TrxR2 increased. The cytosolic/nuclear Nrx, which 
contains Trx and Grx domains, acted comparably to Trx2. Txnip, which was discovered 
as  inhibitor  of  Trx,  but  was  also  shown  to  have  functions  independent  from  the 
oxidoreductase, was also upregulated, showing a higher expression after reoxygenation. 
Similar results were also seen after 24 h of reoxygenation (data not shown).  
Various redoxins, including Grx1, Grx3, Trx1 and Nrx were described to translocate 
through the cell, with a change in localisation being essential for the diverse functions 
of  the  protein  family.  The  cellular  distribution  of  the  redoxins  was  analysed  by 
immunocytochemistry  (described  in  2.2.3.9).  Besides  a  reduction  in  the  general 
intensity of Trx1 staining, no significant changes in the subcellular localisation of the 
above mentioned proteins was detected (data not shown). 
Moreover, the potential secretion of the redoxins was analysed 
in medium samples by performing Western blot analysis. Only 
Trx1  was  detected  in  the  medium  of  cells  grown  under 
hypoxic conditions and after reoxygenation. Within the above 
described  experiments,  cells  were  not  washed  between  the 
hypoxic  insult  and  the  reoxygenation  period.  Therefore, 
secretion  of  Trx1 was  furthermore  analysed  in  cells,  which 
received fresh medium between the two conditions. Trx1 was 
only  observed  in  the  medium  after  hypoxia,  not  after 
reoxygenation (Figure 27). The diverse effect on the cytosolic 
and the mitochondrial  Trx system was also seen in primary 
islet cells derived from pig (compare to 2.1.7.2 and 2.1.8.3.1). 
However, the overall signals in the Western blots were weaker, 
compared to human, mouse or rat antigens (data not shown). 
In  addition,  the  group  of  Prof.  Dr.  Linn  at  the  Justus-Liebig  Universität  Gießen, 
confirmed our data in an animal  model for diabetes or rather the transplantation of 
pancreatic  β-cells. They analysed tissues of healthy, non-diabetic mice and mice with 
streptozotocin-induced diabetes (compare to 2.1.8.3) which received pancreatic β-cells 
via an injection into the portal vein. The injected cells settled in the liver and started 
producing insulin. Pancreas as well as the liver of transplanted animals were analysed 
30 min (hypoxic state) and 120 days (reoxygenation state) after the transplantation by 
Figure  27:  Secretion  of  
Trx1  in  MIN6  cells, 
cultured for 12 h at 20 % 
or  2  %  O2,  plus  12  h 
reoxygenation at 20 %, if 
indicated.
3. Results                                                                                                                           60  
performing immunofluorescence.  Pancreatic  β-cells  were costained with an antibody 
against insulin. Trx1 and TrxR1 were downregulated whereas Trx2 and TrxR2 were 
upregulated  in  β-cells  shortly  after  transplantation.  After  120  days,  no  significant 
changes were detected, compared to untreated β-cells within the healthy pancreas (data 
not shown, compare to 4.3).  
We furthermore  explored  if  the  overexpression  of  hTrx1 and hTrx2 in  MIN6 cells 
affected cell survival after hypoxia and reoxygenation, analysing the phosphorylation 
pattern of the MAP kinases ERK1/2,  JNK1/2/3 and p38. MAP kinases regulate cell 
proliferation, differentiation and apoptosis via phosphorylation cascades in response to 
for instance growth or stress stimuli.                                              
MIN6 cells were incubated for different durations in an atmosphere containing 2 % O2 
or 20 % O2. Upon normoxic conditions nearly no phosphorylated ERK1/2 was detected 
by Western blot.  Increased levels of phosphorylated ERK1/2 were detected after six 
hours hypoxia, increased up to 12 h and were stable up to 24 h (data not shown).  
MIN6 cells were transfected in 6-well plates using lipofectamin. After 12 h cells were 
transferred into the hypoxic chamber for 12 h in an atmosphere containing 2 % O2. Part 
of the cells were reoxygenated for 24 h at 20 % O2. Cells were harvested and lysed in 
NP40-containing  lysis  buffer  supplemented  with  phosphatase  inhibitors. 
MIN6  cells  grown  under  normoxic  conditions  constituted  the  proliferative  state. 
Cells cultured in a hypoxic environment reacted with an anti-stress response, whereas 
cells exposed to hypoxia and reoxygenation responded with an anti-apoptotic reaction. 
Trx1 overexpression slightly increased the phosphorylation of ERK1 and ERK2 under 
normoxic  conditions,  but  not  under  hypoxic  conditions.  Trx2  overexpression 
significantly increased the phosphorylation of ERK1 and ERK2 under normoxic, but 
not under  hypoxic conditions.  
Increasing  the  intracellular  levels  of  Trx1  furthermore  decreased  the  levels  of 
phosphorylated JNK1, JNK2 and JNK3 under hypoxia and decreased the amount of 
phosphorylated p38 under hypoxia and reoxygenation. Elevating the levels of Trx2 also 
led to lower levels of  JNK1, JNK2 and JNK3 under hypoxia, but only decreased levels 
of phosphorylated p38 slightly under hypoxia and reoxygenation (Figure 28). 
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Figure  28:  Phosphorylation  of  MAP kinases  in  MIN6 cells  grown under  hypoxic  conditions. 
MIN6 cells were transfected with an empty pExpress plasmid, Trx1-pExpress and Trx2-pExpress and 
grown for 12 h at 2 % or 20 % O2, followed by 24 h reoxygenation at 20 % O2, if indicated. Cell 
lysates were analysed for levels of ERK1 (row 1), ERK2 (row 2), JNK1/2 (row 3), JNK3 (row 4) and 
p38 (row 5). Column 1 illustrates total protein levels in %, compared to pExpress control cells grown 
at 20 % O2. Column 2 shows phosphorylated protein in %, compared to pExpress control cells grown 
at 20 % O2. Column 3 displays phosphorylated protein in %, compared to pExpress control cells 
grown under each  specific O2  concentration.
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4. Discussion
4.1 New substrates, new functions
The  oxidoreductases  of  the  glutaredoxin  system reduce  disulfides  and  catalyse  the 
de-/glutathionylation in  a  wide range of substrates.  Grxs  were shown to reduce the 
catalytic disulfide of 2-Cys Prxs in plants (Rouhier et al. 2002).              
In mammalian cells on the other hand, the reduction of 2-Cys Prxs was only ascribed to 
the Trx system (Chae et al. 1999). Cytosolic Grx1 was analysed in these studies with no 
detectable  peroxidase  activity  for  the  cytosolic  Prx1  and  Prx2,  as  well  as  for  the 
mitochondrial Prx3 and Prx5 (Seo et al. 2000). Mitochondrial Grx2 was not included. 
Since these studies, Grx2 has obtained a special status in the family, because it is able to 
receive electrons not only from GSH, but also from TrxR, combining the features of the 
Grx and the Trx system 
(Johansson et al. 2004). 
We have shown here for 
the  first  time,  that 
mammalian  Grx2 
catalyses  the  reduction 
of  the  intermolecular 
disulfide  of  the  2-Cys 
Prx3.  Silencing  the 
expression  of  Grx2  or 
Trx2 in  HeLa cells  did 
not increase the level of 
oxidised  dimeric  Prx3, 
indicating  that  if,  upon 
any  stimuli  one  of  the 
two systems is rendered 
inoperative  or  is 
downregulated,  the  other  system  can  take  over.  In  vitro kinetics  of  recombinantly 
expressed proteins, demonstrated that Grx2 can donate electrons to the 2-Cys Prx3, with 
similar reaction parameters as Trx2. Using TrxR2 as electron donor, H2O2 as substrate 
and following NADPH consumption, we showed that the catalytic efficiency of Grx2 
Figure 29: Electron flow of mitochondrial redoxins. NADPH reduces 
TrxR2, which among other substrates (…) reduces Trx2. Trx2 reduces 
protein disulfides (PS-SP), for instance of Prx3 and Prx5. NADPH also 
reduces  GR,  which  donates  electrons  to  GSH,  which  among  other 
substrates  (…)  donates  electrons  to  Grx2.  Grx2  can  also  receive 
electrons  from TrxR2.  Grx2 reduces  low molecular  weight  disulfides 
(LMW(SS)),  GSH-mixed  disulfides  (PS-SG)  and  the  2-Cys  Prx3 
(Hanschmann et al. 2010).
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corresponded to 55 % of the activity measured for Trx2 (Hanschmann et al. 2010). It is 
not clear if under physiological conditions both systems function equally as electron 
donor. Simultaneous silencing of the expression of both redoxins in HeLa cells led to 
the accumulation of up to 60 % oxidised Prx3. We excluded that the oxidation of Prx3 
was the result of increased oxidising conditions due to the silenced expression of the 
two oxidoreductases, measuring protein carbonylation and glutathionylation.  
The  reason why Prx3 was not  fully oxidised  can be explained  by the fact  that  the 
protein levels of Grx2 and Trx2 were only reduced to 5-20 % compared to scrambled-
control siRNA or by the possibility of the existence of another electron donor.  
Moreover, even though the 2-Cys Prx-specific redox blot constitutes a strong tool to 
distinguish between monomeric and dimeric Prxs, it cannot detect single Cys oxidations 
without subsequent dimerisation, due to only minor changes in the molecular weight. 
Cys  residues  can,  for  instance,  be  oxidised  to  sulfinic  or  sulfonic  acid.  Two 
modifications,  which are  generally irreversible.  However,  in  the case of  Prxs,  these 
overoxidations,  can  be  exclusively  reduced  by  sulfiredoxins  (Woo  et  al.  2005). 
The reduction of Prx3 by Grx2 was shown to depend on the dithiol mechanism, because 
the  Grx2  Cys35Ser  mutant,  which  lacks  the  C-terminal  active  site  Cys  and  only 
supports the monothiol reaction mechanism, did not show any activity in the  in vitro 
kinetics (Hanschmann et al. 2010). This finding generally excludes a function for the 
monothiol glutaredoxins as electron donors for 2-Cys Prxs, but does not explain why 
Grx1 cannot reduce the cytosolic 2-Cys Prxs (Seo et al. 2000). Grx2 contains the active 
site motif Cys-Ser-Tyr-Cys, enabling it to receive electrons from TrxR (Johansson et al. 
2004)  and to coordinate  the [2Fe2S] cluster  (Berndt  et  al.  2007).  The Grx1 mutant 
protein (Pro23Ser), mimicking the active site motif of Grx2, was also able to coordinate 
the iron cofactor (Berndt et al. 2007). It is tempting to speculate that the mutant protein 
might also be able to reduce cytosolic 2-Cys Prxs. At the same time the Grx2 mutant 
protein with the active site motif of Grx1 should not be able to reduce mitochondrial 
Prx3. Moreover, cytosolic 2-Cys Prxs, which were identified as interaction partners of 
Grx2c  in  HeLa  cells  by  intermediate  trapping,  might  be  substrates  for  the 
cytosolic/nuclear cancer/testis-specific isoform (Hanschmann et al. 2010).  
An  analysis  of the  distribution  of  the  redoxins  in  tissues  of  the  mouse  by 
immunohistochemistry  confirmed  the  interaction  between  Grx2  and  Prx3.  Different 
tissues clearly showed a distinct correlation between the redoxins TrxR2, Trx2, Grx2 
and Prx3. Cells of the connective tissue displayed a strong staining for Trx2 and Prx3 
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without  detectable  expression  of  Grx2.  In  oviduct  tissue  on  the  other  side  the 
distribution  of  TrxR2,  Grx2  and  Prx3  correlated,  while  Trx2  was  absent  from the 
epithelial  cells.  In the endometrium of the uterus the expression of TrxR2 and Trx2 
correlated as well as the distribution of Grx2 and Prx3 (Figure 30). Because Prxs act in 
regulating the levels of the signaling molecule hydrogen peroxide, these data point to an 
individual,  cell  type-specific  contribution  to  signaling  pathways  of  the  different 
redoxins.  
The  second  mitochondrial  Prx  was  also  included  in  our  studies,  revealing  that  the 
reaction  cycle  of  the  atypical  2-Cys  Prx5  only  relied  on  the  Trx  system  in  vitro 
(compare  to  Figure  29).  Prx5  can  be  glutathionylated  (Fratelli  et  al.  2003),  a 
posttranslational modification that is generally efficiently catalysed by Grxs. So far, the 
de-glutathionylation of human Prxs is only ascribed to sulfiredoxins (Park et al. 2009). 
As discussed above, this modification could not be detected using the 2-Cys redox blot. 
We demonstrated that Prx3 was rapidly oxidised and also recovered in H2O2 treated 
HeLa cells,  emphasizing that redox signaling is a rapid and specific form of protein 
regulation.  One could  not  distinguish  untreated  HeLa cells  from cells,  treated  with 
50 µM H2O2 for 30 min, because the oxidised Prx3 was already recovered (Figure 18). 
Therefore, it is important to run kinetics when analysing redox signaling processes to 
exclude the source of error “incubationtime”.  
The shown kinetic constitutes one example for the specific oxidation and reduction of 
one protein, hPrx3, by one oxidising compound H2O2  with one fixed concentration of 
50 µM in one cell line and should not be translated on other proteins, other oxidising 
agents  or  other  cell  lines.  We  have  analysed  the  oxidation/reduction  of  hPrx3  in 
different  cell  lines  using  different  concentrations  of  different  compounds  including 
phenylarsine  oxide  (inhibition  of  dithiols),  doxorubicin  (ROS  induction,  oxidative 
modifications  of  DNA)  and  terbutylhydroperoxide  (RNS  induction,  oxidative 
modifications of lipids) for different  incubation times.  Due to the limitations of the 
2-Cys Prx-specific redox blot, we were not able to analyse the “overall” redox state of 
the peroxidase. However, the general monomer-dimer ratio drastically differed between 
the cell lines (data not shown), implying distinct levels of Trx family proteins, but also 
the  fact  that  proteins  might  be  differently  affected  and  implicated  in  the  cellular 
response to various conditions.   
Indeed, the field of redox-biochemistry lacks methods which allow the analysis of the 
redox state of any protein in vivo, in general and the time-resolved analysis in specific. 
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Part  of  these  results  was  published  as  Hanschmann  et  al. 2010  in  the  Journal  of 
Biological Chemistry with the title “Both thioredoxin 2 and glutaredoxin 2 contribute to 
the  redox state  of  mitochondrial  2-Cys  Prx3”  (Hanschmann et  al.  2010).  Figure 29 
summarizes the electron flow of mitochondrial redoxins.
Human Grx2 was identified as the first member of the Trx family complexing a FeS 
cluster (Lillig et al. 2005). Lee et al. demonstrated that inhibition of mitochondrial Grx2 
by GSH depletion resulted in mitochondrial dysfunction and iron overload, features of 
Figure  30: Distribution of TrxR2,  Trx2,  Grx2 and Prx3 in  mouse oviduct,  uterus and connective  
tissue. Strong staining for TrxR2, Grx2 and Prx3 was observed in oviduct tissue (magnification: 500x), 
while Trx2 was absent. The endometrium of the uterus (magnification: 500x) showed immunoreactivity 
for Grx2 and Prx3, as well as TrxR2 and Trx2. A strong staining for Trx2 and Prx3, but no staining for 
Grx2 was detected in the connective tissue (Hanschmann et al. 2010).
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neurodegenerative disorders such as Parkinson´s disease  (Lee et al. 2009). Grxs were 
shown to be required for iron homeostasis and FeS cluster biosynthesis. It has been 
proposed that this function is related to the ability to coordinate a [2Fe2S] cofactor. 
Recent studies indicated potential functions as iron sensors, scaffold proteins for the 
synthesis of FeS clusters or as transporters, transferring the cofactor to apo-proteins 
(reviewed in Rouhier et al. 2010).  
The GPAT levels in Grx2 depleted cells were decreased to 60 %, suggesting potential 
functions in FeS cluster  biosynthesis.  Grx5, the second mitochondrial  Grx has been 
implicated in FeS cluster assembly in various organisms. Yeast mutants, which lack the 
monothiol  Grx5  were  characterised  by  iron  overload  and  the  accumulation  of 
inactivated FeS proteins (Mühlenhoff et al. 2010). Loss of Grx5 in the zebrafish mutant 
shiraz and a human patient with decreased Grx5 expression due to a mutation in an 
intronic  region of  the  GRX5 gene showed hypochromic  anemia,  which  is  linked to 
impaired hemoglobin synthesis in erythrocytes  (Camaschella et al. 2007),  (Wingert et 
al. 2005).  Recent studies showed that recombinantly expressed bacterial, yeast, plant 
and  human  Grx5  orthologues  can  coordinate  labile  GSH-ligated  [2Fe2S]  cofactors 
(Bandyopadhyay et al. 2008), (Picciocchi et al. 2007), suggesting a potential function as 
scaffold protein in FeS cluster  biosynthesis.  Comparably to Grx5, hGrx2 contains a 
labile FeS cluster, implying a potential role as scaffold protein. The [2Fe2S] cofactor is 
coordinated by the N-terminal active site Cys from two Grx2 monomers and two GSH 
molecules (Berndt et al. 2007). Grx2 was proposed to act as redox sensor, because the 
iron  cofactor  is  lost  when  the  levels  of  reduced  GSH  decrease,  leading  to 
monomerization and activation of the oxidoreductase  (Berndt et al.  2007). A similar 
mechanism could be the case upon iron deprivation. In yeast, the cytosolic monothiol 
Grx3 and Grx4 form a stable  [2Fe2S]-bridged complex.  Mühlenhoff and coworkers 
demonstrated that Grx3/4 act in iron trafficking and iron sensing, two functions which 
depended  on  the  iron  cofactor.  Depletion  of  both  proteins  in  yeast  impaired  the 
synthesis  of  heme-  and  FeS  proteins.  Even  though  cytosolic  levels  of  iron  were 
comparably high, iron could not be transferred to the mitochondria (Mühlenhoff et al. 
2010). Besides Grx3/Grx4 two other proteins were shown to function in the cellular 
transport of iron. Human poly (rC)-binding protein 1 (PCBP1) was shown to bind iron 
and  load  the  redox-reactive  metal  onto  the  storage  protein  ferritin.  Knock-down of 
PCBP1 in the human hepatoma cell line HuH7 inhibited iron storage by ferritin and 
increased the cytosolic free iron pool (Shi et al. 2008).  
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Depletion  of  lipocalin  24p3/2,5-DHBA,  a  protein  binding  to  siderophores,  led  to 
cytosolic iron overload and mitochondrial iron deficiency.  
Grx2 depleted HeLa cells  did not  show a comprehensibly impaired iron regulation, 
even  though  ferritin  levels  were  significantly  decreased.  However,  only  IRP1  was 
analysed, not IRP2. Cells lacking IRP1 showed a regular iron regulation, conducted by 
IRP2  (Schalinske  et  al.  1997),  which  generally  exists  in  lower  intracellular 
concentrations  (Henderson, 1996) and is not regulated via an iron cofactor. Recalcati 
and  collegues demonstrated  that  IRP1 and  IRP2 responded  in  the  opposite  way to 
NO-induction  in  the  murine  macrophage  cell  line  J774  and  that  IRP2-mediated 
posttranscriptional regulation is essential for controling the cellular levels of ferritin. 
Following the treatment with interferon γ/LPS, IRP1 activity was slightly increased, 
whereas IRP2 activity was reduced, leading to enhanced synthesis of ferritin (Recalcati 
et al. 1998). Grx2 depletion slightly decreased the levels of IRP1 and reduced the levels 
of ferritin to nearly 30 %, compared to control cells. It is tempting to speculate that 
IRP2 expression might be elevated in these cells.                                                  
In the presence of the signaling molecule NO, IRP1 was shown to lose its iron cofactor 
(Drapier et al. 1993), explaining the above described increase in protein activity in J774 
cells. This effect is furthermore enhanced in the presence of reduced Trx1. However, 
Trx1 was shown to have nearly no effect on IRP1 by itself. The authors suggested that 
NO does not only disrupt the cluster but also oxidises the residues Cys503, Cys506 and 
Cys437,  essential  for  cluster  coordination.  Reduced  Trx1  then  reduces  the  potential 
disulfide bond between two of the thiol groups of IRP1, restoring the mRNA binding 
activity (Oliveira et al. 1999). Even though IRP2 does not coordinate an iron cofactor it 
possesses the three cysteine residues, as well as another five thiol groups in its specific 
insertion  sequence,  which  is  essential  for  protein  degradation  upon  iron  overload 
(Iwai et al. 1995). IRP2 was inhibited by peroxinitrite and activated by the reducing 
agent β-mercaptoethanol (Bouton et al. 1997). Oliveira et al. also demonstrated that NO 
donors inhibit the mRNA capacity of IRP2, which can be restored by reduced Trx1, but 
not by GSH (Oliveira et al. 1999).               
Grx3 depletion in HeLa cells displayed a strong effect on iron homeostasis, impairing 
cytosolic and mitochondrial heme- and FeS cluster containing proteins. Cells exhibited 
features of cellular iron deprivation, even though the general iron supply and uptake of 
iron was not affected, as measured by Fe55 incorporation and in a colorimetric assay 
according to  Fish (compare to Haunhorst  et al. 2011, unpublished manuscript,  4.3). 
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Grx3 shares the active site motif of Grx5. It is composed of one Trx- and two monothiol 
Grx domains, with each Grx domain coordinating a [2Fe2S] cluster. Like Grx2 and 
Grx5 the  cofactor  is  coordinated by the  active site  Cys of  two monomers  and two 
covalently bound GSH molecules (Haunhorst et al. 2010).  
The Grx3-depletion phenotype described in this study is similar to what was shown for 
Grx3/Grx4 in yeast, referred to above.  
Knock-down  in  zebrafish,  provided  strong  evidence  that  the  function  of  Grx3  in 
cytosolic iron trafficking is conserved in vertebrates. The above described data, as well 
as the following analysis in zebrafish, are part of the manuscript Haunhorst et al. 2011 
with the title “Glutaredoxin 3 (PICOT) functions in iron homeostasis and is essential for 
hemoglobin maturation in zebrafish.” (compare to 4.3).                
The  model  organism  Danio  rerio  is commonly  used  for  studying  vertebrate 
development and due to the use of the morpholino technique, for the analysis of gene 
function  (Lieschke  and  Currie,  2007). The  zfGrx3 contains  a  Trx  domain  and  two 
monothiol Grx domains, sharing 59 % sequence homology with the human Grx3 and 
37 % with yeast Grx3 and Grx4. It is expressed in the CNS, heart and intermediate cell 
mass,  constituting  the  region  of  embryonic  erythropoiesis,  detected  by  in  situ 
hybridisation (Figure 31A). Grx3 knock-down was induced by injection of a specific 
morpholino directed against  the  translation  initiation codon of  zfGrx3 into one cell 
stage  embryos.  Grx3  depleted  embryos,  48  hours  post  fertilisation  (hpf),  displayed 
impaired maturation of hemoglobin and reduced activity of iron-dependent proteins. 
Approximately 50 % of Grx3 depleted embryos lacked mature hemoglobin (Figure 31 
B-E). This phenotype was rescued by coinjection with 40 pg zfGrx3 capped mRNA per 
embryo (Figure 31F).  
In  addition,  cell  extracts  of  whole  wildtype  and  Grx3  knock-down  embryos  were 
analysed  for  enzymatic  activities  of  total  aconitase  and  cytochrome  c oxidase, 
demonstrating a reduction to  approximately 80 %, similar  to what we have seen in 
HeLa cells. Malate dehydrogenase was measured as internal control (Figure 31G).
4. Discussion                                                                                                                     69  
Figure  31: Grx3 depletion in 48 hpf zebrafish embryos impaired hemoglobin 
maturation  and  the  activity  of  iron-related  proteins. Localisation  of  Grx3 
detected by in situ hybridisation (A). Hemoglobin staining by o-dianisidine in a 
WT (B)  and  Grx3-depleted  (morphant)  embryo  (C).  Hemoglobin  staining  by 
diaminofluorene in WT (D),  morphant (E) and morphant embryo,  rescued by 
coinjection with zfGrx3 capped mRNA (F). Enzyme activity measured in whole 
embryos: aconitase activity, cytochrome c oxidase and malate dehydrogenase as 
control (Haunhorst et al. 2011, unpublished manuscript, compare to 4.3). 
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4.2 Trx proteins in physiology and 
pathology
Even though it is important to gain information about single proteins of the Trx family, 
it is also desirable to understand how these protein networks respond to different stimuli 
or  environmental  changes.  Because these proteins  work in  a network with different 
systems being connected at distinct points, we investigated 16 proteins of the Trx family 
in  physiological  and pathological  conditions.  The so called “Redox Atlas  of  the rat 
brain”,  published  as  Aon-Bertolino  et  al.  2011  with  the  title  “Thioredoxin  and 
Glutaredoxin system proteins-immunolocalization in the rat central nervous system” in 
the  journal  Biochimica  et  Biophysica Acta,  was  an approach to  map these proteins 
under  physiological  conditions.  Together  with  the  “Redox  Atlas  of  the  Mouse”, 
published  by  the  AG Lillig  (Godoy et  al.  2011a)  (compare  to  Figure  35)  and  the 
analysis  of  data  of  redoxins  from the  Human Protein  Atlas  (Dammeyer  and Arnér, 
2011), this study constitutes a data collection of the distribution of Trx family proteins, 
potential  colocalisation  of  proteins  and  new  functions,  achieved  by 
immunohistochemistry.  For this approach specific antibodies were used,  which were 
extensively evaluated for rat by Western blot. All tested antibodies displayed specific 
bands  at  the  estimated  sizes.  Despite  this  validations,  it  is  important  to  take  the 
possibility of unspecific and false-negative staining into account. These problems can 
arise from tissue processing, embedding, fixation and the method of staining as well as 
general differences in the sensitivities of different antibodies. IHC allows a qualitative 
analysis of the distribution of a protein, but does not constitute a quantitative method to 
compare between different antigens (Godoy et al. 2011a) (Aon-Bertolino et al. 2011). 
The redox proteins were detected throughout the rat CNS. Golgi I type neurons showed 
the  most  consistent  immunostaining  in  all  areas  analysed.  The  thioredoxin  system 
(Trx1, TrxR1, Trx2, TrxR2) showed an intense staining for neurons and neuroglia in 
most regions of the CNS. These proteins showed a low staining in the hippocampus, an 
area of the brain which is extremely vulnerable towards oxidative stress. The staining 
for Txnip coincided with the staining of Trx1 with the exception for the spinal cord, 
where no staining for Txnip was detectable. Grx1 seems to be localised in nuclei of 
Purkinje  cells  and  spinal  cord  motoneurons.  Grx1  displayed  a  strikingly  intense 
immunostaining in glia cells in the striatum radiatum. Grx2 was strongly labeled in type 
I neurons and glia cells of all areas investigated. Grx3 and Grx5 displayed a staining 
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pattern in neurons of the spinal cord. A potential nuclear localisation was suggested. 
γGCS  showed  a  strong  staining  in  neurons  and  glia  cells  in  hippocampus  and 
cerebellum and  a  weak  staining  in  neuroglia  in  all  of  the  areas  studied.  Prx1  was 
strongly expressed in neurons, whereas astrocytes only showed a weak staining. Prx2 
showed a strong staining in projection neurons. A similar pattern was seen in Golgi type 
I neurons for Prx3, Prx4, Prx5 and Prx6. Prx6 was furthermore shown to be localized in 
neuroglia. All data are summarized in Table 8. Figure 32 shows exemplary the staining 
for the Trx and Grx systems in the hippocampus.
Protein Cere-
bellum
Hippo-
campus
Striatum Cortex Substantia 
nigra
Spinal 
cord
Retina
Trx1 ++ +/- + (axons) ++ ++ ++ ++
Trx2 + + ++ + ++ + +
TrxR1 + + + +/- +/- - +/-
TrxR2 ++ + +/- + + + (nucleus)
Txnip +/- +/- +/- +/- +/- - +
Prx1 + + + ++ + + (nucleus) +/-
Prx2 ++ ++ + ++ + + ++
Prx3 + + + ++ + + (nucleus)
Prx4 + ++ + ++ + ++ +
Prx5 + ++ + + + ++ (nucleus) + (nucleus)
Prx6 ++ ++ ++ ++ ++ + +
Grx1 + (nucleus) ++ + ++ + ++ (nucleus) + (nucleus)
Grx2 + (nucleus) + ++ (nucleus) + ++ ++ +
Grx3 + + ++ (axons) + + + (nucleus) +/- (nucleus)
Grx5 + + ++ + ++ + (nucleus) +
γGCS + + + + + + +/-
Table  8:  Summary  of  the  distribution  of  16  Trx  family  proteins  in  different  parts  of  the  CNS: 
cerebellum,  hippocampus,  striatum,  cortex,  substantia  nigra,  spinal  cord,  retina  (compare  to 
Aon-Bertolino et al. 2011).
This  data  collection  displays  a  tissue-  and  cell  type-specific  expression  pattern, 
indicating  distinct  protein  functions  and  complex  crosstalk  between  the  family 
members.
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Figure  32:  Immunohistochemical  localization  of  Thioredoxin  proteins  in  the  rat  hippocampus. 
Defined layers are shown in a hematoxilin-eosin stained slice (upper left corner). CC: corpus callosum, 
DG: dentate gyrus, PC: pyramidal cell, GC: glia cell, GCL: granular cell layer, DEN: dendrites, NU: 
nucleus. Scale bar: 10 µM (Aon-Bertolino et al. 2011).
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The collected physiological data on the Trx family proteins were compared to samples, 
collected  from rat  pubs,  suffering  from perinatal  asphyxia.  The  animal  model  was 
implemented in the group of Francisco Capani and constitutes a generally accepted and 
well established model.  
Grx2, Trx1 and Trx2 were upregulated in the hippocampus 4 hours after the hypoxic 
insult. Together with Grx1, which was also analysed, but showed no detectable changes 
in expression or distribution, these proteins constitute the main cellular oxidoreductases 
in  the  cytosol  and  in  mitochondria.  These  redoxins  seem  to  be  essential  in  the 
immediate response. However, 7 days after the hypoxic insult, the levels were back to 
normal. To understand the immediate, but also the longterm effects, triggered by the 
hypoxic insult, it is important to analyse all redoxins in the complete CNS. So far, no 
studies on Trx family proteins in perinatal  asphyxia have been published.  However, 
release of NO and ROS have been implicated in the disease, potentially leading to the 
disregulation  of  redox  signaling,  which  could  be  responsible  for  the  induction  of 
apoptosis  in  the  CNS  and  the  longterm  neurological  deficits  of  the  patients. 
Similar  to  the  pathology  of  perinatal  asphyxia,  the  disruption  of  redox  control  or 
generally the generation of ROS (Bonventre and Weinberg, 2003),  (Wardle, 2005) by 
uncoupling of the mitochondrial chain (Baines, 2009) and inflammation (Weight et al. 
1996), (Hutchens et al. 2008) was described as the most destructive cause of I/R injury. 
We have studied the effects of renal I/R injury on the Trx family using a mouse model, 
established  in  the  AG  Lillig.  The  pedicle  of  the  right  kidney  was  clamped  for 
30 min. The clamp was removed, the restoration of the blood flow was observed and the 
animals were sacrificed after 24 h.  
Blood  and urine  samples  of  sham-operated  and  I/R mice  were  analysed  (Table  9). 
Alterations in the blood cell count of the I/R group were detected, as well as an increase 
of  segmented  nuclei  cells,  indicating  the  beginning  of  an  inflammatory  response. 
Following I/R, urea elimination was significantly decreased and proteinuria, especially 
of high molecular weight proteins like albumin (Figure 33g) was observed.  
The histological analysis of I/R kidneys showed typical changes after I/R injury i.e. 
tubular  cell  flattening,  loss  of  brush-borders  and  luminal  obstruction,  compared  to 
contralateral and sham-operated organs (Figure 33a-f). All these alterations constitute 
common changes after an I/R insult and demonstrated that the induction of renal I/R 
was successful (Godoy et al. 2011b).    
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Parameter Sham animals I/R animals p-
values
Body weight (g) 22.08 +/- 0.33 22.74 +/- 0.22 0.11
Urine protein (mg/ml) 47.73 +/- 11.1 62.24 +/- 6.8 0.26
Urea (mM) 8.47 +/- 0.51 10.8 +/- 0.72 0.04
Creatinine (µM) 14.27 +/- 0.77 14.51 +/- 0.84 0.83
Erythrocytes (T/L) 9.72 +/- 0.19 8.99 +/- 1.32 0.66
Hematocrit (L/L) 0.53 +/- 0.02 0.59 +/- 0.01 0.28
Hemoglobin (g/L) 150 +/- 3.65 165 +/- 5.35 0.06
Leukocytes (g/L) 7.17 +/- 0.7 7.5 +/- 0.33 0.66
Segmented nuclei (G/L; %) 1.48  +/-  0.11  (20.83  +/- 
0.79)
3.23 +/- 0.24 (43.25 +/- 2.92) 0.0001
Lymphocytes (G/L; %) 4.78 +/- 0.55 (66.5 +/- 2.26) 3.35 +/- 0.32 (44.38 +/- 3.49) 0.0001
Monocytes (G/L; %) 0.75  +/-  0.13  (10.33  +/- 
1.84)
0.83 +/- 0.14 (11.38 +/- 1.87) 0.69
Eosinophiles (G/L; %) 0.17 +/- 0.03 (2.33 +/- 0.33) 0.08 +/- 0.0 (0.88 +/- 0.353) 0.01
Basophiles (G/L; %) n.d. n.d. -
Band  neutrophiles  (G/L; 
%)
n.d. 0.01 +/- 0.01 (0.13 +/- 0.13) -
Table 9: Parameters for the successful induction of I/R. Physiological and blood parameters of sham-
operated  and  I/R  mice  were  determined  by Laboklin  (Bad Kissingen,  Germany).  The data  stated in 
parentheses are derived from differential blood count; n.d.: not detected. Data represent the means +/- 
SEM of six sham-operated and 8 I/R animals (Godoy et al. 2011b). 
Our  results  were  published  as  Godoy  et.  al. 2011 in  the  Journal  for  Free  Radical 
Biology and Medicine with the title “Segment-specific overexpression of redoxins after 
renal ischemia and reperfusion: protective roles of glutaredoxin 2, peroxiredoxin 3 and 
peroxiredoxin 6”. Analysing the expression levels of 15 Trx family proteins, we have 
seen significant changes in the ischemic kidneys i.e. an increase in the levels of Trx1, 
Trx2,  and  Grx5  and  a  decrease  of  Grx1  levels.  In  a  previous  study,  Kasuno  and 
coworkers demonstrated that Grx1 levels were generally higher in the cortex than in the 
medulla of the kidney, with no significant changes detectable after I/R  (Kasuno et al. 
2003). Grx1 is a protein which was found to be secreted from cells. Lundberg  et al. 
detected the oxidoreductase in human plasma and demonstrated that Grx1 was secreted 
by unstimulated peripheral blood mononuclear cells, suggesting potential extracellular 
functions (Lundberg et al. 2004). Peltoniemi  et al. showed that alveolar macrophages 
expressed Grx1 and that Grx1 levels were decreased in homogenates of the lung and in-
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creased in the sputum of 
patients  with  chronic 
obstructive  pulmonary 
disease,  with  the  levels 
correlating  to  the  stage 
of the disease and lung 
function  (Peltoniemi  et 
al.  2006). We  detected 
an  accumulation  of  the 
protein at the apical site 
of  distal  convoluted 
cells,  but  not  in 
sloughed  cells,  and  the 
specific  secretion  into 
the  urine  following  I/R 
(data not shown). To our 
knowledge, this has not 
been  described  in  any 
other  study  before. 
However,  no  extra-
cellular  functions  for 
Grx1  have  been 
demonstrated,  so  far. 
We  believe  that  Grx1 
could be used as a marker protein for renal I/R injury. Other redoxins, including Trx1, 
TrxR2, Prx2, Prx4 and Grx3 were detected in the lumina of tubules, but not in urine 
samples. Kasuno et al. have also detected Trx1 in the lumen of proximal tubules, but 
also in the urine (Kasuno et al. 2003). Trx1 was shown to be secreted by various cell 
lines  (Rubartelli et al.  1992) and was detected in blood plasma in various disorders 
(Nakamura et al. 1996), (Jikimoto et al. 2002), (Kakisaka et al. 2002), (Nakamura et al. 
2006).  Extracellular  Trx1  has  been  implicated  in  the  attraction  and  activation  of 
immune cells  (Bertini et al. 1999). The cytosolic Grx3 was also shown to be secreted 
from cells and was implied in the modulation of the inflammatory response (Kato et al. 
2008). However, part of the staining was also detected in sloughed cells, implicating 
Figure  33:  Parameters  for  the  successfull  induction  of  I/R. 
Histological analysis of sham, contralateral and I/R kidneys, i.e. cortex 
(a-c)  and  outer  medulla  (d-f)  by  Schiff´s  periodic  staining.  In  I/R 
kidneys epithelial flattening (dimension lines) and loss of brush borders 
(arrows)  were  detected.  High  molecular  weight  proteins  in  urine 
samples of sham and I/R animals (g).
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that the presence of these redoxins might be due to non-specific processes. Besides the 
translocation of Trx1 from the cytosol into the extracellular space, Trx1 was also found 
in the nucleus, where it is known to regulate the transcription of various target proteins. 
We detected Trx1 in the nuclei of proximal tubule cells. This has also been shown in the 
study of Kasuno and coworkers. In the contralateral kidneys we have seen changes in 
the expression of proteins, too, indicating that the I/R does not only lead to changes 
within the affected organ, but also to systemic effects. An increase in the levels of Prx6 
and Grx5 as well  as a decrease of TrxR2, Prx4 and Prx5 was detected.  Apart  from 
protein levels, we were interested in analysing the distribution of redoxins throughout 
the nephron. Figure 34 summarizes the data, depicting the segments of the nephron and 
the distribution of the proteins, comparing ischemic and sham-operated organs.  
We  detected  a  segment-specific  distribution  of  the  proteins  under  physiological 
conditions. Furthermore, the response to the I/R insult was different in distinct parts of 
the nephron,  implying tissue- or even cell  type-specific  functions  of the Trx family 
proteins. We believe that these differences contribute to the distinct susceptibilities of 
different  parts  of  the  nephron  towards  the  I/R  insult.  The glomeruli  and  the  inner 
medulla cells for instance are relatively resistant, whereas medullary thick limb cells are 
especially susceptible to hypoxia  (Hutchens et al.  2008),  (Gobe and Johnson, 2007). 
Transgenic mice, overexpressing Trx1, were characterised by attenuated reperfusion-
induced mTAL injury  (Kasuno et al.  2003). The authors state that  Trx1 was mainly 
observed in the cytosol of mTALs and decreased in other parts of the kidney, directly 
after the I/R insult.  We confirmed the increased expression of Trx1 and furthermore 
detected Trx2 in mTALs using the  specific marker THP (data not shown).  
In  contrast,  we  observed  enhanced  expression  levels  of  Trx1  in  the  whole  kidney. 
TrxR2, Nrx, Grx1 and Prx5 were also detected in mTALs.  
Proximal tubule cells can regenerate after an I/R insult (Nony and Schnellmann, 2003), 
(Molitoris and Marrs, 1999). The amounts of Grx2, Prx3 and Prx6 were significantly 
upregulated in proximal tubuli after the I/R insult.  
Overexpression of these redoxins in HeLa and HEK293 cells, cultured for 24 h at 0.1 % 
O2 and another 24 h at 20 % O2, showed higher survival and proliferation rates and less 
oxidative damage to the DNA, detected by 8-OH-dG staining, compared to control cells 
(data not shown). 
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These data indicated that higher levels of these redoxins contribute to the regeneration 
process of these cells. As described above, many redoxins have been implicated in cell 
survival and proliferation, as well as the degradation of H2O2.  
Mitochondrial  Grx2 was  shown to  protect  HeLa  cells  from cell  death  (Lillig  et  al. 
2004), (Fernandes et al. 2009), inhibiting the release of cytochrome c (Enoksson et al. 
2005). Thymoma cells, stably overexpressing mitochondrial Prx3 were characterised by 
resistance  against  hypoxia-induced  production  of  H2O2 and  apoptosis  (Nonn  et  al. 
2003). Using rat  insulinoma cells  with modified levels  of Prx3, Wolf and coauthors 
demonstrated that the peroxidase reduced accumulated levels of H2O2  and prevented the 
induction of caspase-9 and caspase-3  (Wolf et al. 2010). Macrophages with depleted 
levels of Prx6 displayed increased levels of H2O2 and an elevated apoptosis rate (Wang 
et al. 2006). Overexpression of Prx6 in breast cancer cells enhanced the proliferation 
and invasion rate of the cells (Chang et al. 2007).  
We included HEK293 cells in this study, because they are a generally accepted kidney-
derived cell  line,  with neuronal  origin.  It  is  elusive to  compare the cell  line to  the 
response of cells within the whole organ. Of course, this is a general problem of cell 
culture, because cells adapt to changes in the environment and might lose their original, 
Figure 34: Segment specific distribution of Trx family proteins in sham and ischemic nephrons.
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characteristic features. Furthermore, cells are usually cultured at 20 % O2, an oxygen 
concentration,  representing  the  concentration  in  the  atmosphere  and  not  necessarily 
physiological,  intracellular  concentrations.  However,  we  have  corroborated  our 
hypothesis,  demonstrating  that  redoxins  can  protect  HEK293  cells  from  hypoxia-
induced apoptosis. We have also analysed the responses of other cell lines in terms of 
cell viability and expression of Trx family proteins. Cell lines dramatically differed in 
the susceptibility towards oxygen deprivation. HeLa cells, HEK293 cells and also the 
rat pancreatic β-cell line INS1 were very resistant to the hypoxic conditions and could 
be  cultured  in  an atmosphere containing  1 % or  less  oxygen for  several  days.  The 
general expression pattern, as well as changes in expression of the Trx family proteins, 
following the hypoxic insult differed in these cell lines, confirming the complexity and 
the  potential  distribution  to  cell  survival  and  the  data  of  the  animal  models. 
The murine pancreatic β-cell line MIN6 was very susceptible to oxygen deprivation and 
could not be cultured at concentrations lower than 1 % oxygen. Exposing the cells to 
1 % or 2 % oxygen for 12 h, led to a decrease in cell viability of around 40 %.  
Cells have developed response mechanisms to cope with low oxygen concentrations. 
HIF-1  is  a  transcription  factor,  regulating  the  gene  expression  under  hypoxic 
conditions. It consists of two subunits, α and β. Under normoxic conditions, HIF-1α is 
degraded  by  the  proteasome,  whereas  HIF-1β  is  not.  Upon  hypoxia,  HIF-1α  is 
hydroxylated  by  oxygen-sensing  prolyl  hydroxylases  (PHD),  protecting  it  from 
ubiquitination.  ROS  and  RNS  can  stabilise  HIF-1α,  by  modifying  PHDs 
posttranslationally, for instance by nitrosylation (Metzen et al. 2003), (Mansfield et al. 
2005),  (Sanjuán-Pla et  al.  2005).  Another regulatory mechanism of the transcription 
factor is the generally increased translation due to phosphorylation of essential proteins 
such as by phosphatidylinositol 3 kinase/Akt-dependent or MAPK signaling pathways 
(Semenza,  2003).  Stress-  and  mitogen-activated  protein  kinase  pathways  generally 
constitute  a  cellular  response  mechanism to  cope  with  alterations  in  the  O2 levels. 
Different studies revealed that the overexpression of Trx1 increased HIF-1α levels in 
cells  grown  under  normoxic  and  hypoxic  conditions.  Inhibiting  TrxR1  activity  in 
different  cell  lines  blocked the  activation  of  HIF-1α  (Moos  et  al.  2003). Zhou and 
coworkers  described  a  diverse  regulation  of  HIF-1α  by  cytosolic  Trx1  and 
mitochondrial  Trx2.  Overexpression  of  Trx1  increased  the  levels  of  HIF-1α  by 
activating  Akt-dependent  translation,  whereas  overexpression  of  Trx2  prevented  or 
diminished hypoxia-induced HIF-1α accumulation (Zhou et al. 2007). In addition, Trx1 
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might be involved in HIF-1α-degradation during reoxygenation  (Jewell  et  al.  2001). 
In  our  MIN6 model,  the  cytosolic  Trx  system decreased  upon oxygen  deprivation, 
whereas the mitochondrial Trx system increased. This study is, to our knowledge, the 
first study showing that both systems responded oppositional to a stimulus, even though 
different functions of the proteins have already been described.  
Since we have not analysed the expression of HIF-1α, we can only speculate at this 
point. Due to the elevated expression of Trx2 it is possible that HIF-1α expression is 
attenuated, preventing an adapted stress response. This effect might be supported by the 
downregulation of TrxR1 and the secretion of Trx1. We have used medium of MIN6 
cells,  exposed  to  hypoxia,  as  well  as  recombinantly  expressed  Trx1  in  an  assay 
measuring the migration of macrophages through an affigel-matrix. In the presence of 
Trx1, the migration rate of macrophages, isolated from mice, was reduced, compared to 
control samples without added Trx1, implying a potential function in preventing the 
initiation of an inflammatory response. This effect could be explained by the inhibition 
of  the  macrophage  migration  inhibitor  factor  (MIF),  a  pro-inflammatory  protein 
released from immune cells.  Various studies have analysed Trx1 and MIF, revealing 
different potential mechanisms of regulation. Son and coworkers demonstrated a direct 
association between the two proteins (Son et al. 2009), inhibiting the release of MIF or 
directly regulating protein expression (Sato et al. 2006), (Nakamura, 2008).  
The  data  on  the  Trx  systems  were  confirmed  in  a  mouse  model  for  β-cell 
transplantation, where mice were treated with streptozotocin to induce type-1 diabetes 
and  received  a  transplantation  of  β-cells  of  a  healthy  donor  into  the  portal  vein. 
Trx1 and TrxR1 were downregulated in the hypoxic state, i.e. after 30 min, whereas 
Trx2 and TrxR2 were upregulated. 120 days after the procedure no significant changes 
in protein expression were detected.  
However, we were not able to quantify the levels of Trx1 in the plasma of diabetic 
animals prior or post β-cell transplantation using the Western blot technique. In order to 
analyse plasma levels of redoxins, it is desirable to establish more specific sandwich 
ELISAs.  
We have  furthermore  analysed  the expression and phosphorylation  of  various  MAP 
kinases. The MAP kinase cascade generally includes three core signaling molecules. 
MAP kinase kinase kinases, such as Ask1, sense the degree of stress-induced damage in 
upstream signaling events and determine the cell fate by regulating MAP kinase kinases 
and  MAP  kinases,  which  then  phosphorylate  substrates  as  the  effector  proteins 
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(Matsuzawa and Ichijo, 2008).  
Phosphorylation and redox signaling do not only constitute similar, rapid mechanisms 
regulating  cellular  functions,  but  they  were  furthermore  shown  to  be  connected  at 
different  points.  As  mentioned  before,  tyrosine  phosphatases  can  be  regulated  via 
posttranslational  modifications  at  a  redox-active  cysteine,  which  is  essential  for 
catalysis. And also MAP kinases can be redox regulated, i.e. being kept in an inactive 
state by a member of the Trx family of proteins. In a similar way as the regulation of 
Ask1 by Trx1, JNK is kept in an inactive state by GST-π1 in unstressed cells. In the 
presence of H2O2 for instance, GST dissociates and JNK is activated (Adler et al. 1999). 
Activation of p38, JNK and ERK was analysed in MIN6 cells following hypoxia and 
reoxygenation.  The  ERK  pathway  transduces  extracellular  stimuli  into  cascades  of 
protein  phosphorylation  and  activation,  regulating  cellular  processes  including 
proliferation and differentiation. ERK1 and ERK2 share similar protein sequences, but 
were  shown  to  regulate  different  functions  due  to  numerous  substrates  in  distinct 
compartments  (Lloyd,  2006). ROS  act  mitogenic,  by  inducing  ERK  signaling  via 
receptor  activation,  i.e.  phosphorylation  (Burdon,  1995).  Furthermore, ERK1/2  can 
function  as  anti-apoptotic  factors,  initiating  cell  survival  following  oxidative  injury 
(Guyton et al. 1996).                     
JNK and p38 are also referred to as stress-activated protein kinases (SAPK), because 
they are activated by various types of stress. Even though, the activation of JNK and 
p38 and the inhibition of ERK was shown to be required for the induction of apoptosis, 
for instance in neuron like PC-12 cells (Xia et al. 1995), SAPK activation might also be 
important  for  cell  proliferation  and  cell  survival  (Matsuzawa  and  Ichijo,  2001). 
There are two ubiquitously expressed isoforms of JNK, JNK1 and JNK2, and the brain-
specific JNK3, which execute similar, but also different functions. JNK was shown to 
act  in  the  same  pathway as  Ask1.  Liu  et  al. for  instance  demonstrated  that  Tnf-α 
activates JNK1, but not JNK2, inducing apoptosis in mouse fibroblasts lacking either 
Jnk1 or Jnk2 (Liu et al. 2004).  
Overexpression of Trx1 and Trx2 affected all analysed MAP kinases. Trx1 increased the 
levels of phosphorylated ERK1/2 under normoxic conditions, inducing proliferation – a 
known function of the oxidoreductase. In addition, Trx1 overexpressing cells displayed 
decreased levels of phosphorylated JNK1/2 upon hypoxia and phosphorylated levels of 
p38  under  hypoxia  and  reoxygenation.  Inhibition  of  SAPK-signaling  inhibited  the 
induction of apoptosis. Cells overexpressing Trx2, showed a similar phosphorylation 
4. Discussion                                                                                                                     81  
pattern of the MAP kinases. However, the extent of the phosphorylation of the different 
MAP kinases by Trx1 and Trx2 differed, which could be explained by different protein 
accessibility  in  different  compartments.  No  direct  interaction  between  the  oxido-
reductases  and  the  MAP kinases  was  analysed.  So  far,  no  direct  redox  regulation 
of kinases was shown. It is possible that the effects seen in the downstream proteins 
of the signaling pathways, are due to a regulatory mechanism of Ask1 by Trxs (Saitoh et 
al. 1998).  
MIN6 cells showed unique alterations in protein levels of the Trx family proteins upon 
hypoxia and reoxygenation. Cytosolic and mitochondrial proteins of the Trx system and 
the Prxs, responded not only differently, but often even oppositional. This organelle-
specific response to  the hypoxic insult  underlines the concept  of compartmentalised 
redox signaling and the importance of the different proteins and isoforms of the Trx 
family. However, the protein levels of all four Grxs were reduced during hypoxia and 
reoxygenation.  Grxs are known as GSH-dependent oxidoreductases. Total GSH levels 
were significantly decreased upon hypoxia in  MIN6 cells,  but  recovered during the 
reoxygenation period. The same pattern was detected for the two dithiol Grxs, Grx1 and 
Grx2. On the contrary, the protein levels of the two monothiol Grxs, Grx3 and Grx5, 
did not seem to recover during reoxygenation. Monothiol redoxins have not been shown 
to be catalytically active and therefore do not rely on GSH in the same way as dithiol 
proteins.  However,  GSH is  needed for cluster  coordination (Haunhorst  et  al.  2010). 
The  total  Grx2  levels,  also  including  cytosolic  Grx2c,  were  significantly 
downregulated.  At  the same time the  cytosolic  Prx2 and Prx6 were downregulated, 
constituting another indication for potential protein interaction.  
The reduction in the levels of the peroxidases might lead to the induction of apoptosis 
following the hypoxic insult. Tulsawani and coauthors exposed retinal ganglion cells to 
hypoxia  and detected  a  reduced expression  of  Prx6,  with  increased  levels  of  ROS, 
activation of NFκB and the induction of apoptosis. Moreover, they demonstrated that 
the overexpression of Prx6 in these cells reduced hypoxia-induced cell death. These 
data also coincide with our findings on Prx6 in the renal I/R model. The peroxidase was 
upregulated  in  tubule  cells,  which  can  regenerate  following  an  I/R  insult  and  the 
overexpression of Prx6 in HEK293 and HeLa cells increased proliferation and protected 
cells against hypoxia-induced apoptosis. Prx3 and Grx2 were also upregulated in the 
tubule  cells  and  acted  proliferative,  as  well  as  anti-apoptotic  in  the  cell  models. 
Interestingly,  these  two  proteins  are  also  downregulated  in  MIN6  cells  following 
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hypoxia  and  reoxygenation.  The  cytosolic  Prx1  responded  differently.  It  was 
upregulated during hypoxia, pointing to a different function of the peroxidase. Kim and 
coworkers discovered the upregulation of Prx1 in a different cell model, A549 cells, 
following 4 h hypoxia and 2 – 24 h reoxygenation (Kim et al. 2007). Different studies 
demonstrated that Prx1 was overexpressed in several cancer cell lines (Yanagawa et al. 
1999),  (Yanagawa et al. 2000). Many cancer cells can grow under hypoxic conditions 
with  the  degree  of  hypoxia  correlating to  tumor  growth and resistance  to  radiation 
therapy (Harris,  2002).  Chen  and  coworkers  have  shown that  these  tumor  features 
correspond to the expression of Prx1  (Chen et al. 2006). Kim and coworkers did not 
only confirm this  proliferative  and anti-apoptotic  function  of  Prx1,  but  furthermore 
explained  it  by  the  finding  that  Prx1  inhibited  the  JNK-signaling  pathway.  This 
inhibition was not dependent on the peroxidase activity, but rather on the interaction 
with the GST-JNK complex (Kim et al. 2006), (Kim et al. 2007).  
Prx5  increased  during  hypoxia,  but  decreased  following  reoxygenation  and  thereby 
showed  a  similar  response  as  Prx1.  This  either  points  to  specific  functions  during 
hypoxic  conditions  or  to  different  contributions  in  the  response  to  hypoxia  and 
reoxygenation. This has already been described above for the regulation of HIF-1α by 
Trx1. During hypoxia it induced the expression of HIF-1α, whereas during hypoxia it 
functioned in protein degradation (Zhou et al. 2007), (Jewell et al. 2001).  
Prx2 levels  were decreased upon hypoxia,  whereas  Prx4 was upregulated,  implying 
specific functions for the peroxidases in MIN6 cells. So far, no studies on the function 
of those proteins during hypoxia have been described. However, Prx2 was implicated in 
the regulation of ERK, JNK and p38 in response to Tnf-α-induced H2O2 production 
(Kang et al. 2004). Both peroxidases were shown to be expressed in different cell types 
of the pancreas. Prx4 was expressed in the insulin producing β-cells, whereas Prx2 was 
located outside the insulin producing islets, in the exocrine pancreas. Figure 35 is part 
of  the  Mouse  Atlas  (Godoy  et  al.  2011a),  showing  the  distinct  expression  and 
distribution of numerous Trx family proteins in the mouse pancreas.          
In  all  analysed  cell  and  animal  models,  the  Trx  family  proteins  showed  a  distinct 
expression and distribution profile and furthermore responded species-, tissue- and cell 
type-specific  to  oxidising  and  hypoxic  conditions,  implying  distinct  functions  and 
contributions to regulating or determining the fate of a specific cell. 
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Figure 35: Trx family proteins in the mouse pancreas. D=duct, EXO=exocrine pancreas, INS=islet of Langerhans, Objective: 25x, scale bar: 50 µm (image from 
the “Mouse Redox Atlas”, Godoy et al. 2011a) 
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4.3 Main conclusions from the papers
Part  of  the  results  presented  in  this  thesis  have  already  been  published  or  have 
contributed  to  the  preparation  of  manuscripts  for  later  submission  and  publication. 
The main conclusions from the individual papers are as follows: 
Paper I: Hanschmann E.M., Lönn M.E., Schütte L.D., Funke M., Godoy J.R., Eitner 
S., Hudemann C. and Lillig C.H. Both thioredoxin 2 and glutaredoxin 2 contribute to 
the  reduction  of  the  mitochondrial  2-Cys  Peroxiredoxin  Prx3.  J. Biol.  Chem. 
285(52):40699-705 (2010)
• Grx2 donated electrons to the 2-Cys Prx3 in a dithiol mechanism in vitro, but 
not to the atypical 2-Cys Prx5.
• Silencing  the  expression  of  either  Grx2  or  Trx2  in  HeLa  cells  by  RNA 
interference  did  not  lead  to  the  accumulation  of  oxidised  Prx3.  Only 
simultaneous knock-down led to an increase in oxidised Prx3, pointing to an in  
vivo function as electron donor for both oxidoreductases. 
• The expression of Prx3 in mouse tissues was either linked to the presence of 
TrxR2/Trx2, GSH/Grx2 or TrxR2/Grx2, suggesting a distinct and tissue-specific 
contribution of the individual systems to the redox state of the mitochondrial 
peroxidase.
Paper II (manuscript): Haunhorst P.*,  Hanschmann E.M.*, Bräutigam L., Stehling 
O.,  Lill.  R.,  Mühlenhoff  U.,  Berndt  C.  and  Lillig  C.H.  Glutaredoxin  3  (PICOT) 
functions in iron homeostasis and is essential for hemoglobin maturation in zebrafish 
(*shared first authorship)
• Grx3-depleted  48  hpf  zebrafish  embryos  showed  an  impaired  maturation  of 
hemoglobin.
• Grx3-depleted  48  hpf  zebrafish  embryos  were  characterised  by  reduced 
activities of the iron-sulfur protein aconitase and the heme protein cytochrome c 
oxidase. 
• Knock-down of Grx3 in HeLa cells led to an iron deprivation phenotype, even 
though iron supply and uptake were not  affected.  The TfR was upregulated, 
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ferritin  and  the  iron  regulatory  protein  IRP1  were  downregulated.  IRP2 
expression was not affected. 
• Enzymatic  activities  of  cytosolic  FeS  proteins,  as  well  as  iron-dependent 
proteins in mitochondria, were significantly downregulated. 
Paper III: Aon-Bertolino M.L., Romero J.I., Galeano P., Holubiec M., Badorrey M.S., 
Saraceno  G.E.,  Hanschmann  E.M.,  Lillig  C.H.  and  Capani  F.  Thioredoxin  and 
Glutaredoxin  system proteins-immunolocalization  in  the  rat  central  nervous  system. 
Biochim Biophys Acta. 1810(1):93-110 (2011)
• All proteins, Trx1, Trx2, TrxR1, TrxR2, Txnip, Prx1, Prx2, Prx3, Prx4, Prx5, 
Prx6, Grx1, Grx2, Grx3, Grx5 and γGCS were detected throughout the rat CNS 
and  showed  a  tissue-  and  cell  type-specific  expression  pattern,  indicating 
distinct protein functions and complex crosstalk between the family members.
Paper IV: Godoy, J.R., Oesteritz, S.*, Hanschmann, E.M.*, Ockenga, W., Ackermann, 
W. and Lillig, C.H. Segment-specific overexpression of redoxins after renal ischemia 
and reperfusion: protective roles of glutaredoxin 2, peroxiredoxin 3, and peroxiredoxin 
6. Free Radic. Biol. Med. 51(2):552-61 (2011), (*contributed equally to this work)
• I/R  kidneys  showed  significantly  increased  levels  of  Trx1,  Trx2  and  Grx5, 
whereas  Grx1  was  decreased.  Contralateral  kidneys  were  characterised  by 
increased Grx5 and Prx6 levels, while protein amounts of TrxR2, Prx4 and Prx5 
were decreased. These differences in both, operated and contralateral kidneys 
provided  evidence  not  only  for  local  but  also  for  systemic  implications 
following the I/R insult. 
• Immunohistochemical  analysis  of  Trx  family  proteins  (Trx1,  Trx2,  TrxR1, 
TrxR2, Nrx, Prx1, Prx2, Prx3, Prx4, Prx5, Prx6, Grx1, Grx2, Grx3 and Grx5) 
showed segment-specific alterations induced by the ischemic insult. 
• Grx2, Prx3 and Prx6 were upregulated in  proximal  tubule  cells,  a cell  type, 
which can regenerate after an I/R insult. Overexpression of Grx2, Prx3 and Prx6 
in HeLa cells led to lower oxidative damage to the DNA, compared to controls.
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• Overexpression of Grx2, Prx3 and Prx6 in HEK293 cells revealed a higher cell 
survival and proliferation rate, compared to controls.
• Following I/R, Grx1 accumulated at the apical side of distal convoluted cells 
and was specifically secreted into the urine. 
• The differences in both the basal equipment and the segment-specific responses 
of the redoxins may contribute to the distinct susceptibilities and regeneration 
processes of the various segments of the nephron to the I/R insult.
Paper V (Manuscript II): Hanschmann E.M., Rawat N., Linn T. and Lillig C.H. The 
cytosolic  and  mitochondrial  Trx  systems  act  diverse  in  a  model  for  β-cell 
transplantation (in preparation)                
• The  cytosolic  and  the  mitochondrial  Trx  systems  responded  differently  to 
hypoxic  conditions  in  the  pancreatic  β-cell  line  MIN6.  Protein  levels  of 
cytosolic  Trx1  and  TrxR1  strongly  decreased,  whereas  the  levels  of  the 
mitochondrial Trx2 and TrxR2 increased. 
• Immunohistological analysis of mice with streptozotocin-induced diabetes with 
subsequent  transplantation  of  pancreatic  β-cells  showed  a  lower  signal  for 
Trx1/TrxR1 and a stronger staining for Trx2/TrxR2 in the hypoxic state, 30 min 
after transplantation, than control animals. After 120 days of reoxygenation or 
rather regeneration, the expression pattern of the transplanted cells was similar 
to healthy pancreatic β-cells.
• Overexpression of Trx1 and Trx2 increased the levels of phosphorylated ERK, 
initiating cell proliferation and differentiation.
• Overexpression  of  Trx1  and  Trx2  decreased  the  levels  of  phosphorylated 
SAPK/JNK and p38, preventing cell death.
• Trx1 was specifically secreted from MIN6 cells upon the hypoxic insult.
• Trx1  inhibited  the  migration  of  macrophages,  potentially  preventing  the 
initiation of an inflammatory response in vivo. 
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4.4 Significance and future perspective
Nowadays, the redox state of a protein is generally accepted as an essential mediator of 
protein  function  and  the  term  redox  signaling  is  widely  applied  in  the  field. 
Concentrations and localisation of ROS and Trx family proteins can control if a cell 
undergoes proliferation or apoptosis. However, we are only beginning to understand the 
general mechanisms and the overall significance of redox signaling.  
This thesis has substantially contributed to broaden and extend the knowledge on the 
thioredoxin family proteins – in physiology and disease.  
We have identified human Grx2 as electron donor for the mitochondrial Prx3, providing 
novel insights into crucial redox signaling events and revealing yet another crosslink 
between members of the Trx family. It remains to be analysed if the cytosolic/ nuclear 
isoforms Grx2b and Grx2c  (Lönn et  al.  2008) can donate electrons to the cytosolic 
peroxidases. Since these isoforms are cancer/testis specific, it would be interesting to 
determine if these redoxins contribute e.g. to the increased proliferation of cancer cells 
and resistance to chemotherapy.          
We  have  discovered  a  novel  function  in  intracellular  iron  homeostasis  and  heme 
maturation for Grx3 in zebrafish and human. We suggest that Grx3 functions in iron 
trafficking through the cytosol.  The general mechanism and potential target proteins 
need to be identified and analysed. Grx3 was shown to exist as dimer coordinating two 
[2Fe2S] clusters (Haunhorst et al. 2010). It would be interesting to analyse whether the 
function  in  iron  regulation  depends  on  these  cofactors.  Trying  to  rescue  the  Grx3 
depletion phenotype in HeLa cells by overexpressing the wildtype protein, as well as 
deletion-mutants lacking the monothiol domain(s) and thus the ability to constitute FeS 
clusters, might answer this question. In addition, one could use co-immunoprecipitation 
to detect  new interaction partners in general,  but also to analyse if there is a direct 
interaction between Grx3 and IRP1, similar to the interaction described for Grx4 and 
the transcriptional activator Aft1 in  S. cerevisiae (Rutherford et al. 2005). Grx4 also 
coordinates an iron cofactor, which is essential for the regulation of Aft1, suggesting a 
potential function as iron sensor (Pujol-Carrion et al. 2006). The fluorescence resonance 
energy transfer technique could be applied to analyse and define the spatial relationship 
between Grx3 and IRP1.                                     
The collaborative projects of human (Dammeyer and Arnér, 2011), mouse (Godoy et al. 
2011a) and rat protein (Aon-Bertolino et al. 2011) atlases were a successful approach to 
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analyse Trx family proteins in numerous organs, tissues and cell types. We retrieved 
new data on single proteins, networks between redoxins and potential new functions. 
Mainly these studies in fact revealed that protein expression and cellular distribution 
were  tissue-,  cell  type-  and  species-specific.  Overall,  we  believe  that  these  studies 
represent a basis and a point of reference for future disease-orientated studies.  
We confirmed the above described complexity of the redox regulatory networks of the 
Trx  family  proteins  in  models  for  perinatal  asphyxia,  renal  I/R  injury  and  the 
transplantation of pancreatic  β-cells - conditions induced by the lack or depletion of 
oxygen.                   
So  far,  Trx  family  proteins  have  not  been  analysed  in  perinatal  asphyxia,  which 
constitutes  a  major  cause of  death  worldwide  (Lawn et  al.  2005). Even though the 
analysis  of  the  hippocampus,  one  of  the  most  affected  regions  of  the  brain  by the 
hypoxic insult,  showed the importance of the redoxins in  general,  it  is  desirable  to 
analyse more tissues and cell types for protein expression and distribution. It would be 
interesting  to  include  transgenic  animals  with  depleted  or  increased  expression  of 
redoxins  in  further  experiments,  analysing  them  for  susceptibility  to  hypoxia,  cell 
survival, regeneration and brain function, compared to wildtype animals.  
Renal  I/R  injury  constitutes  the  leading  cause  of  acute  renal  failure  and  has  been 
correlated to the progression and development of chronic kidney diseases (Weight et al. 
1996),  (Sutton et al. 2002). We believe that the differences in the physiological levels 
and  the  segment-specific  responses  to  the  I/R  insult  contribute  to  the  different 
susceptibilities  and  the  regeneration  of  distinct  cell  types  within  nephron segments. 
Grx2, Prx3 and Prx6 were shown to increase the cell number and decrease oxidative 
damage to the DNA in HeLa and HEK293 cells. However, there is no cell model which 
can mimic the conditions within a whole organ. Therefore it is essential to analyse the 
protective or even regenerative effects of the redoxins in an animal model. Again, it 
would be interesting to run studies on transgenic animals. For the first time, we have 
shown  that  Grx1  was  specifically  secreted  into  the  urine  following  the  I/R  insult. 
Further research, analysing Grx1 secretion in animal models and human patients might 
establish Grx1 as a potential biomarker for renal I/R injury.  
A similar secretion was detected in murine MIN6 cells for Trx1 following a hypoxic 
insult,  which  needs  to  be  confirmed  in  diabetic  animals,  analysing  serum samples, 
shortly after  transplantation.  At the same time the potential  extracellular  function in 
preventing the immune response should be confirmed and the mechanism analysed. 
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The diverse response of the cytosolic and the mitochondrial Trx system upon hypoxia/ 
reoxygenation has never been described in any model, upon any stimuli, before. It is 
essential to investigate the underlying mechanism, as well as the potential functions. 
We have seen that  the overexpression of  Trx1 and Trx2 initiated the anti-apoptotic 
signaling  pathways  and  inhibited  pro-apoptotic  pathways.  However,  simultaneous 
downregulation of Trx1 and upregulation of Trx2 should be included in further studies 
as well as the diverse condition. 
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